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Research linking executive succession and competitive advantage has produced 
inconsistent findings.  Definitive empirical evidence is not available to reconcile how 
executive leadership succession influences competitive advantage and more specifically 
whether organizational insiders or outsiders perform better.  Two significant concerns 
exist about the methods used to explore the executive succession–organizational 
performance phenomenon.  First, improved study designs are needed allowing for more 
robust causal inferences to be made about succession’s competitive impact.  Second, 
disagreements about competitive advantage’s measurement have contributed to 
inconsistent results.  This study suggests design improvements for executive succession–
organizational performance studies with an empirical example using a sample of U.S. 
hospitals.  Propensity score matching was used to simulate a randomized control trial 
with executive succession as the intervention.  Stochastic frontier estimation was used to 
measure organizations’ competitive performances before and after executive succession 
occurred.  The results provided empirical evidence from a simulated random sample 
indicating that change in leadership and specifically outside succession led to increased 
competitive capabilities.  In general, executive leadership changes led to increased 
competitive capabilities in this study and outsiders were able to close the performance 
gap faster in the sampled hospitals.  Insiders performed no better than the control group 
creating a relative reduction in gains to the frontier as compared to outsiders. 
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CHAPTER I 
 
INTRODUCTION 
 
 
Leadership changes are inevitable events occurring at all organizational levels 
(Westphal, 2009).  However, rarely does such organizational leadership change bear more 
significance than that of the Chief Executive Officer (CEO) on operational performance 
and business sustainability (Bower, 2007a).  CEO transitions are significant events for 
both internal and external organizational stakeholders.  Organizations’ strategic direction 
and competitive performance are impacted in the near- and long-terms by CEO 
transitions (Ballinger & Marcel, 2010; Zajac, 1988).  As such, CEO succession has given 
rise to a significant body of management theory literature and to large amounts of 
empirical research (Karaevli, 2007). 
Impending vacancy at the CEO level is a critical point for organizations where 
focus, motivation and direction are closely evaluated and subject to change (Pointer, 
2008). Overall organizational vision and strategy recedes, executive team work patterns 
and relationships are disrupted, and as key individuals begin to fret about what the future 
might hold, organizations can fall into a self-preservation mode with few, if any, new 
performance enhancement initiatives being undertaken (Boyne, James, John, & 
Petrovsky, 2011b).  CEO transitions also reduce efficiency when critical communications 
between stakeholders, governing bodies, and strategic operational units are lost (Pointer, 
2008). 
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Although an organization’s capacity to sustain improved performance over the 
near- and long-terms is highly dependent on CEO leadership, planning for transition of 
this top executive role is often deferred for other more immediate operational priorities. 
According to Bower (2007a), a CEO succession process is lacking in more than 60 
percent of all businesses combined.  A survey of CEO successions performed by Larcker 
and Miles (2010) found that the lack of CEO succession planning was attributable to the 
loss of focus on this invaluable process.  The researchers found that the investment in 
time and energy required by boards of directors and incumbent CEOs was simply 
inadequate to properly prepare for a transition of this magnitude. 
The succession process itself can also be disruptive to organizations if not well 
planned or implemented (Boyne, James, John, & Petrovsky, 2011a).  Passing the baton 
or handing over the reins of leadership can be a substantial source of stress for any 
organization (Behn, Dawley, R., & Yang, 2006).  Change at the upper-echelon of an 
organization without an immediately identifiable successor intensifies this stress and is 
often viewed as uncertainty and instability within the organization (Garman & Tyler, 
2007).  Historically, with large companies such as Apple (Ante & McGregor, 2009), IBM 
(Karaevli, 2007) and Bank of America (Farrell, 2009), succession uncertainty has 
impacted organizational performance negatively.  Conversely, organizations with 
succession at the core of their operational and strategic planning may be better suited to 
handle transition stressors.  These same organizations are also likely to be viewed more 
positively and have more public confidence when leadership change occurs (Garman & 
Tyler, 2007). 
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The decision to look inside or outside the organization for the next CEO can be 
the greatest challenge to successful leadership transition (Bower, 2007b).  Creating a pool 
of highly qualified candidates from which a new leader can be chosen is the first and 
most difficult step in the CEO transition process (Bower, 2007a).  With its identified 
relationship to organizational performance, CEO succession has given rise to a significant 
body of management theory literature and to large amounts of empirical research 
(Karaevli, 2007).  Karaevli (2007) examined five decades of empirical research from 
1954 through 2005 and found mixed results for CEO succession impact on organizational 
performance.  Leadership succession research has not achieved definitive, empirically 
based evidence as to whether succession events in general, and more specifically inside 
versus outside succession, affect organizational performance positively or negatively 
(Karaevli, 2007).  Lack of consistency in the literature limits inferences about the 
succession–performance relationship based on the CEO origin dichotomy of insider 
versus outsider. 
Statement of the Problem 
Despite its importance as a research topic, the CEO succession–organizational 
performance relationship continues to frustrate leading scholars because of the varied and 
conflicting findings (Finkelstein, Hambrick, & Canella, 2009; Karaevli, 2007; Kesner & 
Sebora, 1994).  Moreover, the lack of robust, longitudinal study designs that link CEO 
succession to organizational performance in a causal manner has hampered researchers’ 
ability to inform practice with evidence-based models that are linked to theory 
(Giambatista, Rowe, & Riaz, 2005; Pitcher, Chreim, & Kisfalvi, 2000; Powell, 2002). 
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There are two commonly employed research design features that make it difficult 
to draw causal inferences between the CEO succession–competitive performance 
phenomena (Powell, Lovallo, & Caringal, 2006).  The first relates to the way 
organizations and control groups are selected in executive succession studies.  Typically, 
organizations are selected based on the ease of identifying a leadership change (e.g. 
professional sports teams’ managers and Fortune 500 companies’ CEOs) rather than 
using quasi-experimental sampling designs.  In particular, identifying a sample set of 
organizations a priori and then looking for CEO succession events would be a closer 
approximation of a randomized control trial (RCT).  Approximating an RCT is the gold 
standard for demonstrating the causal effect of an intervention (e.g. executive 
succession’s impact on an organization’s competitive performance).  Without simulating 
experimental study designs, it is difficult to draw causal inferences that the results found 
in the study group(s) would hold true in the general population (external validity) and are 
not characteristics idiosyncratic to the sample used. 
The second issue involves measuring and analyzing the organization-performance 
construct in a manner that accurately reflects competitive advantage changes among 
organizations in the marketplace (Mahmood, Zhu, & Zajac, 2011) in general, and as a 
result of leadership changes in particular (Holcomb, Holmes, & Connelly, 2009). Many 
studies use organization-specific performance measures as proxies for competitive 
advantage that do not fully reflect the competitive advantage construct and lack internal 
validity (Pitcher et al., 2000).  Moreover, the analytic methods employed to assess 
organizations’ competitive performance do not reflect advantages per se, by identifying 
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organizations with resource conversion processes that lead to optimal efficiency, and then 
measuring how far competitors must move to achieve competitive results (Dutta, 
Narasimhan, & Rajiv, 2005; Mahmood et al., 2011).  In other words, most studies look at 
average rather than superior performance in the statistical algorithms employed. 
Therefore, a research design which: 1) has a sampling framework that simulates an RCT 
and 2) estimates the intervention-outcome relationship in a manner consistent with the 
theoretical descriptions of competitive advantage is needed to improve CEO succession–
organizational performance models’ ability to yield causal inferences and predictions. 
Healthcare as a Setting for Succession–Performance Relationship Research 
The U.S. healthcare industry is known for its constant and rapid change (Groves, 
2006), making it a prime research arena for study of the CEO succession–organizational 
performance relationship.  The industry epitomizes the essential nature of strong 
executive leadership during times of transition (McAlearney, 2010). Performance and 
quality can be directly linked to the stability of leadership at the highest levels of 
healthcare organizations.  Strong healthcare CEOs are crucial to bringing efficiency, 
quality and value together under one single guiding vision (McAlearney, 2008). 
According to Weil (2003), responding to the internal or external threats and opportunities 
inherent in the dynamics of healthcare systems necessitates a CEO who can reorganize 
and reframe teams around a common goal or strategy. 
Almost 20 percent of the gross domestic product (GDP) in the United States is 
consumed by healthcare spending (Goldfield, 2010). However, Hartzband (2008) asserts 
that it is a commonly held notion that the healthcare system in America is inefficient and 
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wasteful.  Huerta, Ford, Peterson, and Brigham (2008), relate poor quality across the 
entire healthcare system to inefficiencies that contribute to above average inflation for the 
sector when compared to the rest of the economy.  For healthcare facilities to remain 
economically solvent and for patients to receive the high quality services they deserve, 
healthcare executives must focus on improving health system performance and efficiency 
within the United States (U.S) (Garber & Skinner, 2008). 
According to Hartzband (2008), the overarching goal of improving healthcare in 
the U.S. is the enhancement of care quality and clinical outcomes.  Efficiency and 
productivity often drive many performance optimization and quality of care initiatives in 
U.S. hospitals (Rosko & Mutter, 2008).  Terms like pay for performance, value based 
purchasing and triple-aim are now commonplace in today’s healthcare environment 
stressing efficiency and doing more with less (Garber & Skinner, 2008).  As the 
prevalence and scope of such programs increase, so does the interest in the relationship 
between hospital efficiency and quality (Huerta, Thompson, & Ford, 2011) and the ability 
to maintain a competitive advantage over time in healthcare. 
Maintaining health system efficiency is essential to an organization’s ability to 
provide quality services while remaining competitive in an increasingly compressed 
healthcare marketplace (McAlearney, 2010).  In fact, under the recent pressures of 
healthcare reform, executives have the added responsibility of making these 
enhancements while creating value for the communities they serve (Huerta et al., 2011). 
Value is the product of efficiency and quality relative to comparable peer groups; 
especially those who are competitors within a shared marketplace (Huerta et al., 2008). 
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Creating something of high quality and value within any organization depends on 
the ability of its employees' to apply their collective knowledge and skills effectively 
(McAlearney, 2008).  This orchestration of knowledge and skill across a healthcare 
organization rests on the individual ultimately responsible for overall performance, the 
CEO (McAlearney, 2010) and decisions made by this individual can make or break the 
entire organization (Bower, 2007a).  Executive leadership of healthcare organizations is 
the foundation of strategic planning and vision necessary to provide many of the health 
system services targeted at quality patient outcomes and efficient care delivery 
(McAlearney, 2008).  CEOs maintain the global responsibility for efficiency and strategic 
vision in healthcare organizations (Groves, 2007).  They are significant community health 
system leaders and play formative roles in providing for the long-term success or failure 
of health services provision in their respective communities (McGuire & Kennerly, 
2006). 
Leaders who find new efficiencies and cost savings create revenue streams to 
support hospital initiatives that otherwise would not be possible (Scanlon, 2006). 
Improved performance and efficiency can increase profitability, decrease costs, improve 
resource utilization, improve market share, and provide for the expansion of care delivery 
systems (Skinner & Staiger, 2009).  Cost control efforts in healthcare have not always 
contributed to improved quality or increased value for patients and caregivers (Huerta et 
al., 2011).  In this regard, cutting costs to improve efficiency does not always improve 
quality or value within an organization or service.  This is particularly true with 
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 haphazard cost cutting that lacks strategic vision and leadership which can have 
significant effects over the long run. 
Stability and continuity of executive leadership is important because complexities 
and intricacies of health systems require significant knowledge that can only be gleaned 
through experience.  Change at the CEO level in healthcare organizations occurs at high 
rates with shorter tenures becoming the norm.  Healthcare needs stable leadership due to 
being constantly influenced by both internal and external turbulence (Garman & Tyler, 
2007).  Healthcare executives today are challenged more than ever to handle multiple, 
complex tasks while juggling competing priorities to the provision of efficient, high 
quality patient care (Stichler, 2006). 
Compounding this issue is the ‘talent war’ that currently entices skilled and highly 
competent healthcare leaders toward other organizations and industries, making this 
matter more dynamic for healthcare organizations (Collins & Collins, 2007).  Although it 
has decreased from 18 percent in 2009, CEO turnover for healthcare organizations in 
2010 and 2011 remained high at 16 percent (American College of Healthcare Executives 
[ACHE], 2012); higher than the world’s top 2,500 public companies at 12 percent 
(Favaro, Karlsson, & Neilson, 2010).  Additionally, the next decade guarantees to bring a 
considerable number of senior leaders in healthcare closer to retirement (Garman & 
Tyler, 2004). 
The healthcare industry as a whole has experienced tremendous reductions in its 
executive leadership pipeline because of the diminutive effects of recent cost constraints 
on middle management positions and leadership succession programs in hospitals 
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(Groves, 2006).  Lack of adequate research available despite its potential significance and 
future adaptability to other industries, further supports the need for research of the 
executive succession–organizational performance relationship within the healthcare 
industry (Groves, 2006).  Given the findings presented above, the U.S. healthcare system 
is the ideal setting for the study of executive succession–organizational performance 
relationships.  The abundance of executive change, the crucial nature of performance 
measurement, and the lack of competitive advantage research available make the 
healthcare industry ripe for this type of research. 
Purpose 
The purpose of this study was to describe and demonstrate an improved sampling 
design and analytic strategy for exploring the executive succession–organizational 
performance relationship that addresses limitations common in the literature to date.  
First, the threats to demonstrating a causal relationship between succession and 
performance that arise from natural experiments or convenience sampling strategies are 
presented in the review of literature.  Second, the issue of performance measurement and 
analysis of competitive advantage was discussed in terms of the Resource-based View 
(RBV) of the organization (Barney, 1991).  Third, an improved research study design that 
addresses each limitation was explored to address the CEO succession–organizational 
performance phenomena.  In particular, Propensity Score Matching (PSM, Arena, Ferris, 
& Unlu, 2011; Dehejia & Wahba, 2002) was used to identify a sample that approximates 
an RCT study design.  Stochastic Frontier Estimation (SFE, Dutta et al., 2005; Mahmood 
et al., 2011) was employed to identify those organizations with relative competitive 
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advantage positioning and then compare all other’s distance from that position.  Fourth, a 
study of insider versus outsider executive succession phenomenon’s impact on 
organizations’ competitive performances relative to organizations with no leadership 
change has been conducted.  The insider-outsider succession phenomenon’s impact on 
competitive advantage is a research area with inconsistent findings across numerous 
studies (Finkelstein & Hambrick, 1996; Karaevli, 2007; Zhang & Rajagopalan, 2010a). 
Finally, other domains have been identified where the new research design has the 
potential to increase theory-method congruence and the concomitant strengthening of 
causal inferences. 
Conceptual Framework 
Transformational leadership was used conceptually to guide this study and 
provide a framework for the impact that executive leadership can have on organizational 
performance.  Transformational leadership is well known and widely used within the 
healthcare community and is incorporated into leadership models developed by the 
American Organization of Nurse Executives (AONE), the National Center for Healthcare 
Leadership (NCHL) and the American Nurses Credentialing Center (ANCC) for its 
Magnet Recognition Program®.  Transformational leadership occurs when one or more 
individuals engage one another for the purpose of improving both leader and follower 
performance (Baker, 1992).  Transformational leaders stimulate followers towards new 
approaches to old problems and towards a renewed commitment of a shared vision and 
common goals (Bass & Riggio, 2006).  Boga and Ensari (2009) describe how complex 
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 this balance is for the transformational executive and the dynamic role senior leaders 
play during any change process. 
For more than 30 years, transformational leadership has been used by leadership 
researchers as a construct to characterize one’s ability to articulate a shared vision and 
motivate others towards that vision (Brown & Keeping, 2005).  Research clearly 
demonstrates that transformational leadership is generalizable across organizations (Bass 
& Avolio, 1990; Bass, 1997), cultures (Hartog, House, Hanges, Ruiz-Quintanilla, & 
Dorfman, 1999; Muenjohn & Armstrong, 2007), and populations (Bass, 1997) and is 
positively correlated with a wide range of organizational performance measures (Brown 
& Keeping, 2005).  For this reason, Spreitzer, Perttula, and Xin (2005), refer to 
transformational leadership as the new paradigm for understanding leadership. 
According to Brown and Keeping (2005), substantial investments have been made 
to identify relationships between transformational leadership and organizational 
performance.  In fact, leadership style has been directly linked to a leader’s influence on 
the magnitude of organizational change (Boga & Ensari, 2009); however, a significant 
appreciation for why these relationships exist is yet to be found (Brown & Keeping, 
2005).  Since its inception by Burns in 1978, transformational leadership has encouraged 
leaders and followers to achieve new levels of performance and motivation together. 
Transformational leaders have a unique way of creating enthusiasm around a shared 
vision and the ability to instill confidence in their followers to achieve collective goals 
(Baker, 1992). 
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Transformational healthcare executives have the responsibility to influence the 
quality and availability of organizational services offered (Boga & Ensari, 2009). 
Grasping transformational concepts can make healthcare executives well suited for the 
task by providing greater influence over organizational change and the individuals who 
provide these services (NCHL, 2005).  The CEO role in healthcare affords a unique 
position to motivate through passion and optimism while rallying the organizational 
resources to achieve strategic goals and positive patient outcomes.  Transformational 
leadership encourages investment in human capital and intellectual stimulation which 
contributes to a unified culture which thrives on personal growth and sustainable 
organizational success (Bass & Avolio, 1994).  The transformational organization 
remains focused on recruiting and retaining the right people for the role and culture; 
people who are engaged and ready to perform at their highest potential to be the most 
productive for the organization (Bass & Avolio, 1990). 
Transformational leadership guided the conceptualization of CEOs’ influence on 
healthcare organizational performance in this study.  Elements of transformational 
leadership provided insight into how leaders matter and ways executives can motivate 
followers toward necessary organizational performance improvements.  Key 
transformational leadership components can be used by healthcare executives to motivate 
and inspire followers towards change that more effectively and efficiently provides 
quality patient care with more positive outcomes.  This change compliments growth of 
the healthcare sector and promotes a work environment that uses all inputs efficiently, 
thus achieving optimum organizational performance. 
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Transformational leadership principles also help to emphasize the essential nature 
of clear and succinct succession planning for executive leadership positions in healthcare. 
Efforts by transformational leaders during transition create an environment of stability, 
openness and effective communication.  Transformational leadership principles support 
organizational transparency and the dissemination of vision and strategy to achieve 
collective goals.  Transparency and unified direction in transformational organizations 
can also serve to minimize disruptions when an executive leadership transition is 
imminent.  A further examination of transformational leadership and the rationale for its 
use conceptually to comprehend the impacts individual leaders can have on an 
organization are discussed in the review of literature. 
Specific Aims 
The specific aims of this study were to: 
1.  Examine the effectiveness of using Propensity Score Matching to simulate random 
sampling in an efficiency study of U.S. hospitals.  
Q1: Can Propensity Score Matching be effectively used to simulate random 
sampling of hospitals into control and intervention groups? 
2.  Examine the effectiveness of using cost efficiency production functions and Stochastic 
Frontier Estimation (SFE) techniques to estimate inefficiency in U.S. hospitals. 
Q2: Can hospital inefficiency in this sample be effectively estimated using cost 
efficiency and stochastic frontier functions as in Rosko and Mutter (2008)? 
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3.  Describe the differences in efficiency estimates based on change in CEO leadership 
and CEO succession origin in U.S. hospitals. 
Q3: Using the techniques of simulated random sampling and cost efficiency 
frontier estimates, does a change in CEO leadership and then CEO succession 
origin create a measurable efficiency difference among the sampled hospitals? 
Definitions 
This purpose of this study was to describe and demonstrate an improved sampling 
design and analytic strategy for exploring the executive succession–organizational 
performance relationship in the sampled organizations and to examine executive 
succession’s impact on organizations’ competitive performances with a specific focus on 
successor origin.  The terminology used throughout this study predominately follows that 
given in Rosko and Mutter (2008).  Exceptions to this are defined below.  Metrics and 
variables used in this secondary data analysis, other than those created for the purposes of 
this study, are defined within the 2005 AHA Annual Survey of Hospitals (American 
Hospital Association, 2005) hereafter referred to as “AHA Annual Survey”. 
1.  Allocative efficiency: The use of inputs and their optimization based on demand for a 
product.  Allocative efficiency occurs when production is maximized according to 
consumer preferences.  An organization can be technically efficient at producing goods or 
services no one wants.  Allocative and technical efficiency together determine 
organizations’ cost efficiency.  Cost efficiency functions were used in this study to 
determine a competitive advantage frontier of sampled organizations. 
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2.  Cost efficiency: Also known as economic efficiency and is the combination of 
allocative and technical efficiency which describes the actual costs of production based 
on market price and technology available.  As a result, an organization could be 
technically and/or allocatively efficient but at a cost to the bottom line that is no longer 
market competitive.  Cost efficiency functions were used in this study to determine a 
competitive advantage frontier of sampled organizations. 
3.  Competitive advantage: A strategic advantage which one organization has over 
another within its competitive industry.  Organizations with the ability to generate greater 
value over its rival entities by offering lower prices or by providing superior products and 
services are said to have competitive advantage.  Competitive advantage can also occur 
when an organization is perceived by its target consumers as better than other 
organizations in the marketplace.  Competitive advantage helps to ensure survival and  
prominent market positioning.  It is often considered a key determinant of exceptional 
organizational performance.  Frontier analysis techniques were used in this study to 
operationalize competitive advantage. 
4.  Dynamic efficiency: The use of new technologies and work practices to improve 
efficiency over time.  Dynamic efficiency focuses on research, development and 
innovation and has the ability to quickly adapt to changing conditions.  Dynamic 
efficiency is used conceptually to describe efficiencies sustained or lost over time with 
panel data in this study. 
5.  Propensity score matching (PSM): The conditional probability of assignment to a 
treatment or control group given a vector of observable, pre-treatment covariates.  The 
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use of PSM techniques can assist the researcher in correcting for sample selection bias 
when random sampling is not practical or was not performed in the case of existing data.  
When relevant differences between any two units are captured pre- treatment and used to 
assign a sample to particular treatment group, PSM techniques yield an unbiased estimate 
of the treatment impact.  In this study, PSM techniques were utilized to identify a sample 
that approximates an RCT study design. 
6.  Resource-based view (RBV): Describes the strategic relationship between key 
production resources and competitive advantage.  The fundamental principle of the RBV 
is that competitive advantage of an organization is reliant on its application of available 
resources to organizational processes.  Emphasizing strategic choice, this business 
management tool tasks organizational leadership to maximize returns by identifying, 
developing and deploying valuable resources.  The RBV is used conceptually to aid in the 
competitive performance determination of sampled organizations. 
7.  Stochastic frontier estimation (SFE): The estimation procedure used to determine an 
efficiency frontier for a particular sample.  Organizations operating on or near the 
efficiency frontier are labeled as efficient, and organizations operating beneath their 
efficiency frontier are labeled as inefficient.  Frontier estimates can assume the form of a 
production frontier measuring technical inefficiency or a cost frontier measuring cost 
inefficiency.  The error terms in the stochastic frontier model take the form of a normal 
error term representing random variation in the operating environment and a newer, non-
negative error term which represents various types of inefficiency.  In this study, SFE 
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techniques were employed to estimate a competitive performance frontier by which to 
measure all organizations’ distance from. 
8.  Sustained competitive advantage: A competitive advantage that is maintained over an 
extended period of time.  Frontier analysis techniques were used to describe competitive 
advantage sustained or lost over time with panel data in this study. 
9.  Technical efficiency: The effectiveness with which an organization maximizes 
production with a minimum amount of inputs.  Technical efficiency relies heavily on the 
organization’s production processes, control systems and management of human and 
capital resources.  Technical and allocative efficiency together determine organizations’ 
cost efficiency.  Cost efficiency functions were used in this study to determine a 
competitive advantage frontier of sampled organizations. 
10.  Total factor productivity (TFP): The portion of output not explained by the amount of 
inputs used in production.  Growth in TFP represents output growth not accounted for by 
the growth in inputs. 
Assumptions 
This study is a secondary analysis of data collected by the AHA Annual Survey 
and is limited to that sample.  Results generated from this study may not be generalizable 
to hospitals with characteristics that fall outside of the sample utilized.  Further, 
generalizability could be assured through additional research that broadens this sample.  
Responses received from the participants in that survey were believed to be representative 
of the sample and accurately reflect the data available within their organization at the 
time collected.  Respondents were also believed to have completed the survey tools 
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accurately with truthful disclosure to the best of their ability.  Additionally, because recall 
bias cannot be controlled for in secondary analysis, these biases, if they exist, will have 
entered this dataset to the same extent that they are present in the AHA Annual Survey 
responses. 
Summary 
The purpose of this study was to describe and demonstrate an improved sampling 
design and analytic strategy for exploring the executive succession–organizational 
performance relationship that addresses limitations common in the literature to date.  This 
improved research study design was employed with a sampling of U.S. hospitals to 
analyze the CEO succession–organizational performance phenomena.  The culmination 
of this study was a quasi-experimental panel study of insider versus outsider executive 
successions and their impact on organizations’ competitive performances relative to 
organizations with no leadership change.  The concept of transformational leadership was 
used as a framework to guide this study and to emphasize the influence executive 
leadership has on organizational performance. 
Measurement of the insider-outsider succession’s impact on competitive 
advantage has thus far been scientifically inconclusive across multiple disciplines. 
Continued failure of researchers to address the lack of empirical evidence and to improve 
research designs and analytic inferences related to this phenomenon was problematic. 
Therefore, a study was needed to fill these empirical knowledge gaps.  This study adds to 
the works of Karaevli (2007; 2011) and others by seeking to understand these unique 
associations in the context of U.S. hospitals.  Other domains have also been identified 
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where the new research design has the potential to increase empirical evidence and 
strengthen causal inferences. 
The next chapter presents a thorough examination of current literature from both 
the leadership succession and organizational performance domains.  Threats to 
determining a causal relationship between succession and performance are presented in 
the review.  Issues of performance measurement and analysis of competitive advantage 
which arise from natural experiments or convenience sampling strategies are examined. 
Chapter three details the quasi-experimental, panel study design and data analysis 
conducted.  The chapter describes methods used to identify a sample that approximates 
an RCT study design and those used to estimate organizations’ competitive positions 
relative to each other.  A study of insider versus outsider executive succession impact on 
these competitive positions relative to organizations with no leadership change was 
conducted to further current empirical evidence on the subject. 
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CHAPTER II 
 
LITERATURE REVIEW 
 
 
Chapter two examines the theoretical underpinnings of leadership succession and 
organizational performance literature.  The chapter begins with a synopsis of the 
theoretical views on leadership succession and their historical uses.  The chapter 
continues with a review of current literature related to succession planning and 
succession origin and then more specifically evaluates research exploring relationships 
between organizational performance and CEO succession events.  Finally, the chapter 
concludes by describing and detailing organizational performance measurement 
techniques and their uses in previous works with competitive advantage and the 
succession–performance relationship. 
A wide body of literatures describes leadership succession including pre- 
succession planning and the circumstances leading up to the succession event, as well as 
post-succession performance of both the candidate selected and the organization where 
the succession event occurred (Giambatista et al., 2005).  Multiple disciplines have 
studied leadership succession over the last several decades including athletics, business, 
education, medicine, nursing, psychology and sociology.  In fact, much of the literature 
agrees on the importance of leadership succession planning at all levels and in all 
industries; however, a comprehensive theoretical or conceptual framework for 
successfully implementing leadership succession and for evaluating the organizational  
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performance impact remains elusive.  This review helped to identify any relevant gaps in 
the literature related to executive succession and organizational performance. 
Before beginning this review, leadership succession was distinguished from 
similar terms used interchangeably in the literature.  Searches of several commonly 
available online sources revealed separate distinct meanings and definitions for the 
following:  career development, career planning, leadership development, mentoring, 
succession, succession planning, and talent management.  Despite frequent examples of 
their use interchangeably by authors in both the business and healthcare domains 
(Carriere, Muise, Cummings, & Newburn-Cook, 2009), it is important to understand that 
a distinction between leadership succession and these other terms does exist and their 
differences were not confused in this study.  Previous conceptual confusions such as these 
have created incongruence when comparing and synthesizing the leadership succession 
literature (Carriere et al., 2009). 
Current Theoretical Views on Leadership Succession 
Several theories and constructs have been used in the past half century to guide 
leadership succession research such as: Agency Theory (Zhang, 2005), Strategic 
Contingency Theory (Boyne et al., 2011a, 2011b; Westphal, 2009), Social Network 
Theory (Cao, Maruping, & Takeuchi, 2006; Phan & Lee, 1995), Human Capital Theory 
(Phan & Lee, 1995; Zhang, 2005), Resource Dependence Theory (Pfeffer & Salancik, 
1979), Organizational Learning Theory (Feng & Jeng, 2006; Rowe, Cannella, Rankin, & 
Gorman, 2005; Zhang & Rajagopalan, 2004) and Upper Echelon Theory (Hambrick & 
Mason, 1984; Karaevli, 2007).  Despite their previous usage, none of these theories or 
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constructs clearly stands out as a comprehensive guide in the complex relationship 
between executive succession and organizational performance (Carriere et al., 2009). 
 Appendix A summarizes the theories and constructs recently used in the 
succession–performance literature and their implications for future research.  While not 
an all-inclusive list, these and other leadership theories have important implications for 
the executive succession–organizational performance phenomenon and may offer 
promise for emerging research.  The aim of this study was to build upon existing 
theoretical works and fill several knowledge gaps in the succession–performance 
literature.  The balance of this section summarizes findings from several comprehensive 
reviews of the leadership succession literature. 
At the time of their review, much of the leadership succession research uncovered 
by Giambatista et al. (2005) was lacking a strong theoretical foundation.  Their work 
encouraged scholars to view future empirical succession research through alternative 
theoretical lenses in hopes of building upon existing succession theory.  Although 
Giambatista et al. (2005) were less optimistic than others about a predominant leadership 
succession theory, they cited opportunities which exist for researchers to overcome this 
serious theoretical weakness and better assimilate succession knowledge. 
Giambatista et al. (2005) specifically evaluated progress made by researchers 
from 1994 to 2004 relative to consequences of and precursors to executive succession. 
This work built upon the previous 1994 review by Kesner and Sebora who summarized 
rapid growth in the leadership succession field and attempted to develop guidance for 
future succession scholarship.  In both reviews, the authors highlighted the fragmented 
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(Giambatista et al., 2005) and often “chaotic” (Kesner & Sebora, 1994, p. 327) bodies of 
work that exist in the leadership succession literature.  The dissonance is primarily a 
result of the widely diverse disciplines studying the phenomenon.  The differing 
approaches do provide a means to enrich current theoretical understandings. However, 
much of the succession research in the current literature remains largely atheoretical or 
only provides a perfunctory review of the three well-known succession constructs 
described in the next section (Giambatista et al., 2005). 
According to Giambatista et al. (2005), the leadership succession–organizational 
performance literature has moved forward substantially since Kesner and Sebora (1994) 
although significant opportunities still exist in theoretical underpinnings and 
methodological rigor.  The interest in studying leadership succession in healthcare is 
much like that summarized by Giambatista et al. (2005) and has led to this study’s focus. 
First, leadership succession is a critical, and at times traumatic, event that affects 
stakeholders at every level of the organization.  Second, succession is the opportunity for 
scholars to study the quintessential leadership question of whether or not leadership 
matters.  Finally, according to Giambatista et al. (2005), leadership succession is ideal for 
study since the events surrounding succession are clearly defined and the effects are 
rather apparent throughout the process. 
Giambatista et al. (2005) identified and stressed the need for experimental and 
quasi-experimental designs to establish and test causality in the succession–performance 
relationship.  They also called for researchers to design longitudinal studies that address 
issues of time and performance over the long term rather than simple, short-term pre- and 
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post-succession performance comparisons.  Citing the challenges with establishing 
causality, Giambatista et al. (2005) suggested further exploration and qualitative study of 
the leadership succession phenomenon which would complement the existing quantitative 
analyses of large samples available today. 
One of the most comprehensive reviews of the succession–performance literature 
conducted across multiple industries, was performed by Karaevli in 2007.  Karaevli 
(2007) examined five decades of empirical research from 1954 through 2005 and found 
that no previous research had identified and tested a complete theoretical framework of 
the leadership succession–organizational performance relationship.  This work was an 
attempt to overcome previous inconsistent findings in the literature and to provide new 
empirical findings never realized before in the succession–performance field.  Guided by 
the Upper Echelon Theory of Hambrick and Mason (1984), Karaevli (2007) aimed to 
develop and test a detailed theoretical framework that would allow for more accurate 
predictions of leadership succession effects on organizational performance. No studies to 
date have successfully produced a theoretical model of the pre- and post- succession 
factors of CEO transition and even more specifically as they relate to CEO succession 
origin.  Karaevli (2007) contended that these theoretical conceptualizations were essential 
to establishing predictions of organizational performance associations based on CEO 
origins. 
Another extensive review conducted by Garman and Glawe (2004) of succession 
literature over a ten year period from 1993 to 2003 had similar findings.  The authors also 
concluded that a single theoretical model has yet to dominate the leadership succession 
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arena despite the broad and far-reaching research available within the literature.  Lewis 
and Heckman (2006) identified succession practices in their review that remained quite 
fluid and unguided by concepts or theory, a conclusion similar to the 2004 and 2007 
reviews by Garman and Glawe and by Karaevli respectively. 
Individual Succession Impact and Transformational Leadership 
Although a significant area of research interest in strategic leadership for some 
time (Rowe et al., 2005), the impact of leader succession on organizational performance 
has yielded a history of inconsistent findings and conflicting theories (McKee & Driscoll, 
2008).  A significant factor contributing to the absence of a guiding framework for 
leadership succession is the ongoing debate over a single individuals’ impact on overall 
organizational performance.  According to Rowe et al. (2005), leadership succession 
research provides two contrary perspectives that continue to confound the underlying 
premise of leadership succession’s impact. 
The first of these two perspectives implies that a single, high-level executive 
leadership succession does affect an organization’s performance either positively or 
negatively and leaders do matter (Rowe et al., 2005). The second approach conversely 
suggests that the same high-level executive succession does not affect an organization’s 
performance, meaning that leaders do not matter (Rowe et al., 2005).  In other words, it is 
the leadership changes and/or some other unique characteristics of the organization that 
affects performance. 
The early debate over leadership impact on organizational performance and the 
pursuit of an explanatory effect framework for such impact coined these three terms: 
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vicious-circle (Grusky, 1960), common-sense (Grusky, 1963) and ritual scapegoating 
(Gamson & Scotch, 1964).  These paradigms originated from the interpretation of 
succession events in baseball and the underlying premises presented above.  Grusky 
(1960, 1961) is lauded by many for his pioneering work on the conceptual understanding 
of the impact on organizational performance provided by an individual’s leadership 
ability (Rowe et al., 2005).  He contended that leadership succession was significant to 
organizations because of its universality and the need for all organizations to effectively 
manage it as well as its relationship to the stability achieved within when handled 
successfully. 
Vicious-Circle 
The vicious-circle concept introduced by Grusky in 1960 characterized succession 
as disruptive because of the changes throughout the organization to relationships, 
tradition, policies and practices.  He proposed through this theory that while initial 
decline in performance leads to succession, the disruptive nature of succession leads to 
further decline and the perceived need for further succession.  This early work by Grusky 
(1960) did acknowledge a positive side of the disruptive and destabilizing forces to the 
status quo; however, this vicious-circle and the subsequent conflict ultimately resulted in 
a reduced cohesiveness and organizational ineffectiveness. 
Common-Sense 
To further his work and to support the positive effects of succession, Grusky 
(1963) later introduced the common-sense concept to explain the influence leadership 
change can have on performance improvement.  In this theory, he suggested poor 
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organizational performance and decreased efficiency leads to succession but a good 
leader can turn this around and improve subsequent performance.  According to 
Giambatista et al. (2005), this explanation of succession and leadership change recognizes 
the performance gains realized from choosing the right successor, replacing a failing 
incumbent and capitalizing on a successor’s new outlook and enthusiasm.  Both of 
Grusky’s theories help to support the notion that leaders do affect organizational 
performance and the choice of successor does matter (Rowe et al., 2005). 
Ritual Scapegoating 
The contrary is represented by the third concept of ritual scapegoating submitted 
by Gamson and Scotch (1964) which argues that leaders do not affect organizational 
performance and therefore do not matter because succession occurs merely to express a 
known need for change and to symbolize change is imminent.  Gamson and Scotch 
(1964) do argue with Grusky (1960) that poor performance precedes succession but that 
leadership replacement is sacrificial in nature and a means to appease stakeholders with 
minimal true expectations of the chosen successor to improve performance (Giambatista 
et al., 2005). 
Giambatista et al. (2005) questioned the quality of these three early theories and 
their applicability in today’s research.  They insisted that these concepts, although 
fundamental to our understanding of leader succession impact, fail to answer the when 
(sustainability) and the why (causality) of the succession-performance relationship. 
Giambatista et al. (2005) stressed the need to move beyond these three traditional theories 
and expand on our empirical knowledge of leader succession and its organizational 
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performance impacts.  According to them, the questions posed by the three theories 
already have answers, and attempts to prove one of the theories superior to the others is a 
futile quest not needed in future leadership succession research.  The ability of future 
empirical research to demonstrate a sustained, causal relationship between individual 
leaders and their organizational performance over time will prove more worthwhile 
(Giambatista et al., 2005). 
The findings provided by Rowe et al. (2005) support the thinking that leaders do 
affect organizational decisions impacting performance and leaders chosen do matter 
significantly.  Bertrand and Schoar (2003) also examined this leadership succession 
dilemma in depth and found similar results of leadership influence across a range of 
organizational factors.  Their findings indicated that senior executives alone did have 
influence over policy, strategy, and other performance measures and that this influence 
was persistent over time.  Giambatista et al. (2005) found that much of the strategic 
management theory and research maintains the assumption that leaders’ actions do matter 
to the performance outcomes of their organizations.  They, too, encourage longitudinal 
designs by scholars to better support these assumptions in future studies. 
Transformational Leadership 
Differing perspectives on leadership impact (Boyne et al., 2011a) such as those 
presented above make the development of a succinct framework for leadership 
succession and organizational performance complex.  In light of this known controversy 
and available analysis of the two different perspectives above, this study was guided by 
an existing conceptual framework that is most closely aligned with the former, that 
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leaders do affect followers and therefore organizational outcomes.  As outlined in the 
first chapter, this study was framed conceptually using transformational leadership to 
highlight the significance of motivation, stimulation, engagement and encouragement 
among leader and follower to promote organizational performance. 
Transformational leadership is characterized by a leader’s ability to influence 
others and motivate them collectively towards a common goal (Colbert, Kristof-Brown, 
Bradley, & Barrick, 2008).  Transformational leadership expands on the common sense 
approach of Grusky (1963) by highlighting the change that has occurred for the better in 
both leader and follower, not just the change in the organization’s performance.  In direct 
contrast to transformational leadership, the latter perspective that leaders do not matter 
implies that a leader’s abilities and relationships with individuals carry little significance 
in the strategic course of an organization and its ability to perform optimally.  Although 
not professed by some as the ostensible leadership style (Jennings, Disch, & Senn, 2008), 
transformational leadership does have merit as evidenced by its support described in the 
previous chapter and provides a solid framework of leadership influence to guide this 
research. 
Transformational leadership was first introduced in 1978 in a book entitled 
Leadership written by J. M. Burns.  In his book, Burns (1978) initially characterized 
transformational leadership by the impact of change on a follower’s behavior.  The 
experience allows growth in the follower as their needs are met and new needs, beliefs, 
and values begin to emerge.  Growth and development as a result of the process enables 
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followers to become leaders.  According to Burns (1978), leaders also grow as a result of 
the transformation process. 
Bass (1985) applied Burns’ (1978) concepts to create a formal organizational 
management model of transformational leadership.  In his book, Leadership Performance 
beyond Expectations, Bass (1985) suggests that leaders using this model transform the 
entire culture of their organization.  This occurs through the engagement of followers and 
by raising awareness of significant issues threatening the organization’s vision and 
values.  Engaged followers can include subordinates, clients, or colleagues who assist the 
leader in conducting mutually satisfying ambitions.  An organization employing 
transformational strategies is focused on the evolution of employees and improving their 
performance over time rather than a transactional approach to an end result or an 
expected return (Bono & Judge, 2004). 
Bass (1985) compared a transformational culture to that of one merely 
transactional and found transactional organization to be predominantly focused on short- 
term initiatives to improve performance and the motivation of individuals through 
personal gain.  As suggested, a transformational culture does not rely on an exchange of 
commodities or a formal reward or incentive program (Bass, 1985).  A transformational 
leadership culture surpasses incentivizing followers for desired performance but rather 
develops and inspires them to rise above their own interests for a higher shared purpose 
or goal (Bass & Avolio, 1994).  The reward or incentive in transformational leadership is 
the individual growth and development of the follower during the change process (Bass 
& Avolio, 1990). 
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From Theory to Practice - Succession Planning in Healthcare 
According to McAlearney (2010), leadership succession and development 
practices vary widely across healthcare organizations and there is little guiding evidence 
that validates program content or evaluates program effectiveness.  He also insists that 
these practices are essential to maintaining a strong and capable health system leadership 
team with the skills and knowledge necessary to affect organizational performance 
(McAlearney, 2010).  A recent review of these practices by Silzer and Church (2009) 
indicated that today’s leadership teams and their organizations have significant pressure 
to define and identify potential internal and external talent as well as ensuring that 
practical and effective measures are in place to attract and retain them both. 
Well-known authors in the field of leadership succession suggest modeling the 
achievements made by the business sector to develop frameworks that guide succession 
planning best-practices (Rothwell, 2002a).  According to Carriere et al. (2009), further 
research efforts are needed in healthcare to build a framework that provides consistency 
and optimal efficiency for healthcare organizations and satisfaction for both employees 
and patients.  The authors insist that a uniform theoretical framework for healthcare 
organizations to guide successful succession planning and implementation will ensure 
effective leadership transitions that support both the objectives of the organization and 
individual employees (Carriere et al., 2009).  The absence of a succinct healthcare 
succession framework based in evidence and best practices and the lack of concept clarity 
result in succession practices that are inconsistent and ineffective. 
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Succession planning is a structured process necessary to identify and prepare 
individuals to assume vacancies which occur within an organization (Carriere et al., 
2009). It is an organized, well-planned strategy that ensures qualified candidates are 
matched with appropriate roles suited for their level of knowledge, skills and abilities 
(Bonczek & Woodard, 2006).  According to McAlearney (2010), succession planning 
should be uniquely tailored in such a way to support the strategic vision and mission 
objectives of the organization.  Numerous sources in the literature have long recognized 
succession planning as an essential business strategy providing excellent returns on an 
organization’s investment (Bolton & Roy, 2004; Bonczek & Woodard, 2006; Bower, 
2007b; Carriere et al., 2009; Evans, 2008; Larcker & Miles, 2010; Wolf, Bradle & 
Nelson, 2005). 
With a recent and rapid ascent to the forefront of healthcare strategic initiatives, 
succession planning is paramount today due to challenges in the industry such as: 
increased market competition, workforce supply and demand issues, and less than 
optimal reimbursements (Carriere et al., 2009).  These same challenges have 
simultaneously diverted much attention and focus away from succession planning and 
towards daily operational goals.  According to Evans (2008), hospitals and health systems 
have failed to prepare future executives to fill top-level vacancies.  He contends that 
hospitals lack focus in the preparation, training and tracking of future leaders with the 
potential to succeed (Evans, 2008). 
Selecting a new CEO is critical to an organization’s performance and strategic 
direction (Karaevli, 2007).  However, as previously discussed, the practice of well 
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developed succession planning has yet to receive adequate attention in healthcare 
organizations (Thompson, 2008).  When compared to other industries or sectors, U.S. 
hospitals have a less-than-flattering record on their evaluation and preparation of 
potential top executives and their ability to cultivate employees with leadership 
potential (Garman & Tyler, 2007).  In a 2004 study, a mere 17 percent of U.S. hospitals 
had identified their next CEO compared to 60 percent in the business sector (Garman & 
Tyler, 2004).  Furthermore, ACHE (2012) reports that two of every five corporate 
CEOs new to their role fail in the first 18 months. 
Further study of the literature reveals what Sinnott (2008) describes as “the 
healthcare crisis nobody talks about” in his article by the same name.  The ‘crisis’ he and 
Garman and Tyler (2004) describe is that over half of healthcare organizations surveyed 
admitted to having no succession plan at all to replace their top executive.  Put into 
context by Garman and Tyler (2004), this trend among U.S. hospitals is 20 percent 
higher than that of other industries.  Recent works from organizations such as the ACHE 
(Garman & Tyler, 2007), The Governance Institute (Gordon & Shields, 2012) and The 
National Center for Healthcare Leadership (NCHL, 2005) also illustrate executive 
succession planning deficiencies in healthcare.  They estimate no more than 20 to 25 
percent of hospitals currently have an active CEO succession plan in place should the 
need arise.  Bonczek and Woodard (2006) assert that this lack of preparation for 
leadership succession puts care philosophies, strategic initiatives and workforce 
development in jeopardy for the future of many healthcare organizations.  Weil (2006) 
identified in his report that when a successor to the top job was identified, succession 
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planning was three times as likely to be routinely conducted for other key positions 
within the hospital. 
The healthcare industry is known for constant and rapid change, highlighting the 
need for strong executive leadership (McAlearney, 2010) and the fertile ground the 
industry provides when studying talent management and succession processes (Groves, 
2006).  The industry has experienced extensive cuts at the middle-management level in 
order to control costs and these cuts have decreased what was once a valuable pool of 
candidates with a wealth of workforce experiences to pull from (Groves, 2006).  
Corporate longevity relies heavily on an effective succession program according to 
Collins and Collins (2007) and yet succession planning still has not taken priority over 
operations as an important strategic initiative for most hospitals (Garman & Tyler, 2004). 
Collins and Collins (2007) argue that the shortage of proven healthcare leaders means 
succession planning is more than just prudent but rather it is necessary for the survival of 
most healthcare organizations.  However, according to Garman and Tyler (2007), 38 
percent of America’s hospital CEOs believed their organizations approaches to 
succession planning remain ineffective. 
Organizational Management of Leadership Succession 
Operational succession programs, when in place, can allow for seamless 
leadership turnover (Bonczek & Woodard, 2006).  However, many organizations struggle 
in the management of this crucial organizational event despite its importance to lasting 
success and prosperity (Bower, 2007a).  According to Rothwell (2010a), implementation 
challenges are responsible for long-term failure in approximately 70 percent of all 
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succession planning efforts.  Larcker and Miles (2010) suggest that succession programs 
today provide a false sense of security for most companies and are not nearly adequate. 
Results of their survey of 140 CEOs and board members indicated that critical lapses 
exist at some of the largest public and private corporations in their succession planning 
programs (Larcker & Miles, 2010).  Their results revealed that almost 40 percent of CEO 
respondents indicated that they were without any qualified internal candidates.  These 
succession planning lapses, Larcker and Miles (2010) contend, are serious threats to 
corporate health and longevity and can have ruinous effects on companies who are not 
prepared. 
Bower (2007a) indicates that organizations who poorly manage succession 
and the individuals who may be potential candidates for the top job are likely to do so 
because the organizations are simply poorly managed altogether.  Lack of succession 
planning may be indicative of other, more serious problems within organizations like 
poor strategic development or poor resource utilization which further contribute to 
perceptions of instability and uncertainty for the future (Bower, 2007a).  A tunnel 
vision focus on day-to-day operational needs poses a severe threat to long-term 
organizational health.  Organizations without a truly operational succession plan can 
be left vulnerable, placing them at grave risk for devaluation in the marketplace, 
regulatory liabilities or damage to their public appeal (Bower, 2007b). 
Ready and Conger (2007) found that 97 percent of organizations surveyed 
reported having a formalized leadership succession and development program.  However, 
just three percent of these same organizations reported being satisfied with their available 
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leadership talent should the need arise to replace their CEO. Therefore, the effectiveness 
of such a program to produce highly qualified and prepared leadership talent was not 
believed to be adequate even though a formalized program did exist (Ready & Conger, 
2007).  Collins and Collins (2007) insist that most organizations still have limited 
knowledge of where to begin in the development of an effective succession planning 
program notwithstanding its crucial value to long-term success of an organization. 
Garman and Tyler (2007) found that newness of their CEOs was most often mentioned as 
a barrier to actively practicing succession planning while its lack of usefulness was least 
often mentioned.  According to Bower (2007a), best practice organizations began the 
process with the new CEO within the first year of their installment. 
According to Groves (2007), many organizations confuse replacement planning 
with effective, strategic succession planning.  Replacement planning is a concept 
frequently identified in the literature and describes a narrow focus on the identification of 
a second in command or back-up plan for an executive leadership position (Groves, 
2007).  This process of merely filling a vacancy with any available internal candidate 
when the vacancy is imminent or has recently occurred can have serious consequences 
for any organization (Rothwell, 2010a).  A reactive or aloof approach that is not well 
thought out nor thoroughly explored for alternative options should never be a substitute 
for the proactive, thoughtful replacement of a leadership position (Groves, 2007). 
Experts contend that long-term, comprehensive planning allows for better 
alignment of leadership competencies and organizational strategy than vacancy-by- 
vacancy, replacement-type planning ever will (Rothwell, 2010b).  Groves (2007) 
37 
 
highlights the need for a pipeline of talent that results from comprehensive external 
assessment and internal development practices across the organization and recognizes 
organizations such as Bank of America, Colgate-Palmolive, Dow Chemical, Eli Lilly and 
Sonoco Products for their long-term approach to succession planning, avoiding near- 
sighted replacement planning throughout their organizations.  These organizations, 
according to Groves (2007) have focused on developing the role of leadership in their 
respective organizations rather than simply developing individual leaders, ending any 
reliance they may have had on replacement planning for existing leaders. 
CEO Succession and Turnover 
Leadership succession can be an intense, anxiety producing time for many 
employees when familiar organizational cultures, standards and philosophies are 
vulnerable to change and previous practices or policies are at risk (Bonczek & Woodard, 
2006).  For most organizations, whether expected or unexpected, CEO vacancy 
heightens anxiety and presents a challenging time in an organization’s history (Pointer, 
2008). Purposeful CEO succession planning facilitates smooth leadership turnover and 
diminishes disruption in organizational performance and employee well-being (Bonczek 
& Woodard, 2006).  Succession planning for the top job should not be disruptive to the 
organization, its employees or the current CEO (Pointer, 2008).  Bass (1985), with his 
decades earlier work in transformational leadership, understood this concept and 
asserted that organizations engaging in proper leadership succession planning which 
included clear communication of expectations for all parties involved, could avoid the 
disruptive consequences of leadership turnover. 
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Providing strong executive leadership has no shortcuts (Lucier, Schuyt, & Tse, 
2005) and the development of an effective CEO succession plan is vital to corporate 
stability and longevity (Collins & Collins, 2007). The process of CEO succession alone 
is not overly challenging and no particular step in the process is any more difficult than 
the other (Larcker & Miles, 2010).  The absence of a plan or the lack of a systematic, easy 
to understand process is what results in CEO succession failure and unnecessary CEO 
turnover (Groves, 2007).  Costs of this failure, both direct and indirect, can be astonishing 
and significantly impact any organization (Sinnott, 2008). 
Direct costs and fees to an organization associated with replacing a CEO can 
include things like severance payouts, recruitment expenses and salary increases for the 
successor.  According to Sinnott (2008), the direct cost alone for turnover can debt an 
organization nearly two to three times the incumbent CEO’s salary.  Indirect costs of 
CEO turnover often refer to productivity losses as a result of organizational slowdown 
during transition or periods of uncertainty.  These costs, although much more difficult to 
estimate, are often considered greater than the direct costs of turnover and their impacts 
are often felt for many years (Zhang & Rajagopalan, 2004).  Strategic development and 
planning for new services is most significantly impacted during CEO turnover (Sinnott, 
2008).  New initiatives are often postponed or terminated upon CEO departure and if 
reinstituted, are likely to get a new strategic direction with any successor (Lucier et al., 
2005).  The toll is also felt when employees are pulled from other areas or other 
operational duties to modify, dismantle or develop new strategic initiatives after turnover 
has occurred (Sinnott, 2008). 
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In many cases, other senior leaders follow the CEO out of the organization 
(Sinnott, 2008).  Chief Financial Officers (CFOs), Chief Operating Officers (COOs) and 
other vice-presidents are likely to leave within a year after the new CEO arrives (Shen & 
Cannella, 2002), which further adds to direct and indirect turnover costs (Sinnott, 2008).   
This phenomenon was also identified by Khaliq, Walston and Thompson (2006) when 
hospital CEOs they surveyed reported high percentages of senior executives leaving the 
organization within one year of the departure of their predecessor. 
The problem of CEO turnover is nothing new for corporate America given the 
quick fix or turnaround agent mentality of the recent past (Zhang & Rajagopalan, 2010a). 
When Fortune 500 companies begin to falter or lose money, the incumbent CEO is often 
moved out and replaced by a star performer (Davis & Nosal, 2009).  While this is the way 
other U.S. industries have gone, it is dangerous territory for healthcare in light of the dire 
situation of the current healthcare leadership pipeline discussed in previous sections 
(Sinnott, 2008).  With a shortage of qualified executive leaders in healthcare and the 
current struggle for leadership talent across multiple industries, excess CEO turnover and 
poor succession planning has the potential to be very disastrous (Collins & Collins, 
2007). 
Healthcare CEO turnover data is a good indicator that CEO succession has failed 
at many healthcare organizations (Khaliq et al., 2006).  Although it has decreased from 
18 percent in 2009, CEO turnover for healthcare organizations in 2010 and 2011 has 
remained high at 16 percent (ACHE, 2012), which is higher than that of the world’s top 
2,500 publicly traded companies at 12 percent (Favaro, Karlsson, & Neilson, 2010).  
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Healthcare CEO turnover percentages have hovered around 14 to 16 percent since 2002 
and based on results from an ACHE survey of free-standing hospitals, only 20 percent 
have plans for this executive leadership succession (Garman & Tyler, 2007).  Only 41 
percent of hospitals studied by ACHE in 2005 had had one CEO for the previous five 
year period; 22 percent had had three or four over the same time period (Khaliq et al., 
2006).  These data support a renewed focus on succession planning practice and research 
in healthcare. 
According to Evans (2008), healthcare CEO turnover has gained significant 
interest from researchers as of late because of the anticipated impact it has on American 
hospitals if trends such as those described above continue.  This is especially true in the 
uncertain and increasingly competitive environment which has evolved in our current 
health system (Evans, 2008).  Further study of hospital CEO succession effect expands 
our current knowledge of the phenomenon and associated trends and helps to inform all 
stakeholders including:  boards of directors, CEOs, executive search organizations, 
individual candidates themselves and even programs whose focus is preparing potential 
candidates academically (Khaliq et al., 2006). 
CEO Tenure 
According to Karaevli (2007), organization and industry tenure of senior 
executive leaders provides the primary basis for organizational strategic initiatives and 
relates executive tenure and organization performance using Upper Echelon Theory.  
For most organizations, a reasonably long tenure is necessary for a CEO to have an 
organizational impact and to influence strategic change (Bower, 2007a).  However, 
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there is a balance between what Bower (2007a) advocates is a reasonably long tenure to 
acclimate the new leader and what Karaevli (2007) suggests is the socialization that 
promotes the status quo. 
The socialization processes that Karaevli (2007) identifies as coming from inside 
the organization have a tendency to lead overly long-tenured executives to a narrowed 
perspective and a reduced capacity for processing new or different information.  He adds 
that this long organizational tenure also limits executives’ ability to make needed change 
within an organization because of their social relationships and developing reliance on the 
status quo (Karaevli, 2007).  Lengthy industry tenure also supports an executive’s 
dependence on the status quo since many organizations within the same industry are 
homogeneous making the consideration of alternative strategy or logic difficult for long 
industry tenured executives (Karaevli, 2007).  According to Karaevli (2007), a CEO’s 
choice of strategy and logic is significantly influenced by his or her organizational and 
industry specific tenure suggesting an executive tenure effect on organizational 
performance. 
Bower (2007a) suggests that the process of developing influential people to 
succeed an incumbent CEO often takes more than a decade.  Current literature indicates 
that succession planning and leadership development processes in most organizations are 
not adequate to accomplish this task (Cohn, Khurana, & Reeves, 2005) while the average 
CEO tenure continues to decline across many industries (Lucier et al., 2005).  CEO 
tenure in the 1980s was nine and a half years on average compared to just over seven in 
the late 2000s (Bower, 2007a) which might suggest to leadership succession researchers 
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that the management of and planning for CEO succession across many industries is 
deteriorating. 
Khaliq et al. (2006) report even more troubling figures for CEO tenure in U.S. 
hospitals.  According to their work prepared for the ACHE, average tenure for a hospital 
CEO is just over five and a half years for the same time period, with a median of only 
three and a half years.  Bower (2007a) insists that the CEO role is not as comfortable as it 
once was.  There has been a considerable increase in the level of responsibility and 
accountability to multiple stakeholders for the CEO and Bower (2007a) contends that it 
has become extremely challenging, round-the-clock sort of work with very limited 
downtime.  Another interesting facet discovered by Khaliq et al. (2006) was that hospital 
CEO tenure remained relatively the same regardless if their employment ended 
voluntarily or involuntarily, presenting healthcare industry leaders and researchers with a 
serious dilemma when considering the employment life-cycle of hospital CEOs (Khaliq 
et al., 2006). 
Further research is needed with healthcare executives to determine what factors 
contribute to this dilemma and if communication of expectations and timeframes to 
achieve them are reasonable and realistic for the industry (Sinnott, 2008).  Healthcare 
executives and boards should recognize that CEOs are being motivated to leave at the 
three to five year mark of their organizational tenure (Khaliq et al., 2006).  Sinnott (2008) 
suggests hospitals should increase their focus on work/life balance and their awareness of 
the imbalances that have the tendency to arise with leaders.  He contends if this problem 
is not ameliorated and an acceptable work/life balance among hospital CEOs is not 
43 
 
maintained, the industry is destined for repeated premature turnover at the executive level 
(Sinnott, 2008). 
CEO Succession Origin 
Bower (2007a) indicates in his book that the decision to look inside or outside 
the organization for the next CEO can be the greatest challenge to successful leadership 
transition.  Commonly held beliefs in the organizational management literature are that 
outsiders are more often selected to succeed when an organization is performing poorly 
and change is needed, while insiders are chosen when continuity and stability are the 
desired outcomes (Zhang & Rajagopalan, 2010a).  Some propose it plausible that a 
suggestive effect accompanies inside versus outside succession which may have a more 
pronounced affect on organizational performance than any specific characteristics of the 
individual successor (Bower, 2007b; Karaevli, 2007; Zhang & Rajagopalan, 2010a). 
Intellectual and human capital may be one of the greatest commodities an 
organization can possess and competitively retaining it can be crucial to the long-term 
success of an organization (Collins & Collins, 2007).  Creating a pool of highly qualified 
candidates from which a new leader can be chosen must be an inherent part of effective 
succession planning programs (Karaevli & Hall, 2003).  However, most organizations are 
still lacking in this area and are left with a false sense of security with their existing 
programs as discussed previously.  One report concluded that the trend to go outside of 
the organization for leadership talent has risen across many industries because 
historically, succession planning has not been a priority for most organizations (Lucier et 
al., 2005).  Grooming and mentoring young executives in preparation for potential 
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succession to the top job continues to be neglected, especially in healthcare (Bonczek & 
Woodard, 2006).  More and more organizations are not prepared and thus are looking 
outside for their next leader because they have nowhere else to look for qualified 
candidates (Bower, 2007a). 
As with any succession, how organizations manage the development of insiders is 
related to how they have managed their company and determines the quality of the 
successor who is eventually chosen (Bower 2007a).  According to Bonczek and Woodard 
(2006), retaining high performers internally allows the organization to cultivate existing 
knowledge and expertise while maintaining perspective with regards to the corporate 
climate and culture.  Collins (2001) insists that retaining internal talent should provide a 
huge advantage to the organization through the credibility and fluency retained at all 
levels of the organization.  Sinnott (2008) agrees suggesting that internal successions are 
not as costly, consume less time and energy and are overall more efficient for the 
organization. For these reasons, it is strongly recommended each organization establish 
their own internal leadership bank for further talent development of potential candidates 
within the organization (Karaevli & Hall, 2003). 
Internal leadership succession focuses on exposing high potentials to new areas 
and to new roles which stretches their abilities and provides them visibility with senior 
executive leaders, board members and others throughout the organization (Groves, 
2007). Cultivation and training can provide the most effective internal executive 
candidates and Collins and Collins (2007) submit that it makes practical business sense 
to have leadership candidates focus on activities that are hands-on and geared toward the 
45 
 
organization’s strategic initiatives.  According to Rothwell (2010a), these developmental 
activities promote leadership competencies within the individual and better position the 
organization strategically at the same time.  Experiences like these force leaders out of 
their functional silos where they are most comfortable and into the strategic arena where 
they learn skills necessary for senior level executive positions (Groves, 2007).  If the 
internal candidate is selected, both parties have benefited and are better than before the 
process began.  This mutual growth is representative of exemplary succession planning 
programs (Rothwell, 2010a). 
Outsiderness, according to Karaevli (2007) is the experience and wisdom gained 
from a CEO’s previous roles in other organizations and industries.  The appeal for 
organizations of an outside successor is often believed to be a new set of skills, 
knowledge and perspective needed to effectively implement and manage change within 
the organization (Karaevli, 2007).  Outsiders are often seen as more capable of making 
strategic changes therefore increasing the likelihood they are chosen to lead poor 
performing organizations.  There is limited empirical evidence that supports these change 
agent theories as the sole rationale for the selection of an outside successor (Zhang & 
Rajagopalan, 2010a) however; the practice is very common in many industries (Bonczek 
& Woodard, 2006).  Both the upper echelon and resource dependence theories support 
the notion that hiring a CEO from outside the organization and the industry is 
advantageous (Karaevli, 2007). 
Repeated recruitment attempts of organization or industry outsiders as saviors is 
commonplace in the business and industrial sectors but can lead to talented internal 
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candidates being overlooked (Collins & Collins, 2007).  The increasing trend to seek 
out outside saviors, according to Lucier et al. (2005), has been identified as the 
corporate revolving door (Clarke, 2008).  The assumption of outside CEOs new to an 
organization is that immediate, massive changes are expected in a relatively brief period 
of time, which can have resulting negative organizational effects that ultimately lead to 
their untimely departure (Zhang & Rajagopalan, 2010a). 
Karaevli (2007) presents studies which suggest board pressures for drastic 
changes often place new CEOs recruited from outside at risk for making mistakes and 
inappropriate strategic actions.  Zhang and Rajagopalan (2004) also stress that the 
anticipated need for change and initiated strategies from outsiders do not always 
improve organizational-performance after succession has occurred.  The changes made, 
rather than being real transformations, can be more indicative of quick fixes, of 
questionable quality that lack true staying power (Karaevli, 2007).  Without sufficient 
personal networks and a deep understanding of the organizational culture and climate, 
outside executives can often fail in their transition to a new role if not acclimated 
appropriately (Collins & Collins, 2007).  Although selected for their outside knowledge 
and perspective, outsiders’ strategic change may hurt rather than transform an 
organization if a working knowledge of internal operations and key stakeholders is not 
achieved (Karaevli, 2007). 
A 2004 survey of freestanding hospitals in the U.S. conducted by ACHE (Garman 
& Tyler, 2004) produced interesting results related to succession origin considerations in 
hospital CEO decisions.  More than half (56%) of the hospitals surveyed who had 
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identified a CEO successor indicated they had only considered candidates from within the 
organization for the position (Garman & Tyler, 2004).  Thirteen percent indicated that 
only candidates from outside the organization were considered while the remaining 31 
percent indicated considering both insiders and outsiders as candidates for the position 
(Garman & Tyler, 2004).  Not surprisingly, those organizations indicating that they had 
considered inside candidates for the top job rated the quality of their succession programs 
higher than organizations who had only considered outsiders (Garman and Tyler 2004). 
Khaliq et al. (2006) found in their study of hospital CEO turnover, that new 
hospital CEOs were most often promoted from inside their own health systems.  These 
findings further highlight the significance of succession planning reform for potential 
CEOs in U.S. hospitals. This, combined with the cost saving middle-management cuts 
within hospitals described by Groves (2007), stresses the heightened need for hospital 
succession programs to fill a valuable leadership development role which these 
operational positions once filled.  With insiders chosen over half of the time to succeed 
as CEOs, the importance of succession planning and leadership development research in 
U.S. hospitals is clear (Khaliq et al., 2006). 
The replacement method has traditionally been used by hospitals in the past to fill 
leadership vacancies when succession planning was not well developed or thought 
through (Collins & Collins, 2007).  As discussed above, this method should not take the 
place of a comprehensive succession planning program for hospital CEOs and may even 
result in some ill-prepared internal candidates failing at the top job.  According to Groves 
(2007), resisting the heir apparent approach or the temptation to focus undue attention on 
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likely internal successors or direct reports is paramount to avoiding the replacement 
mentality we have become accustomed to in healthcare.  His work indicates that best 
practice organizations avoid this silo and focus their succession planning efforts on 
identifying and developing multiple potential executive leaders for a range of internal 
positions (Groves, 2007).  Collins and Collins (2007) agree that leadership candidates for 
future executive roles should not only be considered from within the ranks of 
management but also from outside the mainstream leadership track of the organization. 
CEO Succession Origin and Organizational Performance 
Conflicting theories and inconsistent empirical findings related to the impact of 
leader succession on organizational performance has plagued the leadership succession 
research literature for many years (McKee & Driscoll, 2008).  This has contributed to 
mixed findings in prior succession–performance relationship research as it relates to 
CEO succession origin as well (Karaevli, 2007).  This study culminated in an empirical 
test of insider versus outsider executive succession impact on competitive performances 
of U.S. hospitals relative to those with no leadership change. 
Karaevli’s (2007) research of top executive successions spanned five decades of 
empirical research from 1954 through 2005.  Unfortunately, this review of 50 years of 
literature provided no definitive insight into the existence of associations between 
succession origin and organizational performance.  Karaevli (2007) found that these 
inconsistent findings over time led scholars away from whether executive succession 
influences organizations positively or negatively and on to the succession context itself 
and what specific circumstances of the succession event affect performance.  A scholarly 
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consensus has yet to be reached on the association, if any, between organizational 
performance and specific events surrounding CEO succession, particularly inside or 
outside successions (Karaevli, 2007).  Although identified as an important element of the 
succession context, CEO origin has been beleaguered with mixed results when associated 
with organizational performance (Karaevli, 2007). 
According to Karaevli (2007), the present day dichotomy of succession origin 
and the concepts of insider versus outsider contribute significantly to a lack of 
understanding and agreement on the effect leadership succession has on organizational 
performance. Karaevli’s works (2003; 2007) strived to improve succession origin 
constructs and the binary conceptualization of leadership succession origin in previous 
research.  Karaevli (2007) attempted to reconcile inconsistent findings on organizational 
performance consequences of new CEO origin and develop a framework that illustrates 
the dynamic that exists between the construct of inside versus outside CEO succession 
and organizational performance.  Although outside of the scope of this study, Karaevli 
(2007) suggests a new concept of CEO outsiderness in which succession origin is 
measured on a continuum rather than as a binary, dichotomous indicator.  For ease of 
conceptualization and use with existing data, CEO origin in this study remains a binary 
variable as is commonplace in previous leadership succession research (Karaevli, 2007). 
In recent literature, poor pre-succession performance of an organization has 
received the most attention as a contributing factor to selecting an outsider to succeed as 
CEO (Zhang & Rajagopalan, 2010b).  However, definitive empirical knowledge of the 
post-succession impact on these same organizations as a result of this outside 
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succession is far more limited (Boyne et al., 2011a).  Outside successors who, under 
poor performance conditions, can initiate significant strategic change and fundamentally 
alter performance standards are more prone to deliver improvements in organization 
performance (Karaevli, 2007).  Again, some of the effects realized as a result of CEO 
succession may be merely suggestive, signaling an organization's intent to redirect, 
reorganize, or rejuvenate. 
As discussed previously, any CEO succession is disruptive to an organization and 
has great potential to affect performance.  Rapid, strategic changes initiated after CEO 
successions, although commonly seen as necessary for organizational turnaround, often 
fail to produce the positive organizational performance expected (Karaevli, 2007).  Zhang 
and Rajagopalan (2010b) wanted to understand this and theorized in their research that 
the potential of strategic change to affect performance is the difference between the 
change’s disruptive effect and the adaptive ability of the organization to overcome it. 
Strategic change at low impact levels positively affects overall organizational 
performance if the adaptive effect dominates whereas the opposite is true if high levels of 
strategic change allow the disruptive effect to take over (Zhang & Rajagopalan, 2010b). 
Results such as these provided by Zhang and Rajagopalan (2010b) suggest that a balance 
exists between the amount of strategic change undertaken and the competitive advantage 
an organization is able to create and maintain. 
Zhang and Rajagopalan (2010b) found that CEOs succeeding from within enjoy 
greater human capital backing and organization specific knowledge that helps to shield 
the organization from disruptive effects which may result from increased levels of 
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strategic change.  CEO insiders maintain a connectedness to the organization and tend to 
better understand the internal resources and environment in which to carry out its vision 
and mission.  However, this connectedness can constrain the insider to change only what 
builds on past performance and existing organizational capabilities rather than dramatic 
strategic change that may be needed.  Thus, Zhang and Rajagopalan (2010b) indicate 
changes from insider CEOs tend to be safer while benefiting organizations in a steadier, 
incremental way.  Small, incremental changes, usually seen by insiders, are less 
disruptive but are also not as likely to produce the improvements necessary in poor 
performing organizations and may reinforce the status quo, further exacerbating 
performance decline (Karaevli, 2007). 
Outside successors tend to make more significant and more rapid changes initially 
which ultimately amplifies the associated organizational disturbance (Zhang & 
Rajagopalan, 2010b).  Outsiders also have a limited understanding of existing resource 
capabilities and constraints within the organization, which make choosing effective and 
appropriate strategic change more difficult (Shen & Cannella, 2002).  These issues 
contribute to more pronounced disruptive effects under outside CEO leadership 
necessitating a greater adaptive response on behalf of the organization (Zhang & 
Rajagopalan, 2010b).  In contrast, outsiders succeeding in poor performing organizations 
may, in some instances, have less resistance than insiders implementing change because 
radical change is expected as a result of performance decline and may be supported by 
critical stakeholders.  Outside successors are also not emotionally constrained by the 
status quo and corporate culture when considering significant strategic change.  For these 
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reasons, change under outside CEO leadership can be more adaptive in nature than that of 
insiders under certain circumstances (Zhang & Rajagopalan, 2010b). Zhang and 
Rajagopalan (2010b) conclude their research with the consensus that outside CEOs 
intensify the effects of strategic change over that of the insider, regardless of whether 
those effects are positive or negative. 
Lucier et al. (2005) also examined CEO succession origin and organizational 
performance and first introduced time into the complex succession-performance 
relationship.  This research found that outside CEOs positively impacted organizations 
early on in their tenure and typically this improved performance waned as time passed. 
Insiders on the other hand, were found to have relatively steady performance regardless 
of the passage of time.  These findings agree with those of Zhang and Rajagopalan 
(2010b) in that increasing CEO tenure heightens performance disadvantage 
experienced by outsiders.  CEOs tend to excel at rapid, strategic turnaround needed by 
poor performing organizations but are not always able to deliver long-term, sustained 
performance (Lucier et al., 2005), further confirming the revolving door phenomena 
discussed above.  This study included the variable of time through panel analysis as 
discussed in the methods section below. 
Measuring Organizational Performance and Competitive Advantage 
Previous studies utilize a variety of outcomes measured before and/or after a 
succession event combined with longitudinal research designs which treat the succession 
phenomenon as a ‘natural experiment’ and make statistical inferences about the 
executive succession–organizational performance relationship (Kesner & Sebora, 1994).  
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As a first step, researchers identify a sample of organizations that experienced an 
executive succession event (the ‘naturally’ occurring part of the experiment) and 
conjointly analyze those organizations with others that did not have a change or 
experienced some other form of leadership transition.  Executive succession analyzed in 
this fashion relies on variables classified into three domains: antecedents, succession 
event types and consequences.  Depending on the study’s purpose, measures drawn from 
two of the domains are the variables of interest (e.g., dependent and independent 
variables) and the third domain’s measures are used as controls.  The analytic algorithm 
most often used is linear regression. 
For example, the study by Ballinger and Marcel (2010) compared Fortune 500 
organizations that experienced executive succession events with and without an interim 
leader being used and its impact on organizational survival.  As part of their study, the 
organizations’ financial performance prior to the events was controlled for (an 
antecedent) while organizational survival served as the dependent variable (the 
consequence) and the succession event was an independent variable.  Survival analysis, 
a form of linear regression relying on correlations (Miller & Tsang, 2011), was then 
used to assess the relationship between the succession event and the organization’s 
longevity. Their study found using an interim CEO was associated with a lower 
likelihood of organizational survival. 
Next, they explored a sub-sample of the dataset where an organization insider, 
usually the board chair, served as the interim CEO.  When the interim CEO was also the 
board chair, the impact on the organization’s survival was moderated in a positive fashion 
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compared to the use of an outside interim.  Their use of a sub-sample in the research 
design is a common feature in research because it implies that the magnitude of the effect 
of the intervention differs when the form of the intervention varies (Fredrickson, 
Hambrick, & Baumrin, 1988; Porter, 1991).  However, drawing causal inferences from 
such research designs is difficult when changing the sampling frames or model 
specifications alters the results in non-generalizable ways, as was the case in the study 
described above.  Therefore, improvements to sampling designs in CEO succession–
organizational performance research makes both the theoretic and empirical relationships 
easier to explore. 
There are many definitions of organizational performance as it relates to 
competitive advantage in the business and strategy literature.  The resource-based view 
(RBV) is a widely accepted framework asserting that organizations secure and transform 
inputs into outputs to gain and sustain a competitive advantage relative to its competitors 
(Barney, 1991; Rumelt, Schendel, & Teece, 1994; Wernerfelt, 1984).  Resources 
themselves do not create output or productivity (Grant, 1991) however, the coordination 
and management of their usage in the transformation process is important to producing 
results (Hooley & Greenley, 2005). 
Poor performance compared to others within the same industry is an indicator that 
current operations are ineffective and stimulates adaptation to better align internal and 
external inputs to improve production outputs Karaevli (2007).  According to the RBV of 
organizational performance, an organization reaches a sustainable competitive advantage 
by managing its unique resources so that inputs are converted to outputs in such a way 
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that is not easily imitated by competitors.  These resources transformations ultimately 
create a competitive barrier for the organization and cannot easily be recreated, imitated 
or acquired through purchase or acquisition. 
The ‘transformation’ criterion has become a focus of management researchers 
because it is the organization’s capabilities which executives can influence most in the 
near term (Augier & Teece, 2009; Helfat, 2011; Teece, Pisano, & Shuen, 1997).  In 
particular, dynamic capabilities are an area that new executives are often charged with 
managing (Agarwal & Helfat, 2009). The dynamic capabilities charge requires 
reconfiguring capacity used in the input-output transformation process through such 
mechanisms as workflow redesign (Pavlou & El Sawy, 2011).  For theoretical and 
methodological congruence, it is necessary for an analytic algorithm to measure an 
organization’s capabilities for input-to-output transformation and to relate that measure to 
competitive market positioning. 
To explore organizations’ competitive market positions, researchers typically 
measure resources and capabilities and then correlate these variables with a specific 
performance measure (Ray, Barney, & Muhanna, 2004).  Organizations performing 
above average are said to have a competitive advantage, and those  doing so over 
extended periods of time demonstrate a sustained competitive advantage.  While these 
approaches have been widely used, they do have limitations.  One shortcoming of this 
view is that it relies on highly aggregated organizational performance measures such as 
stock price as a proxy for competitive advantage (e.g., Tobin's Q; Hasan, Kobeissi, &  
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Wang, 2011).  Using a single performance variable may or may not capture the 
competitive advantages which specific resources and capabilities give an organization. 
One solution to address this limitation is to measure organizations’ capacity for 
transforming resource inputs into outputs and use that index as the dependent variable 
(Ray et al., 2004).  However, measuring organizations’ resource transformation 
capabilities is not sufficient to link the objective analysis to the latent concept of 
competitive advantage.  It is also necessary to compare its capability level to other 
organizations in the marketplace.  Thus, an additional element of the RBV which must be 
measured is the transformation process relative to the competitors’ performances in 
employing their capabilities.  The relative aspect of firm-to-firm comparisons has not 
been as rigorously studied.  Until recently, most research designs relied on some form of 
regression that measured an organization’s distance from a line that defines average 
performance on a set of variables (Rosko & Mutter, 2008). 
While being above average may qualify as being competitive, an analysis that 
identifies organizations that are superlative, or ‘pushing the envelope’ at transforming 
inputs into outputs, would be more consistent with the theoretical description of dynamic 
capabilities.  Moreover, relative performances of organizations should be measured as the 
distance to the frontier where competitive advantage emerges, versus the linear average 
where relative mediocrity dwells (Kumbhakar & Lovell, 2000). Therefore, a statistical 
algorithm is necessary that ‘envelopes’ the data and identifies organizations which 
demonstrate distinct and sustainable performance thus, residing along a competitive 
advantage frontier. 
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Stochastic Frontier Estimation 
As discussed above, organizations can fail to optimize production functions and 
lose efficiency and thus their competitive advantage. To overcome the shortcomings of 
previous inefficiency measures, frontier techniques have been developed.  Frontier 
methods establish best practice as it relates to production efficiency and measure the 
distance between actual performance and this best practice frontier.  A production frontier 
characterizes the minimum necessary combinations of inputs to produce the maximum 
output (Constantin, Martin, & Rivera, 2009).  Organizations are considered efficient if 
they operate above the frontier and inefficient when they fall under. According to Rosko 
and Mutter (2008), frontier inefficiency estimation should be undertaken for several very 
important reasons:  to establish a best practice target, to inform industry leaders and 
policy makers of that target and then to encourage changes in both towards its 
achievement. 
SFE is the preferred parametric approach that emerges as a theoretical and 
practical framework for defining and estimating production frontiers (Rosko & Mutter, 
2008).  SFE uses more theoretically sound estimates than previous frontier methods as it 
allows for deviations from the frontier rather than attributing random variations or 
changes in input productions to inefficiency. SFE calculates a theoretical frontier 
providing a more objective determination of best practice which more closely resembles 
that which occurs randomly in the natural world (Constantin et al., 2009). 
Nonparametric approaches, such as Corrected Ordinary Least Squares (COLS) 
and Data Envelopment Analysis (DEA) assume a deterministic frontier based on actual 
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performance that does not allow for natural deviations from the frontier.  These 
deviations or residuals might include random shocks, statistical noise or measurement 
errors (Rosko & Mutter, 2008).  Since nonparametric models lack a stochastic 
component, concerns exist among econometricians that their use has the potential to 
overestimate inefficiency through random errors or statistical noise (Jacobs, Smith, & 
Street, 2006). 
In stochastic production frontier models, it is recognized that labor or capital 
performance variations which affect production are beyond the control of the 
organization (Constantin et al., 2009).  Therefore, when using this method, variations in 
technical efficiency can be separated from labor or capital performance impacts on 
production.  In the presence of inefficiencies, SFE models better differentiate an 
organization’s technical inefficiency from random factors affecting production outside of 
their control (Constantin et al., 2009). 
Stochastic frontier techniques were developed independently and simultaneously 
by both Aigner, Lovell, and Schmidt (1977) and Meeusen and van den Broeck (1977) 
during the same time period.  Since that time, there have been considerable contributions 
to extend and apply the model (Kumbhakar & Lovell, 2000).  Reviews of these works are 
provided in Baten, Kamil, and Haque (2009), Battese and Coelli (1995), Constantin et al. 
(2009), Cooper, Seiford and Tone (2007), Lita and Stamule (2011) and (Zhu, 2009).  SFE 
methodologies are used extensively in the economics (Del Gatto, Di Liberto, & Petraglia, 
2011) literature and have recently informed the strategic management field, thus 
strengthening the ties between those domains.  In particular, the trans-log specification of 
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the SFE, using the costs of capital and labor as inputs to produce services, models closely 
to economics’ perspective for assessing relative competitive advantages among 
organizations.  Frontier analyses, particularly SFE, have become the standard for 
assessing productivity and efficiency in the econometrics literature (Del Gatto et al., 
2011). 
Wagstaff (1989) published the first healthcare SFE by examining efficiency in 49 
Spanish hospitals.  The first study of U.S. hospitals using SFE followed in 1994 by 
Zuckerman, Hadley and Iezzoni (1994).  Rosko and Mutter (2011) provided a thorough 
review of the 27 U.S. hospital SFEs performed since then and the lessons learned.  The 
gap which remains in the literature is a theoretical model of inefficiency in healthcare 
using stochastic frontier production functions to explain the phenomena in terms leaders 
and strategist can understand.  Rigorous work is not available that quantitatively studies 
healthcare efficiency levels using SFE with the purpose of identifying contributory 
variables and making recommendations for improvement. 
In addition to those mentioned above, the major advantage to the use of SFE, 
especially in healthcare efficiency studies is that it allows for cost-oriented efficiency 
research rather than simply that of technical or production efficiency as is the focus of 
DEA (Rosko & Mutter, 2008).  Cost efficiency stems from the combination of both 
allocative and technical efficiency and describes the actual costs of production based on 
market price and technology available.  Technical efficiency is what the organization 
does with a given amount of inputs to maximize production.  This relates with the 
organization’s production processes, control systems and management of human 
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resources.  Allocative efficiency on the other hand, relates to the use of inputs and their 
optimization based on demand for a product.  As a result, an organization could be 
technically or allocatively efficient but at a cost to the bottom line that is no longer 
market competitive.  This supports establishing a measure of cost efficiency and the use 
of SFE in the competitive differentiation of hospital efficiency. 
Complete specification fit of the SFE model in hospital studies has been difficult 
due to their multiproduct nature and production complexities detailed earlier.  However, 
consensus has been reached among the national hospital studies reviewed by Rosko and 
Mutter (2008) as to the cost function variables used for the price of capital and labor. 
These variables were obtained from similar national databases such as the AHA Annual 
Survey and the Medicare Cost Reports in 11 out of 19 studies as well (Rosko & Mutter, 
2008).  Outputs representative of inpatient and outpatient services provided are 
recognized as essential in all hospital SFE studies. 
Also common is the use of case-mix descriptor variables and some measure of 
quality according to Rosko and Mutter (2008).  Concern exists that if these dimensions 
are not controlled for erroneous assumptions of efficiency may result due to decreased 
quality or a less resource intensive case mix.  As SFE models with these added 
descriptors become more specified and begin to explain more of the previously 
unexplained errors, average inefficiency estimates of hospitals are likely to decrease 
(Jacobs et al., 2006).  For this reason, the use of product descriptor variables and other 
methods of case-mix grouping are needed when estimating hospital inefficiency in the 
absence of randomized controlled trials (Rosko & Mutter, 2011). 
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Estimating Cost Efficiency 
Cost has historically been used as an indirect measure of inefficiency in many 
hospital studies (Rosko & Mutter, 2008).  The assumption being that decreasing costs 
meant improved efficiency.  However, cost containment may have been attributed to 
reduction in the quality and quantity of services and this assumption may be faulty. 
Therefore, a more responsive measure of hospital inefficiencies was needed to alleviate 
the reliance on such assumptions and to better evaluate competitive advantage (Rosko & 
Mutter, 2008). 
As an alternative, cost efficiency has been estimated using a variety of cost 
production functions in previous hospital inefficiency studies.  The Cobb-Douglas, 
transcendental logarithmic (trans-log), Leontief, and constant elasticity of substitution 
(CES) production functions have all been used in conjunction with SFE to determine a 
cost frontier (Rosko & Mutter, 2008).  As described above, the cost frontier is then used 
to determine inefficiency for each entity based on its performance variation.  According 
to Rosko and Mutter (2008), the trans-log and Cobb-Douglas cost production functions 
are the two most popular models used to estimate cost efficiency in hospital studies. 
In most applications, Cobb-Douglas is used to represent the production 
relationship of inputs, commonly labor and capital, versus output measured by production 
units or value produced.  In general, a production function requires both factor inputs to 
produce the output and increasing either of the inputs results in a related output increase. 
The Cobb-Douglas production function in its simplest form can be represented in  
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Formula One: 
 
 
(1) Y=ALaKb  
 
 
where Y stands for output, A for total factor productivity, L for labor, and K for capital. 
Labor is typically represented by full-time equivalents or man-hours.  Capital is the 
investment in equipment or supplies utilized to produce output.  Total factor productivity 
represents the portion of output not explained by inputs used.  Growth in TFP represents 
output growth not accounted for by an increase in inputs. 
The Cobb-Douglas was later generalized to the trans-log production function by 
adding squared and interaction terms for all the variables.  With its desirably more 
flexible form, the trans-log function is used extensively in the micro and macroeconomic 
fields when describing how outputs relate to levels of input (Constantin, Martin, & 
Rivera, 2009).  However, this flexibility is gained at the expense of degrees of freedom 
while the more structured Cobb-Douglas avoids the cross-product and squared terms of 
the trans-log and saves degrees of freedom (Rosko & Mutter, 2008).  Overall, the trans- 
log production function is statistically more favorable and preferred analytically over the 
Cobb-Douglas for obtaining cost functions (Baten et al., 2009; Rosko & Mutter, 2008). 
To illustrate a cost production function in terms of a healthcare example, capital 
could be represented in terms of hospital beds and labor in terms of nursing hours.  A 
large purchase of new hospital beds would incur a significant capital expense but has the 
potential to improve efficiencies and aid nursing staff in providing better patient service. 
New beds can reduce position related complications of hospitalization, improve patient 
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comfort and reduce work related injuries for staff.  This outlay in capital may create a 
reduced need for nursing hours or result in improved care outcomes thus returning the 
scale to constant post capital investment and potentially increasing returns over the long- 
term.  On the other hand, no capital investment and an increase in labor or nursing hours 
may have the same effect on service and quality, maintaining or increasing returns with 
regards to output. 
The appropriateness of using cost production function models in the 
manufacturing sector where labor and capital directly produce a tangible product is 
intuitively appealing.  The uses of these resources are causal in the production outputs. 
Some consideration is necessary when applying these models to the service sector.  The 
causal relationship between output and resource allocation is not as objectively clear. 
Production of output in service industries such as healthcare requires delivering services 
in response to demand.  Although increases in labor or capital might be necessary due to 
increases in demand, their ability to generate future demand for service is unclear. 
Recognizing this complexity, however, resource allocation between labor and 
capital is a crucial management decision in the service sector.  Successful leaders in the 
service sector remain responsive to demand for services and balance production with 
available resources.  Optimum resource allocation within the constraints of industry 
standards have traditionally manifested in more efficient operational strategy and 
improved performance (Rosko & Mutter, 2011).  In this case, the cost production function 
models would provide results in service industries such as healthcare that are analogous 
with those in manufacturing. 
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Summary 
This chapter has examined the theoretic leadership succession and organizational 
performance literature and identified relevant gaps related to the executive succession–
organizational performance relationship.  Several theories and constructs have been used 
in the past half century to guide leadership succession and organizational performance 
research but none clearly stands out as a comprehensive guide in the complex 
relationship between executive succession and organizational performance.  Conflicting 
theories and inconsistent empirical findings related to the impact of leader succession on 
organizational performance continue to plague the leadership succession research 
literature. 
Karaevli (2007) found these inconsistent findings over time have led scholars 
away from the most important question of whether executive succession influences 
organizations positively or negatively.  Unfortunately, most researchers have moved on 
to the succession context itself and what specific circumstances of the succession event 
affect performance.  Citing the challenges with establishing causality, Giambatista et al. 
(2005) identified and stressed the need for quasi-experimental designs to establish and 
test causality in the succession–performance relationship.  They also called for 
researchers to design longitudinal studies to address issues of time and performance over 
the long-term rather than short-term, pre- and post-succession performance comparisons.  
No studies to date have conducted or simulated a randomized controlled trial to attempt 
to establish causality in the succession–performance relationship. 
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Available theories and concepts fail to answer the when (sustainability) and the 
why (causality) of the succession–performance relationship and Giambatista et al. (2005) 
stressed the need to expand on our empirical knowledge of leader succession and its 
organizational performance impacts.  The empirical research to demonstrate a sustained, 
causal relationship between individual leaders and organizational performance is a 
worthwhile endeavor (Giambatista et al., 2005).  The aims of this study are to answer the 
call for empirical evidence to link executive succession to organizational performance in 
a causal manner and to build upon existing theoretical works, filling several knowledge 
gaps in the succession–performance literature. 
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CHAPTER III 
 
METHOD 
 
 
The following chapter details the quasi-experimental, panel study design 
conducted and the specific methods used for data analysis within each specific aim.  
The purposes of this study were to describe and demonstrate an improved sampling 
design and analytic strategy for exploring the executive succession–organizational 
performance relationship that addresses limitations identified in the previous chapter.  
Particularly, PSM was used to identify a sample which approximates an RCT study 
design and SFE was employed to estimate organizations’ competitive positions relative 
to each other.  A study of insider versus outsider executive succession impact on these 
competitive positions relative to organizations with no leadership change was 
conducted and is described in the following paragraphs. 
Secondary data were utilized in this study to analyze the associations in the 
sampled organizations.  Secondary analysis of existing data allowed for quick and 
efficient answers to research questions not originally studied (Gliner, Morgan, & Leech, 
2009).  To answer a different question, an investigator, with the primary investigator’s 
permission, can add several measurements to an existing study and create an ancillary 
study (Hulley, Cummings, Browner, Grady, & Newman, 2007).  After simulating a 
random sampling procedure, analysis followed the dominant functional specification in 
the literature based on the work of Rosko and Mutter (2008) and formalized cost 
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efficiency in the production function of a stochastic frontier for panel data.  Cost 
efficiency functions were modeled and compared to determine if a difference existed in 
hospital efficiency based on leadership change and CEO succession origin. 
Research Approach and Study Design 
This quasi-experimental study of existing data employed a panel analysis of 
repeated cross-sectional observations occurring within a relatively short time series.  The 
AHA Annual Survey provided data collected annually from a single point in time to 
describe characteristics of operations and leadership among member hospitals. 
Aggregating several years of data, as with the creation of panel data utilized in this 
study, provided a more robust, longitudinal representation of phenomena which may be 
occurring. The combination of time series with cross-sections enhanced the quality and 
quantity of data in ways which would not be possible using only one of these two 
dimensions alone (Gujarati, 2003). 
An experimental design is the most widely-recognized approach suited to 
determine causality (Gliner et al., 2009) and secondary data analysis does not lend itself 
to experimental designs.  Previously collected data do not allow for manipulation of 
predictor or independent variables and the dependent variables have already been 
affected.  The research design perhaps most desirable when studying executive 
succession is the time-series, treatment-control design where characteristics are evenly 
distributed across groups. Campbell and Stanley (1973, p. 57) described this structure as, 
“an excellent quasi-experimental design, perhaps the best of the more feasible designs.” 
In fact, they singled out this design for studies of executive change because it met all the 
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standards for internal validity that such interventions are most concerned with meeting. 
The primary threat to the external validity of this design was that sample selection bias 
effects could account for changes in the variable of interest (Caliendo & Kopeinig, 2008). 
Using PSM to select samples in observational studies or natural experiments corrected for 
this threat (Bai, 2011). 
Dehejia and Wahba (2002) provide an overview for exploring causal inferences in 
non-experimental situations, such as those surrounding CEO succession events.  To 
substitute for the absence of experimental control units, data can be obtained for a set of 
potential comparison units.  Organizations do not need to be drawn from the same 
industry (i.e., population) as the treated units, but the same set of pre-treatment (e.g., pre- 
succession) covariates needs to be measurable.  Drawing a control group from the same 
population would be better still. 
PSM pairs treatment and control units (e.g., organizations) which are similar in 
their observable characteristics in order to achieve covariate balance in studies with 
binary treatments or interventions.  When the relevant differences between any two 
organizations are captured in the observable covariates, matching can yield an unbiased 
estimate of leadership changes’ impacts on organizations’ performances by comparing 
the treatment and control groups’ changes in efficiency over time as if they originated 
from a random sample drawn from a single population.  Appendix B describes the PSM 
method used for matching organizations using the nearest neighbor algorithm. 
When the organizational-performance measurement and PSM are done prior to 
the intervention (i.e., before the CEO succession event), and are drawn from a known 
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population of organizations (e.g., a single industry), two inferences can be made.  The 
first is the determination of a causal effect arising from the executive succession 
intervention on organizations’ competitive performance ceteris paribus.  Second, by 
knowing the treatment and control groups were in effect randomly assigned using the 
PSM simulation; comparing them along the selection dimensions to the broader 
population is feasible.  Therefore, inferences and forecasts about how such interventions 
would impact the overall population can be made.  The main challenge remaining in the 
research design is selecting appropriate strategy for measuring organization-performance 
relative to other organizations, over time, as it relates to CEO succession.  This is 
discussed below with the use of Stochastic Frontier Estimation. 
Setting 
This study used existing data to examine the succession performance 
relationship effects described in the previous section.  The AHA Annual Survey for 
fiscal years (FYs) 2003 through 2007, inclusive, provided the panel data for this study.  
The process for formulating the panel data is described in the Procedures Section.  Over 
6,000 AHA member organizations across the country were surveyed each year during 
the five-year study period.  The AHA (2008) reports an average of 85 percent response 
rate to its survey each year. 
Sample 
Random sampling is an ideal instrument to determine causality. This study 
simulated a random sampling of the target population which, for this study, was all 
organizations in the U.S. providing acute care hospital services.  An accessible 
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population of this target were organizations who were members of the AHA.  From this 
accessible population, those organizations within the secondary dataset who responded to 
the 2003 through 2007 AHA Annual Surveys were chosen as the selected study sample 
to create the necessary panel data.  The actual sample studied resulted from the PSM 
simulation process described in the Procedures Section. 
According to Gliner et al. (2009), representativeness of a sample is more critical 
than its size.  Their assertion is that non-representative samples can be very large and still 
produce results which are misleading.  A PSM simulation (described in the Procedures 
Section) was used to simulate a random sampling of participants from the existing 
dataset.  Inclusion criteria consisted of: (a) AHA member organizations within the 
existing dataset who (b) responded to the 2003 through 2007 AHA Annual Surveys and 
(c) provided general, short-term acute care hospitalization during the entire study period 
with (d) more than 25 inpatient beds.   Exclusion criteria consisted of: (a) federally- 
owned or other hospitals not accessible by the general public, such as prison hospitals, (b) 
specialty, rehabilitation or very small hospitals (<25 beds) which serve as infirmaries, 
clinics, or non-acute care facilities, (c) organizations responding with incomplete survey 
data for which imputation did not occur, and (d) organizations for which clear CEO 
leadership demographics as defined in the study’s Procedures Section were not available.  
Excluding non-member organizations and those with incomplete or missing data as well 
as restricting the sample to general, short-term care hospitals with more than 25 inpatient 
beds provided consistency with previous studies and maintained more homogenous 
outputs (Rosko & Mutter, 2008). 
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Human Subjects Protection 
Prior to examining the dataset for this study, an Institutional Review Board 
(IRB) Determination Form from The University of North Carolina at Greensboro 
(UNCG) was completed and submitted for review.  The UNCG IRB determined this 
study was “not human subjects’ research by federal definition” and further 
documentation or approvals were not necessary to proceed with the study.  Variables or 
data elements related to specific individuals, such as the CEOs in this study, are 
publically available and were aggregated at the organizational level in the broadest of 
classifications (e.g., succession origin, geographic region, etc.).  Information at the 
individual level is not reported and it would likely be impossible to link the study data to 
any specific hospital leader.  Other than the source of succession (inside vs. outside), the 
research questions do not revolve around individual characteristics but rather the 
organizational efficiencies as a result of said characteristics.  Confidentiality was 
maintained by only using individual CEO data such as name, employer and location to 
code the individuals’ immediately previous work history as inside or outside of the 
organization.  After the coding for all sample organizations was complete, matching 
CEO specific data was destroyed and no longer available to the PI.  Specific individuals 
and their associated background data are not analyzed as only the origin of their 
succession, and no other identifying information is the focus of this analysis. 
Procedures 
This study employed a quasi-experimental research design using panel analysis of 
existing data to address each of the three specific aims outlined in Chapter One.  A 
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detailed data analysis plan for each specific aim follows, describing the necessary 
analyses performed.  All analyses were considered statistically significant at an alpha of 
<0.05 unless otherwise indicated. 
Data Analyses Plan 
Determining the type of statistical analysis required for secondary data is heavily 
dependent on the research question, the primary hypothesis and the variables needed to 
test the hypothesis (Gliner et al., 2009).  The ultimate goal of the statistical analysis in 
this study was to apply SFE techniques to estimate efficiency deviations from a best 
practice frontier and to determine if any significant differences were created in 
organizational performance post-succession due to changes in CEO leadership or CEO 
succession strategy utilized within the study sample. 
The most prudent and commonly used forms of the PSM and SFE algorithms 
were employed.  The data analysis for this study had three steps aligned with the study’s 
three specific aims.  First, PSM was used for creating sampling frames to compare 
organizations which have experienced CEO succession, versus those that have not, in a 
manner simulating an RCT.  Second, a longitudinal SFE of organizations’ relative 
performance levels over a five-year time frame was executed.  The time frame bracketed 
the executive succession intervention with two-year windows before and after the event 
year, for a total of five years.  Lastly, the effects of changes in organization leadership, 
with the successor being drawn from either inside or outside of the organization, were 
compared to organizations that had no change in CEO. 
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Initial preparation of the existing dataset was necessary prior to addressing any of 
the specific aims.  The first step in preparing the existing dataset for analysis was to 
identify executive succession events.  The AHA Annual Survey includes the name of the 
current CEO.  The 2004 and 2005 FYs were compared to identify any changes in the 
CEO position for the 6,349 hospitals reporting that period.  Next, the 2004 AHA Guide, 
which contains the names of all the C-level officers, was used to determine if the new 
CEO originated from inside or outside of the hospital.  Secondarily, searches of the 
ACHE and the American Organization of Nurse Executives (AONE) membership 
databases using first and last name were utilized to identify succession origin if an 
unknown change occurred. 
According to Gliner et al. (2009), calculating descriptive statistics early on to 
explore the data and describe key features of a sample can assist the researcher in 
evaluating assumptions for each statistical method.  Descriptive statistics were initially 
calculated to explore and describe the main features of the study sample.  These 
statistics included the means and standard deviations for both the study population and 
the actual PSM sample providing information about the sample’s tendency, distribution, 
and variability.  Descriptive statistics also identified the frequency at which inside and 
outside succession strategies were pursued in sampled hospitals.  Organizations with 
missing data were excluded from this study per the exclusion criteria.  Once the 
exclusion criteria had been used to refine the dataset and excluded organizations had 
been removed, the initial data analysis of this study began.  Data analyses for each 
specific aim and research question are outlined below. 
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Instruments 
The instrument used to collect panel data for this study was the AHA Annual 
Survey of Hospitals (American Hospital Association, 2005).  The AHA’s Annual 
Survey has been soliciting voluntary responses from member organizations since 1946 
(American Hospital Association, 2008).  Every fall, participants are asked to complete 
the survey online or by mail to compile this most widely used healthcare data resource 
(Mullner & Chung, 2002).  The comprehensive survey is an invaluable resource 
assembling the most reliable healthcare database on the market (American Hospital 
Association, 2008), collecting authoritative financial, utilization, personnel and services 
data for U.S. hospitals.  The AHA reports an extraordinarily high overall response rate 
of 85 percent to the survey each year and for those hospitals not responding in a given 
year, statistical models were used to estimate a number of key variables (American 
Hospital Association, 2008). 
Data is requested from the organization’s most recently completed fiscal year to 
ensure accuracy and to consistently compare 12 month periods.  Data is collected from 
more than 6,000 US hospitals and health systems related to each organization’s structure 
and leadership, their resource utilization, facilities and services offered, revenue and 
expenses, and their strategic planning efforts (Burke, Yu, Au, & Menachemi, 2009).  The 
availability of such a rich source of healthcare data enables multiple research 
opportunities and allows for forecasting and prediction into the future (Mullner & 
Chung, 2002).  Historical archives facilitate multiple years of data for comparison and 
longitudinal study especially around hospital operations and healthcare service trends. 
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Data Analyses for Specific Aims 
Specific Aim #1 
Examine the effectiveness of using Propensity Score Matching to simulate 
random sampling in an efficiency study of U.S. hospitals. 
Q1: Can Propensity Score Matching be effectively used in this study to 
simulate random sampling of hospitals into control and intervention 
groups? 
The first specific aim assured the appropriate sampling frame for this study and 
addressed the absence of an experimental control group which, when combined with the 
intervention group, would simulate random selection from a common population.  To 
identify the control group, this study looked to FY2003 to identify a group of hospitals 
who had pre-intervention characteristics comparable to hospitals which experienced a 
CEO succession in FY2005.  By looking backward in time to find the control group, this 
study simulated the RCT design of assigning subjects to a study arm (i.e., either 
intervention or control) before administering the intervention.  Therefore, the 
intervention’s effect can be measured over time and causal inferences are strengthened.  
PSM was employed to identify the control group. 
Propensity score matching. 
Propensity score matching is a quasi-experimental technique used to aid in 
the estimation of an intervention’s impact.  It allows treatment group outcomes to be 
compared to those of a control group constructed through matching of pre-treatment 
propensity scores.  Propensity score matching creates ‘balancing scores,’ which 
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determine the comparison units that best match treatment units when random 
assignment is not feasible (Rosenbaum & Rubin, 1983).  The propensity score is a 
conditional probability of assignment to a particular group given a vector of observed 
covariates. When the score is sufficiently comparable across subjects, unbiased 
estimates of the treatment or intervention’s effects can be made (see Appendix B for 
a description of the standard PSM methodology).  Testing the ‘balancing hypothesis’ 
assesses the effectiveness of the PSM process.  The hypothesis states that the 
covariates used in the classification do not vary significantly from one another, either 
individually or collectively.  This can be tested using a variety of tests for statistically 
significant differences among covariates as described in Dehejia and Wahba (2002). 
In this study, if hospitals can be effectively matched on observable characteristics 
in a time period prior to the CEO succession event, then an unbiased estimate of the 
subsequent impact the event has on performance (e.g., the treatment effect) can be made 
as if the organizations were randomly assigned.  According to Luellen, Shadish and Clark 
(2005), a crucial step in designing a quasi-experiment using propensity scores is 
identifying relevant, observable covariates from which to derive scores from, specifically 
those expected to affect outcomes and treatment selection.  The selection of observable 
characteristics for matching hospitals is explicitly addressed in the AHA Annual Survey 
when missing data is imputed.  Those variables are: 1) Total facility admissions, 2) 
Adjusted admissions, 3) Total births (excluding fetal deaths), 4) Total facility inpatient 
days, 5) Full time equivalent personnel, 6) Total surgical operations, 7) Total outpatient 
visits, and 8) Adjusted patient days (American Hospital Association, 2008).  These 
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variables account for both variations in the scale and scope of operations typically used to 
group hospitals for research comparisons and regulatory purposes. 
Descriptive statistics of the PSM variables in this study were calculated and are 
summarized in Table 1(Appendix D).  In addition to these variables, a measurement of 
the hospital’s cost efficiency in FY2003 (see SFE discussion below) was calculated and 
included in the PSM to ensure the hospitals had comparable input-to-output conversion 
capabilities prior to the executive succession event.  In doing so, organizations were 
matched not only on their structural similarities, but also on their dynamic capability 
comparability prior to the executive succession event (Grimes, Ren, & Stevens, 2011).  
Therefore, the average effect of treatment on the treated (ATT) approach to PSM was 
employed (Becker & Ichino, 2002). 
The PSM algorithm uses the matching with replacement option meaning that 
control group organizations could be matched to more than one organization in the CEO 
succession group.  In order to increase statistical precision in subsequent steps, a three-to- 
one (3-to-1) matching was employed.  Because matching was done with replacement, the 
actual control group size was not exactly three times that of the treatment group.  Rather, 
each treatment organization had three (3) control unit organizations which closely 
approximated their condition prior to CEO succession with some controls being matched 
to more than one treatment organization.  Lastly, the nearest neighbor method was used 
to match organizations who experienced a CEO succession to those in the control group.  
Based on this sampling of organizations from the general population of hospitals, the  
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comparison of their relative competitive performance levels before and after the CEO 
succession event were estimated. 
Specific Aim #2 
Examine the effectiveness of using cost efficiency production functions and SFE 
techniques to estimate inefficiency in U.S. hospitals. 
Q2: Can hospital inefficiency in this study sample be effectively estimated using 
cost efficiency and stochastic frontier functions as in Rosko and Mutter (2008)?  
This specific aim estimated inefficiency of U.S. hospitals using stochastic frontier 
techniques and cost production function models.  This aim also demonstrated the 
robustness of efficiency estimates using these techniques with respect to the sample 
population. 
Stochastic frontier estimation. 
For the purposes of this study, it was necessary to measure an organization’s 
capabilities for input-to-output transformation and to relate that measure to competitive 
market positioning.  SFE using stochastic frontier techniques addressed both the multiple 
input-to-output transformation measurement issue and the comparative performance 
challenge described earlier.  Appendix C provides the technical description of the SFE 
model used in this research.  Figure 1 illustrates the basic difference between regression 
and frontier estimation approaches.  In both illustrations, the data points are identical and 
inputs are used to create outputs.  The regression identifies the function that represents 
the average (mean) efficiency relationship between inputs and outputs such that the net  
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deviations (illustrated in red) of the observations form the line of best fit (the regression 
 line) and the slope represents the average efficiency among variables. 
 
 
Figure 1. Linear Regression and SFE Approaches to Measuring Performance 
 
 
 
 
 
 
 
Frontier estimation measures organizations’ relative capabilities with respect to 
transformational efficiency.  The result of frontier estimation is an index for each 
organization which describes the transformational efficiency of inputs to outputs that 
varies from zero to 1, with 1 representing the frontier of maximum efficiency.  The 
average of this index across all organizations is then an overarching measure of relative 
transformational efficiency.  Frontier estimation’s approach to comparing organizations’ 
performances is more closely aligned to RBV than linear regression because it begins by 
identifying organizations with a competitive advantage.  Frontier estimation measures 
organizations’ relative capabilities with respect to transformational efficiency and 
inquires how organizations achieve the best output with the minimal demand on inputs. 
Frontier estimation gets its name because it seeks to identify the ‘frontier,’ 
‘leading edge,’ or ‘edge of the envelope’ on which the most productive and efficient 
organizations balance inputs and outputs.  This frontier reflects the most efficient 
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transformation of inputs to output as experienced by the organizations analyzed.  In 
frontier estimation, the residuals are the distance of each observation from the frontier and 
represents slack, or the degree to which an organization falls short of maximum 
efficiency.  It also shows the opportunity that an organization has to either increase 
outputs with the same level of resource inputs, or produce the same outputs while 
decreasing inputs.  Put another way, regression analysis identifies the line that best 
represents the relationship among variables; whereas frontier estimation identifies the line 
that represents the best relationship among variables.  The SFE views the market from 
competitively advantaged organizations’ perspectives based on their dynamic capability 
to transform resources.  It then measures everyone else’s capabilities, and how far they 
must progress to reach the competitive advantage frontier. 
The use of stochastic frontier techniques to assess hospitals’ performances has 
been an active area in the healthcare literature since the mid-1990’s (Rosko, 
Chilingerian, Zinn, & Aaronson, 1995) and multiple literature reviews synthesizing those 
studies’ findings have been published (Hollingsworth, 2003; Hussey et al., 2009; 
McGlynn, 2008; Rosko & Mutter, 2008; Rosko & Mutter, 2011).  As most of the 
research has arisen from the economics’ perspective, it has tended to study the 
relationship between hospital inefficiencies and policy/environmental influences 
(Furukawa, Raghu, & Shao, 2010). Using frontier estimation to measure hospital 
inefficiency has raised some concerns because of the assumptions necessary to conduct 
an appropriate analysis (Rosko & Mutter, 2008).  These assumptions are based on a more 
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 simplistic cost-production structure which may ignore the more complex and costly 
healthcare delivery in U.S. hospitals today. 
However, in the studies they reviewed, Rosko and Mutter (2008) found stochastic 
frontier techniques to be fairly robust when measuring U.S. hospitals’ cost inefficiency 
with many model variations having correlation coefficients greater than 0.95.  Jacobs et 
al. (2006) also notes that as specificity has increased with SFE models and new 
explanatory variables have been introduced, previously unexplained inefficiency 
attributed to random error is now being captured and dissected with stochastic 
techniques.  This study follows previous hospital applications of SFE in the literature and 
focuses on cost inefficiencies.  Similarly, hospital-level cost efficiency functions were 
estimated using the standard approach and variables detailed in Rosko and Mutter (2008) 
and described below to establish an inefficiency frontier. 
Cost efficiency functions. 
This study employed the trans-log cost function used most frequently in previous 
hospital cost inefficiency studies for the flexibility and other dimensions provided.  The 
Cobb-Douglas eliminates squared and cross-product terms of the trans-log function to 
save degrees of freedom but sacrifices flexibility (Rosko & Mutter, 2008).  In their work 
with panel data of tea industries, Baten et al. (2009) rejected Cobb-Douglas in favor of 
the trans-log to estimate cost efficiency.  Further review of the literature and empirical 
analyses by Rosko and Mutter (2011) suggests that neither inefficiency ranking nor the 
estimates of mean or relative inefficiency are significantly impacted by the cost function 
utilized. 
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Theory as well as previous studies utilizing similar cost functions, applied to 
comparable national databases provided guidance in this study to determine variables for 
the trans-log cost function.  Specification of input, output and other descriptor variables 
used in a cost function model can be a formidable task for researchers given the 
multiproduct nature of hospitals.  Rosko and Mutter (2008) did find consistency 
definitions and common variable use among 11 national hospital studies with the AHA 
Annual Survey as their data source.  Cost function variables used in previous studies 
have been similar and typically consisted of labor and capital costs as the input price 
variables and outpatient procedures, cases treated or inpatient days as the output of 
production (Rosko & Mutter, 2008).  Definitions and descriptive statistics for the 
hospital cost function variables and the correlates of efficiency variables are provided in 
Tables 2 and 3 (Appendix D).  These variables are described in more detail below. 
This study used input price variables of capital and labor in the cost function in a 
similar manner to those hospital cost-inefficiency studies described by Rosko and Mutter 
(2008).  Depreciation and interest expense (DEPEXP) divided by the total number of 
hospital beds (BDTOT) represented the price of capital (PK) as is the case in all but one 
of the national studies reviewed.  Also in following with past practices, the price of 
labor (PL) was calculated by dividing the sum of employee benefits and other payroll 
expenses (PAYTOT) by the total number of full-time equivalents (FTE). 
Output variables used in cost function models of previous hospital inefficiency 
studies have been less consistent, again representing the multiproduct nature of 
hospitals. However, some version of patients treated (admissions, cases, procedures, 
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discharges, etc.) had been used in the studies Rosko and Mutter (2008) reviewed.  Due 
to the ease of conceptualization and its availability in the existing data set, this study 
used inpatient adjusted admissions (ADJADM) as the output variable for the cost 
function model.  As recommended by Rosko and Mutter (2008), this study used 
outpatient visits (VTOT) as an additional measure of output, recognizing the need to 
include both inpatient and outpatient productivity as has been done with other previous 
hospital inefficiency studies. 
In addition to the input and output variables described above, product descriptor 
variables were also included in cost efficiency functions of this study.  Each hospital 
inefficiency study reviewed by Rosko and Mutter (2008) included some form of product 
descriptor variable(s) to represent the case mix and services provided by sample 
hospitals.  Consistent with these studies, two new product descriptor variables 
representing hospital case-mix were created including:  OPDSURG, representing the 
ratio of outpatient surgeries (SUROPOP) to total outpatient visits (VTOT) and a binary 
variable, HITECH6, representing technology intensive facilities as determined by the 
availability of at least six out of the eight high-technology services (NICHOS, 
ICLABHOS, ADTCHOS, TRAUMHOS, ESWLHOS, MRIHOS, PTONHOS, 
ATRANHOS) as described in Rosko and Mutter (2008). 
Consistent with previous works in the literature, quality in this study was 
represented by the sample hospital’s teaching status.  Teaching status of hospitals was 
the most common structural measure of quality and resource availability in previous SFE 
studies according to Rosko and Mutter (2008) and they cite general consensus that 
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patient care quality in teaching facilities tends to be higher than in that of non-teaching 
hospitals. Two new binary variables were created to striate major and minor teaching 
hospitals. COTH represented a member of the Council of Teaching Hospitals (MAPP8), 
or major teaching hospital and MNTEACH represented minor teaching hospitals which 
are non-COTH members but have at least one FTE of medical resident (FTER).  Rosko 
and Mutter (2008) recommended the inclusion of quality and case-mix descriptors in the 
hospital cost function.  Their review of previous hospital inefficiency studies revealed 
inefficiency estimates were significantly impacted when these variables were omitted 
while their inclusion had minimal affect.  Rosko and Mutter (2008) support capturing the 
multidimensional nature of hospital services and quality over a simplified cost 
production function that assumes uniformity among organizations. 
Specific Aim #3 
Describe the differences in efficiency estimates based on change in CEO 
leadership and CEO succession origin in U.S. hospitals.   
Q3: Using the above techniques of simulated random sampling and cost 
efficiency frontier estimates, does a change in CEO leadership and then CEO 
succession origin create a measurable efficiency difference among the 
sampled hospitals? 
This specific aim used panel data derived from the cost efficiency estimates and 
SFE procedures described to assess for any measurable difference in hospital efficiency 
after change in CEO leadership and then based on selected CEO succession origin.  
Previous hospital studies have used cross-sectional designs to examine hospital 
85 
 
efficiency in terms of organizational or environmental factors such as health system 
membership, ownership or tax status, and inpatient bed size.  Following the trend of 
more recent studies which have emphasized panel designs (Rosko & Mutter, 2008), this 
study also used this panel approach for the potential advantages provided over cross-
sectional approaches alone. 
First, panel designs can increase degrees of freedom without the need to increase 
sample size.  This was beneficial to this study which was limited to a relatively small 
sample of hospitals which experienced a CEO leadership change in the year being 
analyzed. Additionally, panel approaches capture time-invariant effects of all phenomena 
under study which might otherwise go unmeasured in relatively short or intermediate 
time-series designs (Rosko & Mutter, 2008).  Panel designs can also avert some of the 
strong distributional assumptions required when using cross-sectional designs. 
Panel analysis. 
With repeated observations of enough cross-sections, panel analysis permits the 
researcher to study the dynamics of change within relatively short time series.  The 
combination of time series with cross-sections can enhance the quality and quantity of 
data in ways which would be impossible using only one of these two dimensions 
(Gujarati, 2003).  A longitudinal regression model for hospital competitive performance 
was developed to examine the effect of CEO succession on organizations’ dynamic 
processes. The effects of changes in organizational leadership, with the successor being 
drawn from either inside or outside of the organization, were compared to organizations 
who had no change in CEO.  SFE methods described were used to calculate the change 
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in organizations’ year-to-year efficiency compared to the market.  This change in 
efficiency was used as the dependent variable in this regression analysis. 
The Hausman test was used to indicate the appropriate regression model to 
create. The null hypothesis of the Hausman test is that the fixed and random effects 
models provide similar coefficients.  The alternative hypothesis is that the fixed effects 
estimation is appropriate and the random effects estimation is not and in this case, 
differences between the two models coefficients would be expected.  The fixed-effects 
model controls for all time-invariant differences between the subjects, so the estimated 
coefficients of the fixed-effects models cannot be biased because of omitted time- 
invariant characteristics.  Substantively, fixed-effects models are designed to study the 
causes of changes within an organization.  A time-invariant characteristic cannot cause 
such a change, because it is constant for each person. 
Using the cost efficiency estimates derived from the SFE procedure above as the 
dependent variable (DV), a five-year panel analysis of hospitals was performed.  The 
CEO succession events studied all took place in the third year of the analysis.  Therefore, 
Insiders and Outsiders were dummy coded with years 2003 and 2004 being equal to zero 
(0) and the remaining years equal to one (1).  The coefficients of the Insider and 
Outsider variables are interpreted as intercept adjustments for their linear estimates.  A 
Time variable was included and scaled one through five to assess the general secular 
trend with respect to organizations’ cost effectiveness.  The interpretation of the Time 
variable’s coefficient is that it is the slope of the control group’s linear trend.  Interaction 
terms for Time and the two variables of interest were created (Insider slope and Outsider 
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slope).  As the labels indicate, the interpretation of the interaction terms is that they are 
rates of change and are used to assess if Insiders and/or Outsiders as an intervention 
impact a organizations’ Cost Efficiency after they take over, which is the question being 
explored in this specific aim.  The results of the empirical analysis follow in the next 
chapter. 
Limitations 
There are limitations when performing secondary analysis of existing data as is 
the case with this study.  The main disadvantage of using secondary data analysis is that 
the researcher has limited, if any, control over the sampling and quality of data 
collected.  Existing data also has the potential to be inaccurate, incomplete or not suited 
to answer the research question (Hulley et al., 2007).  This study was a secondary 
analysis of existing data collected by the AHA Annual Survey and was limited to that 
study’s original sample of respondents.  With this in mind, AHA member organizations 
may be significantly different from non-member organizations.  Responses received 
from participants in the original dataset were believed to be representative of the sample 
and accurately reflect the data available within their organization at the time collected.  
Respondents were also believed to have completed the survey tools accurately with 
truthful disclosure to the best of their ability. 
A quasi-experimental study design tested the feasibility of using PSM techniques 
to simulate a randomized sampling from the existing dataset.  Known limitations do 
exist when using these PSM techniques with existing data.  PSM does not allow for 
matching of unmeasured contextual variables and assumes that all relevant covariates 
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have been measured (Dehejia & Wahba, 2002).  Biases may remain hidden that affect 
treatment estimates if this is not the case.  PSM also requires substantial overlap of the 
propensity scores between groups of matched variables to prevent a regressive effect 
toward the mean (Dehejia & Wahba, 2002).  Matching with replacement in this study 
design helps to correct for this effect.  Finally, the value of comparison or control groups 
may deteriorate over time and this bias effect is substantially more significant in the 
medium- to long-terms (>3-5 years).  The use of panel data measuring the intervention 
effect after two years of comparison data helped to limit this impact to the current study. 
Several other limitations to this quasi-experimental study design are also 
acknowledged.  The cross-sectional nature of the chosen dataset isolates organizational 
data to one point in time.  An approach of this nature has the tendency to misrepresent 
the dynamic concept of CEO succession and the many influencing factors.  Use of panel 
analysis over a five-year period of time, as with this study, helped to provide a more 
robust representation of the phenomena occurring.  In addition, participants from 
different regions of the country may vary considerably although the use of PSM and the 
nearest-neighbor approach helps to mediate this effect.  This secondary analysis and the 
dataset chosen may limit external validity and generalizability but the sampling 
technique chosen minimizes these limitations within the sample more so than other 
techniques would have. 
Summary 
A quasi-experimental study using panel analysis to combine cross-sectional and 
time series designs was conducted to describe competitive position deviations in U.S. 
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hospitals due to changes in CEO leadership and CEO succession strategy utilized 
relative to organizations with no leadership change.  The AHA Annual Survey was used 
as the data source in this secondary analysis.  Propensity Score Matching was utilized to 
simulate random sampling two years prior to the year the succession event occurred.  A 
longitudinal SFE of organizational performance levels over a five-year time frame was 
executed to determine competitive positioning relative to an efficiency frontier.  This 
study followed previous hospital applications of SFE in the literature and hospital-level 
cost efficiency functions were estimated using the standard approach and variables 
detailed in Rosko and Mutter (2008).  The effects of changes in organizational 
leadership, with the successor being drawn from either inside or outside of the 
organization, were compared to organizations who had no change in CEO.  The 
empirical analysis of executive succession in U.S. hospitals using this design follows in 
the next chapter. 
The application of PSM and SFE in a sampling design and analytic framework to 
explore the impact of executive succession on organizational performance satisfies many 
shortcomings identified thus far in the literature.  PSM provides for greater causal 
support and strengthens inferences that can be made relative to the impact executive 
succession has on organizational performance.  SFE aligns competitive advantage 
measurement with that of other organizations in the marketplace.  A theoretical model 
that allows for causal inferences about the succession–performance phenomena in terms 
leaders and strategists can understand was needed.  Rigorous work was not available that 
quantitatively studies organizational inefficiency levels using PSM and SFE with the 
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purpose of strengthening causal inferences of the executive succession–organizational 
performance relationship and that makes methodological recommendations for 
improvement.  Therefore, this study was necessary to fill these gaps in knowledge. 
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CHAPTER IV 
 
RESULTS 
 
 
Introduction 
 
The intent of the results reported here are to describe and demonstrate an 
improved sampling design and analytic strategy for exploring the executive succession–
organizational performance relationship that addresses limitations common in the 
literature to date.  An improved research study design which addresses each limitation 
was used to analyze the executive succession–organizational performance phenomena.  
This chapter follows the specific aims and research questions outlined in the 
introductory chapter.  First, PSM was successfully used to simulate a random sample of 
U.S. hospitals into control and intervention groups based on executive leadership 
change.  Next, hospital inefficiency in the simulated, randomized sample was estimated 
using cost efficiency and stochastic frontier techniques.  Finally, the improved research 
design using the techniques of random sampling and cost efficiency frontier estimates 
resulted in a quasi-experimental panel study of insider versus outsider executive 
successions and their impact on organizations’ competitive performances relative to 
organizations with no leadership change. 
Study Demographics 
Although there were more than 6,000 organizations reporting data each year for 
the AHA Annual Survey during the five year study period, incomplete data and other 
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exclusion criteria reduced the main sample to 3,941 per year.  Of these, 734 hospitals 
(18.6%) had a leadership change at the level of CEO from the 2004 to 2005 survey years. 
Although slightly higher than the national average of 16 percent reported by ACHE 
(2012) in 2010 and 2011, this is consistent with historical patterns reported previously. 
This succession event was the intervention studied and these organizations became the 
intervention group with which a control group was matched using PSM to simulate an 
RCT. 
To indicate whether an inside or outside succession had occurred, the 2003 and 
2004 AHA Annual Survey data as well as professional membership directories from 
ACHE and AONE were used to match background demographics of the newly selected 
CEOs in the 734 organizations experiencing a CEO leadership change.  Among the 734 
hospitals which had a CEO succession event occur, 622 (84.7%) drew executive 
leadership from outside the organization while 112 (15.3%) drew from within.  Outsiders 
were chosen almost six to one in the sampled hospitals to succeed as the CEO between 
the 2004 and 2005 survey periods. 
Results for Specific Aims 
Results for each specific aim and research question are outlined below.   
Specific Aim #1 
Examine the effectiveness of using Propensity Score Matching to 
simulate random sampling in an efficiency study of U.S. hospitals. 
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Q1: Can Propensity Score Matching be effectively used in this study to 
simulate random sampling of hospitals into control and intervention 
groups? 
The purpose of the first specific aim was to assure the appropriate sampling 
frame for the study and to produce an experimental control group to compare with a 
known intervention group, simulating random selection from a common population.  
PSM was successfully employed, as described in the previous chapter, to identify this 
experimental control group and simulate a random sampling design.  The results of the 
PSM follow in the next section. 
As discussed in the previous chapter, PSM allows intervention group outcomes to 
be compared to those of a control group constructed through matching of pre-
intervention propensity scores.  To identify a control group, this study examined 2003 
survey data for hospitals most closely resembling the pre-succession characteristics of 
CEO succession hospitals in 2005.  Looking backward in time for these characteristics to 
identify a control group, allowed for a close approximation of an RCT which would have 
assigned organizations to an intervention or control group prior to any intervention.  This 
matching using pre-intervention characteristics allowed the executive succession impact 
on organizational performance to be isolated and assessed more accurately thus 
improving the causal inferences that could have been made using other methods. 
The PSM approach (Appendix B) utilized in this study applied eight covariates to 
create balancing propensity scores which were then used to simulate a random 
assignment.  The means and standard deviations of the AHA estimation procedure 
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variables used in the PSM for both the population and the sample organizations along 
with their collective correlations are presented in Table 1 (Appendix D).  An additional 
variable was added (efficiency measure) to compare hospitals’ input-to-output 
conversion capabilities prior to the executive succession event and included in the PSM. 
The effectiveness of the PSM process and the covariates utilized was tested using 
a ‘balancing hypothesis’ assessment.  The PSM’s covariance balancing results are 
reported in Table 4 (Appendix D).  The first criterion of the balancing hypothesis is met 
because none of the individual covariates is a significant discriminator among 
organizations.  The second criterion is also met because the Pseudo-R squared after 
matching is close to zero and insignificant.  That is, the covariates have no explanatory 
power for predicting CEO succession between the matched samples (Pseudo R2 = 
0.0021; p > 0.673).  Therefore, through this matching the CEO succession event would 
appear to have been assigned randomly and an unbiased estimate of the post-event 
impact on organizational performance can be made. 
Using 3-to-1 nearest neighbor matching, the PSM process simulated a random 
sample of 1,640 hospitals for the next two specific aims.  Because matching was 
performed with replacement, the control group created is not exactly three times the 
intervention group.  In this study, each CEO succession organization had three control 
organizations that approximated conditions prior to the succession event with some 
controls being matched to more than one intervention organization. 
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Specific Aim #2 
Examine the effectiveness of using cost efficiency production functions and SFE 
techniques to estimate inefficiency in U.S. hospitals. 
Q2: Can hospital inefficiency in this study sample be effectively estimated using 
cost efficiency and stochastic frontier functions as in Rosko and Mutter (2008)?  
The purpose of this specific aim was to estimate inefficiency of U.S. hospitals using 
stochastic frontier techniques and cost production function models and to demonstrate 
the robustness of efficiency estimates using these techniques with respect to the sample 
population. 
Stochastic frontier techniques and cost production function models were 
successfully used in this sample population of U.S. hospitals to measure their capabilities 
for input-to-output transformation and competitive market positioning.  A longitudinal 
SFE of relative performance levels over a five-year time frame was executed to bracket 
the executive succession intervention with two years before and after the event occurred. 
Appendix C provides the full technical description of the SFE model used in this 
research.  The frontier created in this study reflects the most cost-efficient transformation 
of inputs to output in the sampled organizations.  Radial distances from each observation 
to the frontier were calculated to represent an organization’s inefficiency in transforming 
resources and the progression needed to reach the competitive advantage frontier.  The 
results of the frontier estimation procedure provided an index of transformational 
efficiency for each organization to determine their ability to maximize the conversion of 
inputs into outputs. 
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Three hypothesis tests were discussed in the previous chapter to determine a 
suitable SFE model to be used in this analysis and these results are summarized in Table 
7 (Appendix D).  The first was to test the cost-efficiency functions of the Cobb-Douglas 
versus the trans-log.  Likelihood ratio tests rejected the Cobb-Douglas over the trans-log 
function for this SFE.  Next, the utility of using SFE over OLS regression was tested 
where the test statistic revealed the need to reject the null hypothesis and that SFE is 
superior to OLS in this analysis.  Finally, the probability distribution of the efficiency 
component of the SFE is tested.  In this case, the truncated model fails to converge and 
therefore the null hypothesis of normality for the underlying distribution is rejected. 
Definitions and descriptive statistics for the hospital cost function variables and 
the correlates of efficiency variables are provided in Tables 2 and 3 (Appendix D).  
The input price variables of capital and labor were used in the cost functions of this 
study in a similar manner to those described by Rosko and Mutter (2008).  
Depreciation and interest expense (DEPEXP) divided by the total number of hospital 
beds (BDTOT) represented the price of capital for the sampled organizations while the 
sum of employee benefits and other payroll expenses (PAYTOT) divided by the total 
number of full-time equivalents (FTE) represented the price of labor.  Inpatient 
adjusted admissions (ADJADM) was used as the output variable for the cost function 
model due to its ease of conceptualization and its availability in the existing data set.  
Outpatient visits (VTOT) were also used as an additional measure of output, 
recognizing the need to include both inpatient and outpatient productivity as has been 
done with other previous hospital inefficiency studies. 
97 
 
Table 5 (Appendix D) details the means, standard deviations and correlations of 
the variables used in this longitudinal SFE of U.S. hospitals and Table 6 (Appendix D) 
follows with the resulting model statistics and coefficients.  SFE decomposes residuals 
from the regression model into two parts to extend the analysis.  These two parts helped 
to decipher within the sampled population what is random statistical error and what is 
non-random inefficiency. The relationship between organizational inefficiency and the 
variable of interest is represented by the coefficients.  In other words, coefficients 
convey a distance from the frontier and a positive coefficient indicates an increased 
relative inefficiency.  For example, the Natural log of normalized price of capital (β = 
0.211) can be interpreted as: a hospital’s distance to the competitive advantage frontier 
increases as its capital expenditures increase meaning increased inefficiency is 
associated with higher capital spending.  The trans-log functions used to estimate cost 
efficiency in the SFE perform consistent with the notion of economies of scale and a 
resource-based view of production. The positive Natural log of patient days and the 
negative Natural log of adjusted admissions illustrate this point well.  Utilizing less days 
than peers to provide equivalent care would be considered more efficient. 
Specific Aim #3 
Describe the differences in efficiency estimates based on change in CEO 
leadership and CEO succession origin in U.S. hospitals. 
Q3: Using the techniques of simulated random sampling and cost efficiency 
frontier estimates, does a change in CEO leadership and then CEO  
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succession origin create a measurable efficiency difference among the 
sampled hospitals? 
The purpose of this specific aim was to use panel data derived from the cost 
efficiency estimates and SFE procedure to assess measurable differences in hospital 
efficiency based on change in CEO leadership or CEO succession origin.  Following 
the trend of recent studies which emphasized panel designs (Rosko & Mutter, 2008); 
this study used a panel approach for the advantages it provided.  This was beneficial in 
this study which is limited to a relatively small sample of hospitals who had 
experienced a CEO leadership change in the year analyzed.  Panel approaches also 
captured time-invariant effects under study that might have otherwise gone 
unmeasured.  Using panel designs in this study also averted the strong distributional 
assumptions that would have been required if cross-sectional designs had been used.  
Based on this sampling of organizations from the general population of U.S. hospitals, 
the comparison of their relative competitive performance levels before and after the 
CEO succession event was estimated. 
Using the cost efficiency estimates derived from the SFE procedure above as the 
dependent variable (DV), a five-year panel analysis of hospitals was performed.  The 
CEO succession events studied all took place in the third year of the analysis.  Therefore, 
the Insiders and Outsiders were dummy coded with years 2003 and 2004 being equal to 
zero (0) and the remaining years equal to one (1).  The coefficients of the Insider and 
Outsider variables are interpreted as intercept adjustments for their linear estimates.  A 
Time variable was included and scaled one through five to assess the general secular 
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trend with respect to organizations’ cost effectiveness.  The Time variable’s coefficient is 
the slope of the control group’s linear trend and represents efficiency improvements over 
time.  Interaction terms for Time and the two variables of interest were created (Insider 
slope and Outsider slope).  These interaction terms were interpreted as the rates of 
change and were used to assess if Insiders and/or Outsiders impacted an organizations’ 
Cost Efficiency after taking over, which is the question being explored in this specific 
aim.  The results of the empirical analysis follow. 
Longitudinal regression was used to examine the effect of CEO succession on 
organizations’ dynamic processes.  The effects of changes in organizational leadership, 
with the successor being drawn from either inside or outside of the organization, were 
compared to organizations who had no change in CEO.  A longitudinal regression 
model for hospital competitive performance was developed. The SFE methods 
described above were used to calculate the change in organizations’ year-to-year 
efficiency compared to the market.  This change in efficiency was used as the dependent 
variable in this regression analysis. 
The Hausman test was used to indicate the appropriate regression model to 
create. The null hypothesis of the Hausman test is that the fixed and random effects 
models provide similar coefficients.  The alternative hypothesis is that the fixed effects 
estimation is appropriate and the random effects estimation is not and in this case, 
differences between the two models coefficients would be expected.  Test results failed 
to reject the null hypothesis at the 5 percent level (p = 0.0834) indicating that either the 
fixed or random effects model were appropriate.  In fact, both models returned similar 
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results for this study as indicated by the coefficients displayed in Table 8 (Appendix D).  
The fixed- effects model was chosen due to its ability to control for all time-invariant 
differences between the subjects.  In other words, the estimated coefficients of the fixed-
effects models cannot be biased because of omitted time-invariant characteristics.  This 
makes fixed-effects models better suited to study the causes of change within an 
organization. 
Initially, the panel analysis was used to measure global performance and 
efficiency changes over time of all sampled hospitals.  Using the Time variable alone, 
an assessment of the general trend in competitive performance among hospitals within 
this sample was made.  Hospitals in this sample demonstrated a significant positive 
trend indicating that collectively, they were moving the competitive advantage frontier 
outward, pushing the dynamic capabilities envelope.  In other words, the gap to the 
efficiency frontier is closing for most hospitals. 
Next, using only the 734 hospitals experiencing executive change (the 
intervention), more specific performance assessments relative to the frontier are made. 
Looking back with PSM, hospitals that changed CEOs had decreased efficiencies in 2003 
compared to those with no change.  In the year prior to the intervention year studied, 
hospitals that experienced executive succession had decreased efficiencies as their 
baseline compared to that of the control group (-0.361; p=0.018).  Furthermore, change 
in CEO within sampled organizations also negatively affected organizational 
performance. All sampled hospitals with either inside or outside succession experienced 
a statistically significant (p=0.05) negative jolt to their efficiency in FY2005. 
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The coefficients for both Insiders and Outsiders also demonstrate this 
phenomenon at a statistically significant level.  They are both positive and significant 
indicating that both origins of CEO succession increased the hospitals’ distance from 
the competitive advantage frontier compared to the control group where no succession 
occurred.  The results clearly demonstrate a negative jolt to performance where 
organizations were less competitive post leadership change (Table 9, Appendix D).  In 
other words, the change event itself caused hospitals to move away from the frontier and 
have an inefficiency increase relative to those with no change. 
Table 10 (Appendix D) summarizes the efficiency estimates over time for those 
hospitals experiencing executive leadership change.  These results suggest that CEO 
succession may take longer than one year to effect strategic changes.  Although in the 
year immediately following the succession event performance declined as above, by 
the year 2007, all organizations experiencing executive leadership change were 
performing better and demonstrated less inefficiency than in the periods before the 
change.  In other words, in 2007 their performance was closer to the frontier than it had 
been in the year the change occurred or in 2003 when baseline measurements were 
made.  The overall indication is that change in leadership ultimately improved 
performance in the hospitals sampled despite any negative or disruptive effects of the 
initial change.  The intercept of Time with Change also validates this by indicating the 
general trend of efficiency in sampled hospitals experiencing executive change is 
improving and that most hospitals are closing the gap on the frontier (Table 11, 
Appendix D). 
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When executive change occurred, outsiders were chosen almost six to one in 
the sampled hospitals to succeed as the CEO between the 2004 and 2005 survey 
periods.  In the years following the succession event, competitive advantage was 
assessed using the outsider and insider slope coefficients.  The negative coefficient 
indicates that organizations were closing the efficiency gap in the years following 
executive change. The interaction of Outsiders and Time in the form of an outsiders 
slope was significant (p = 0.009) and negative.  The insignificant results (p = 0.152) for 
the Insider and Time interaction, insider slope indicate that these organizations had a 
rate of change in their dynamic capabilities that did not differ from the control group 
over the period studied.  In other words, hospitals that experienced an outsider CEO 
succession event were able to close the gap to the competitive advantage frontier faster 
than comparable firms in either the control group or hospitals that used an insider.  
Organizations that had a lower competitive performance level to start the study period 
responded more to an outsider CEO succession event. 
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CHAPTER V 
 
DISCUSSION 
 
 
This study makes four contributions to the management and healthcare literatures. 
First, it combines two statistical techniques that are relatively new to the fields – PSM 
and SFE.  Coupled together, the ability to make stronger causal inferences using PSM 
and to demonstrate changes in organizations’ relative competitive advantages by using 
SFE overcomes two major limitations identified in the literature.  In addition, the PSM 
and SFE methodologies are used extensively in sociology (An, 2006) and economics (Del 
Gatto et al., 2011) literatures, respectively; thus this study strengthens the ties of 
management and healthcare to those domains.  In particular, the trans-log specification of 
the SFE, using the costs of capital and labor as inputs to produce services, hews closely to 
economics’ perspective for assessing relative competitive advantages among 
organizations, furthering the hospital SFE works of Rosko and Mutter (2008; 2011). 
Third, findings from this study add to the comprehension of the executive succession – 
competitive advantage phenomenon laying the foundation for future research.  Finally, 
the paper updates Karaevli’s (2007) literature review of the executive succession–
organization performance research literature. 
Summary of the Study 
The purpose of this study was to describe and demonstrate an improved sampling 
design and analytic strategy for exploring the executive succession–organizational 
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performance relationship that addresses limitations common in the literature to date. 
An improved research study design was employed with a sampling of U.S. hospitals to 
analyze the CEO succession–organizational performance phenomena.  The study 
culminated in a quasi-experimental panel study of insider versus outsider executive 
successions and their impact on organizations’ competitive performances relative to 
organizations with no leadership change.  The concept of transformational leadership was 
successfully used as a framework to guide this study and emphasized the influence 
executive leadership has on organizational performance. 
Overview of the Problem 
Despite its importance as a research topic, the executive succession–
organizational performance relationship continues to frustrate leading scholars because of 
the varied and conflicting findings (Finkelstein et al., 2009; Karaevli, 2007; Kesner & 
Sebora, 1994).  Moreover, the lack of robust, longitudinal study designs which link 
executive succession to organizational performance in a causal manner has hampered 
researchers’ ability to inform practice with evidence-based models that are linked to 
theory (Giambatista et al., 2005; Pitcher et al., 2000; Powell, 2002). 
Major Findings 
This research provides an empirical examination of CEO selection, specifically 
the dichotomy of CEO succession origin, and its implications for organizational 
performance.  Adding to the existing science of the executive succession–organizational 
performance relationship, this study provides new insights into how this relationship 
specifically impacts U.S. hospitals over time.  Methodological enhancements were also 
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realized, providing an improved empirical model for future research.  PSM was 
successfully used to simulate RCT and assign organizations to intervention and control 
groups based on matching pre-succession characteristics.  Frontier estimation techniques 
provided a powerful direct measurement tool for relative inefficiency in U.S. hospitals. 
Evidence from this study further substantiates the use of PSM and SFE in future 
healthcare research scenarios.  This study also supports current theoretical knowledge by 
validating an existing conceptual model for use in future leadership succession studies. 
Transformational leadership provided a succinct conceptual roadmap in this study for the 
influence leaders can have on individual followers and thus organizational performance. 
Generalized to the greater population, the overall results of this research indicate 
healthcare organizations are improving efficiency and pushing the market performance 
frontier.  Hospitals in this sample demonstrated a significant positive trend indicating that 
collectively, they are moving the competitive advantage frontier up and outward.  Thus it 
may be inferred that they are pushing the dynamic capabilities envelope.  The trans-log 
cost efficiency functions of the SFE perform as expected, highlighted the importance of 
economies of scale and resource-based care delivery necessary to remain competitive in 
today’s current healthcare environment. 
The pre- and post-succession measurement using a panel design was also a 
significant strength of this study.  Empirical evidence is provided to support results found 
in the literature indicating prior poor performance is associated with leadership change in 
hospitals.  In the year prior to the intervention year studied, hospitals that experienced 
executive succession had decreased efficiencies compared to that of the control group, 
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indicating that poor performance led to leadership change in the sampled hospitals. 
Further supporting the literature, organizations that chose an outsider had significantly 
lower pre-succession performance than those choosing an insider. 
Studying executive succession and organizational performance relationship 
constructs’ in cause and effect terms is challenging because over time one can cause the 
other and vice versa.  In general, executive leadership changes led to increased 
competitive capabilities in this study over the years studied.  Results suggest CEO 
succession may take longer than one year to affect strategic changes.  Although in the 
year immediately following the succession event performance declined, by the year 2007, 
all organizations experiencing executive leadership change were performing better and 
demonstrated less inefficiency than in the periods before the change.  In other words, in 
2007 performance was closer to the frontier than it had been in the year the change 
occurred or in 2003 when baseline measurements were made.  The overall indication is 
that change in leadership ultimately improves performance in hospitals. 
Empirical findings from this study are consistent with the literature in that 
leadership change is disruptive to organizations.  Both inside and outside succession led 
to a negative jolt or shock to efficiency in sampled hospitals.  The results of the SFE 
clearly demonstrated that change in the CEO negatively affected organizational 
performance in the year following the change.  All sampled hospitals with inside or 
outside succession moved away from the frontier and experienced an increase in 
inefficiency relative to hospitals with no change.  However, placing unsuccessful 
organizations under new management can make a positive difference to long-term 
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performance which may outweigh any short-term disruption to structures and processes.  
The negative impacts of executive leadership change empirically demonstrated may, at 
times, be clearly indicated.  Although outside the scope of this study, Boyne et al. 
(2007b) suggest that the disruptive effects to high performing organizations is more 
pronounced and can ultimately be detrimental to overall performance.  Recommendations 
for future research address this as a potential need. 
When executive change occurred, outsiders were chosen by sampled hospitals 
almost six to one to succeed as CEO during the 2004 and 2005 survey periods.  Post- 
succession, both insiders and outsiders trended toward the frontier closing the efficiency 
gap however, only outsiders did so at a statistically significant level.  Hospitals choosing 
an outsider to succeed as CEO closed the gap to the competitive advantage frontier faster 
than comparable hospitals without executive change or those who chose an insider. 
Outsiders were able to improve this performance gap at a significant rate while insiders 
performed no better than the control group.  Additionally, organizations that had a lower 
competitive performance level to start the study period responded more to an outsider 
CEO succession event.  Outside CEOs bring a fresh, new perspective and come equipped 
with a new set of tools for the organizational performance tool box.  They often bring 
new concepts and ideas for strategy and problem solving to the organization.  An outside 
perspective may also allow them to reach more broadly towards strategic solutions for 
change among industry leaders and maintain a competitive advantage.  However, this 
same perspective according to the literature contributes to more disruptive successions 
occurring when an outsider is chosen. 
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Insiders in this sample made a greater departure from the frontier than did 
outsiders in the succession year studied.  This possibly indicates better measurements of 
the construct occurring.  It could also indicate that blame for previous poor performance 
rests on the incumbent and other pre-succession circumstances where a greater, more 
immediate departure from the status quo was perceived necessary by the insider or the 
Board of Directors.  Insiders in this sample of hospitals may have felt as if they knew 
what needed to be done early on and got to work quickly whereas outsiders may have 
tended to hold back and attempt to learn the organization; giving themselves more time 
and thwarting any reputation as ‘hatchet’ man or woman.  A small sample size (n=112 
[15.3%]) may have impacted these results but speaks to something significant occurring 
in healthcare succession. 
This study confirms the reported above average rate of healthcare CEO succession 
compared to other industries with an 18.6 percent turnover rate in sampled organizations 
during the succession year studied.  Results from the panel data demonstrate that current 
CEO succession practices continue to fail many healthcare organizations, further 
supporting a renewed focus on succession planning practice and research in healthcare.  
The growth in executive succession–organizational performance relationship research is 
encouraging.  The need for a renewed focus on the essential nature of leadership 
succession planning across the entire healthcare industry remains. The crucial strategic 
nature of CEO selection and the magnitude of this individual’s influence on future 
organizational performance are widely recognized in the business sector (Zhang & 
Rajagopalan, 2010a). 
109 
 
A key role of healthcare leaders is to define the strategic goals and priority 
outcomes for their organizations and align the efforts of all stakeholders with these goals 
and outcomes.  The conceptual use of transformational leadership in this study improves 
comprehension of the influences strategic decisions made by leaders ultimately have on 
followers to achieve organizational performance goals.  Transformational leaders 
communicate a clear vision and strategic direction for the organization which becomes 
the basis of future behavior modeling and goal setting and that emphasizes collective, 
rather than individual interests.  Followers have a common understanding of the 
importance of specific visions and strategies, creating a highly cohesive unit with a high 
degree of goal congruence.  This empirical research and conceptual model empowers 
healthcare leaders to more fully understand how the executive succession–organizational 
performance relationship might be used to maximize quality of care and patient 
experience in U.S. hospitals. 
Conclusions 
Researchers continue to be challenged by inadequate research designs when 
exploring organizational phenomena such as executive succession and competitive 
performance in the marketplace.  Executive succession–organizational performance 
studies that use convenience sampling strategies and measure competitive performance 
using proxies make causal inferences difficult to understand for diverse or lay audiences. 
Such studies are also difficult to replicate as a means of building a case for causality 
because the competitive landscape shifts over time.  Each of these limitations poses a 
different threat to researchers’ abilities to develop and test theories dealing with the cause 
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and effect relationship between the executive succession–organizational performance 
constructs. 
There are three improvements to executive succession–organizational 
performance research designs as a result of this study that increased the congruence 
between theory and empirical findings.  First, using PSM to retrospectively simulate a 
randomized sampling of intervention and control groups better estimated causal 
relationships which exist between succession and performance since an RCT was not 
feasible.  Second, directly measuring organizations’ relative abilities to convert multiple 
inputs into multiple outputs rather than relying on proxy variables as in previous research, 
has increased the scientific realism of the competitive performance variables explored. 
Finally, applying robust analytic techniques to distinguish organizations who are 
managing resources to create competitive advantages from those who are performing sub- 
optimally has allowed for inferences to be made about similar organizations in the 
broader marketplace.  Findings from this quasi-experimental panel study using these new 
techniques in healthcare provide implications for improvement within the industry and 
are discussed below.  Opportunities for future research were also identified and 
considered as well in further discussion. 
Contributions to the Literature 
This current study both replicates and extends past research on the executive 
succession–organizational performance relationship.  This study adds to the works of 
Karaevli (2007; 2011) and others (Finkelstein et al., 2009; Holcomb et al., 2009) by 
seeking to understand these unique associations in the context of U.S. hospitals.  This 
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study fills several knowledge gaps by examining the impact CEO successions in U.S. 
hospitals have on organizational performance and the ability to effectively provide care.  
Prior to this study, empirical knowledge had been limited as to whether inside or outside 
CEO candidates perform better in these organizations. 
Karaevli (2007) provided a review of 52 inside-outsider executive succession 
studies published from 1954 to 2005 (see Appendix A for an update of this review 
through 2011).  Of those studies, only the two conducted by Samuelson, Galbraith, and 
McGuire (1985) and Wiersema (1992) employed control groups as part of the research 
design.  From 2005 through 2011, only one study by Arena et al. (2011) attempted to 
construct control groups to measure competitive performance measures.  However, none 
of these studies attempted to construct samples in which pre-succession organization 
characteristics were evenly or randomly distributed across intervention and control 
groups as part of the design. 
This research contributes to the larger body of leadership succession knowledge in 
multiple ways.  One key contribution of this study was the discussion and application of 
propensity score matching methods and stochastic frontier estimation techniques, which 
are relatively new to the healthcare literature.  Without simulating an experimental study 
design, it is difficult to draw causal inferences from the study group to the general 
population and maintain external validity.  PSM allows researchers to examine the 
primary effect of interest in non-experimental designs and substitute experimental control 
units using pre-intervention covariates.  This set of comparison units extends an 
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 experimental framework to settings where cause and effect relationships might not have 
been ethically, financially, and/or logistically feasible. 
Being prudent with regards to its limitations, researchers can use PSM to reduce 
selection bias in quasi-experimental and non-experimental designs.  PSM methods are 
particularly useful in the presence of a high dimensionality of observable characteristics 
which is the case in the healthcare industry.  When there are many variables to consider it 
can be difficult to determine which to match upon.  PSM is a method that can be used in 
future healthcare studies to assist researchers in simulating an event retrospectively and 
creating intervention and control groups as if they were randomly assigned. 
Direct measurement of organizational performance and competitive advantage has 
complicated efficiency research in the past and produced inconsistent findings with 
regard to the succession-performance relationship.  According to Kumbhakar and Lovell 
(2000), in order for an organization to maximize output and achieve or maintain 
competitive advantage, they must be both allocatively and technically efficient. Realizing 
that organizations are never fully efficient, researchers and others can use stochastic 
frontier analysis to isolate and measure efficiency gaps.  SFE is also used to explain 
random events that may lead to an efficiency shortfall not provided with other techniques.  
Thus, finally answering the question of whether inefficiency occurs at random or whether 
some organizations are predictably more efficient and can sustain a competitive 
advantage.  Patterns of sustained competitive advantage create model organizations 
which lie close to the frontier that others can emulate.  This estimation technique allows 
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 organizations to target potential increases in output or potential cost reductions that could 
be achieved in relation to the frontier of maximum efficiency. 
Techniques such as these have yet to be used extensively in healthcare research or 
operations.  Analysis using frontier approaches to understand and improve upon 
healthcare inefficiencies holds great promise in the U.S.  Scientists could potentially use 
the techniques to set performance benchmarks on the basis of inefficiency and to identify 
and correlate inefficiencies among healthcare organizations.  Healthcare organizations 
might use frontier estimation techniques to reward and promote efficient leaders who are 
meeting or exceeding organizational performance targets.  These techniques have great 
promise for value based purchasing initiatives by encouraging organizations to operate 
more efficiently and measuring the degree to which others fail to do so.  In order to 
effectively measure operating efficiency and competitive advantage, healthcare as an 
industry must move away from average performance and toward a best-practice frontier 
that better represents true sustainable results.  Therefore, frontier estimation techniques 
for measuring organizational performance and competitive advantage are likely to be an 
essential tool for healthcare leaders and researchers in the near future. 
SFE techniques used in this study helped to provide a conceptual model of 
inefficiency in healthcare to explain the succession–performance phenomena in terms 
leaders and strategists can understand.  This study quantitatively examined healthcare 
inefficiency using this model with the purposes of identifying executive succession–
organizational performance impacts and making recommendations for improved future 
measurement.  No studies have been published to date with a model which explains 
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associations between CEO succession origins and organizational performance in U.S. 
hospitals.  Very limited empirical evidence exists in the healthcare literature as to whether 
inside or outside candidates to succeed the CEO perform better in these organizations. 
This study answers the call of previous research demanding that inconsistent 
findings with regards to CEO succession origin and organizational performance need to 
be reconciled and current methodologies need to move beyond simple associational 
research addressing pre- and post-succession factors (Boyne et al., 2011a; Karaevli, 2007; 
Mahmood et al., 2011; McKee & Driscoll, 2008).  This narrow conceptualization has left 
a gap in our understanding of the executive succession–organizational performance 
relationship and this study bridges that knowledge gap.  Studies such as this examining 
hospital CEO succession and its organizational impacts can provide valuable decision 
support for all stakeholders including incumbent CEOs, boards of directors, executive 
search firms, and academic programs which prepare potential candidates.  This research 
provides specific findings that can be used to assist in structuring programs and informing 
stakeholders of critical facets of executive succession and changes in organizational 
performance as a result. 
Effective executive succession planning and an understanding of its impacts on 
organizational performance will provide the tools necessary for organizations to thrive 
during leadership change, supporting both organizational goals and developmental 
opportunities for employees (Wolf et al., 2005).  Findings from this study support 
recommendations in the recent literature that previously held notions of succession as 
simplistic and mundane need to be cast-off and left behind.  The lack of a best-practice 
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succession framework for healthcare that is clearly guided by theory and empirical 
evidence may contribute to the inconsistent implementation and outcomes that result. 
This study contributes to concept clarity and validates transformational leadership as a 
viable conceptual framework for future succession research and planning efforts. 
Understanding leadership succession best-practices in U.S. hospitals and how leadership 
succession strategies should be implemented to improve overall organizational 
performance will add to the current state of the science within the industry. 
Implications for Healthcare 
A better understanding of these concepts by healthcare executives and other key 
decision makers will assist in making the appropriate improvements to executive 
transition processes which maximize leadership influence over the delivery of already 
scarce healthcare resources.  This research provides discernment for healthcare 
succession strategies which organizations may use to enhance their competitive 
advantage in the marketplace and guidance for healthcare executives to measure, monitor, 
and benchmark their impact on organizational performance.  Now that the significance of 
executive leadership succession and successor origin in healthcare can be identified, we 
are better able to predict and measure the organizational performance gained or lost as a 
result.  We may also better control or manipulate this impact through improved 
succession planning and processes geared toward performance improvement which in 
turn will result in a positive impact on patient outcomes. 
Up to this point, an integrated framework detailing the succession–performance 
relationship of healthcare executives has not yet been developed.  Therefore, it has 
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become increasingly important for healthcare leaders and researchers to study these 
phenomena within the context of healthcare organizations and the inherent characteristics 
of the industry.  This study provides a research launching point forward and a foundation 
for healthcare organizations to build upon.  Understanding CEO succession factors that 
influence performance in healthcare organizations is vital to the industry and the future of 
efficient care delivery.  The succession–performance relationship could potentially 
provide a powerful means for healthcare executives to address a whole spectrum of 
challenges in today’s healthcare environment, including cost-containment, market 
competitiveness, and quality performance alongside ever-increasing supply and labor 
costs. 
Combining this research with a heightened awareness and increased application of 
proper succession planning techniques can foster long-term solutions for the current 
deficiencies of leadership talent in healthcare which, as discussed previously, are 
paramount to future organizational success.  The review of literature conducted in 
conjunction with this research revealed significant growth in the research domains of 
leadership succession and human resource management.  A broader awareness of the 
need to identify and prepare potential successors across all organizational levels for key 
roles has led to the emergence of a new construct called strategic talent management 
(Silzer & Dowell, 2010).  Considered a key competitive advantage in the marketplace, 
strategic talent acquisition and management enables organizations to acquire and 
maintain talent which may have been elusive to them in the past using traditional 
methods. 
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Effective talent management programs that include internal development while 
maintaining an external presence in the marketplace create a continuous pipeline of 
qualified leadership candidates who can provide the organization with confidence and 
assurance over the long term.  As discussed previously, agreement about the type of 
leader and skills needed for the future of an organization is also essential to the process, 
either with internal or external candidates.  Development programs will need to be 
adapted to accommodate the strategic needs of the organization and for the continuity of 
leadership.  Once talent management programs are implemented, evaluation is essential 
to ensure strategic succession frameworks align with the organizational mission and 
vision and are included in all aspects of the leadership development process. 
Strategies for Succession 
Succession literature in both the business and healthcare sectors indicates that 
formalized succession planning is likely to provide organizations a healthier, more 
stable operational appearance and better position them to positively and proactively 
address strategic challenges over the long-term.  However, succession planning in 
private-sector organizations continues to be practiced far more frequently than it is in 
healthcare (Favaro et al., 2010).  Although the pervasiveness of its implementation is 
less than desired, the perceived importance of succession planning in healthcare is 
widespread (Garman & Tyler, 2007). 
Formal, strategic succession planning for senior leaders can better position 
healthcare organizations to address changes in leadership and prevent any gaps in 
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services provided.  Senior leadership transitions that occur smoothly promote a sense 
of continuity and stability for healthcare organizations and the communities they serve. 
According to Garman and Tyler (2006), the extent of threats and opportunities 
created for healthcare organizations by senior leadership transitions are highly dependent 
on the effectiveness of succession plans in place.  Implementation and evaluation of 
leadership succession strategies remain troubling for most healthcare organizations 
however. An integrative review of both business and healthcare literature by Carriere et 
al. (2009) indicated that a best practice, leadership succession framework for healthcare 
does not exist.  Their review did find similarities between the business and healthcare 
sectors in which both emphasize continuous planning, the clarification of expectations 
and potential needs, and the identification of future leaders as imperative to the 
leadership succession process. However, even with these similarities, there remains no 
actionable model of healthcare leadership succession available based either in theoretical 
conceptualization or on empirical data. 
On average, 16 percent of U.S. hospital executives leave their positions during a 
typical year having served a term of less than six years (Pizzi, 2010).  This revolving 
door phenomenon can be even more pronounced at some hospitals.  Healthcare 
organizations can ensure their future success by presumptively preparing for executive 
leadership changes before they happen.  According to Bower (2007b), this is a process 
that can take over a decade or more and presents the greatest challenge some 
organizations will ever face.  Leadership succession can be an intense, anxiety producing  
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time for many employees and whether expected or unexpected, vacancy at the CEO level 
heightens this anxiety. 
Organizations experiencing a succession event, even those that have performed 
exceptionally well for several years, have a natural tendency to regress back to average 
or even below average performance during times of transition.  Grusky (1960) forecasted 
the disruptive nature of succession events on organizational performance in the early 
sixties and this supposition holds true for this analysis as well.  The results here indicate 
a significant drop in efficiency during the year CEO succession occurred within the 
study sample, supporting the notion that executive succession is a challenging time 
organizationally.  Purposeful CEO succession planning may help to facilitate a smooth 
transition and diminish the disruptive effects of succession on organizational 
performance and employee well-being. 
The addition of rigorous and strategic leadership development and succession 
planning at all levels in healthcare organizations is essential.  Hospitals must begin to 
think more like large, strategic corporations when it comes to succession and 
leadership development.  To avoid further crisis, it is essential for healthcare 
organizations to abandon their current fiscal year thinking and expand to that of years 
and decades. Major, best-practice initiatives are needed in healthcare to guide 
extensive leadership development, recruitment, succession and retention programs that 
ultimately improve accountability and overall performance of the organization. 
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Investing in Leadership Succession and Development 
The lack of universally practiced executive leadership succession planning and 
development in U.S. hospitals is alarming given the void of candidates in healthcare 
with the adequate skills, knowledge and experience to succeed as CEO.  The supply of 
highly skilled and knowledgeable healthcare leaders qualified to lead in the industry is 
far less than the opportunities needing to be filled.  In addition, desirable leadership 
qualities and experience are often transient across multiple industries and can lead to 
significant recruitment and retention challenges for healthcare leadership roles.  
Healthcare organizations are competing with other industries to attract qualified 
leadership candidates, further exaggerating the healthcare leadership supply / demand 
misalignment. Continued failure of the healthcare industry to invest in a sustained pool 
of aspiring, accomplished executive leaders will lead to continued inappropriate filling 
of leadership vacancies and potentially poor organizational outcomes. 
Limited succession planning in the U.S. healthcare industry despite its 
significance to future success further supports the need for research of the CEO 
succession-organizational performance relationship within this industry.  To close the gap 
on the frontier of performance, highly successful organizations maintain a pipeline of 
talent that can take their organization to the next level.  Succession planning and 
leadership development programs in healthcare can benefit both participants and 
organizations by promoting mutual goals and priorities.  Despite its clear advantages, the 
rationale for not employing a comprehensive succession plan as a component of 
leadership development activities within healthcare organizations remains elusive.  A 
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strong succession plan should rank at the top of any organizational to-do-list however, 
succession planning for most healthcare organizations is more difficult to institute than it 
might appear at face value.  According to the ACHE, over half of hospitals stated that 
they had no succession plans at all, which is 20 percent greater than other industries 
(Weil, 2006).  Considerable barriers still exist in the implementation and maintenance of 
such planning, especially at the CEO level.  These barriers need to be understood and 
addressed by today’s healthcare leaders in order for their organization’s to proactively 
prepare for leadership transitions in the future. 
The emphasis needed on cultivating future leaders to ensure longevity and a 
sustained competitive advantage is missing in many healthcare organizations.  In fact, 
healthcare as an industry has not invested in succession planning or other leadership 
development activities at a level equal to that of other industries.  Groves (2006) reports 
that data from the American Management Association indicates just 1.25 percent of 
payroll expenses are spent on leadership development and training within the healthcare 
industry while the top 100 companies average four percent.  Heightened CEO turnover 
in the healthcare industry (ACHE, 2012; Stephens, 2006) and a decline in CEO tenure 
over the same time period (Khaliq, Walston, & Thompson, 2006; Sinnott, 2008) 
highlight the further deterioration potential if adaptations are not made. 
A major strategic need of organizations during the leadership succession process 
is the transfer of responsibility and knowledge among leaders and employees.  This 
demonstrates a significant commitment by an organization that is much more than 
merely promoting individuals to fill vacancies.  Cumulative knowledge of an 
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organization’s employees and their ability to effectively apply it is crucial to long-term 
success.  The onus of knowledge transfer relies on executive leaders who are ultimately 
responsible for organizational performance.  Rothwell (2010b) describes best practice 
succession planning where strategic knowledge transfer needs of the organization are 
integrated with career development of individual employees into a single comprehensive 
talent management program.  Enhancing the strengths and balancing the weaknesses of 
both programs, succession planning and career development are more potent tools 
working together towards an organization’s competitive succession strategy (Rothwell, 
2010a). 
Rothwell (2010b) also indicates that for organizations today to be successful they 
must shift their focus from traditional succession thinking to what he calls tactical, daily 
succession.  Citing responses from executives that no time exists for strategic succession 
planning due to the demands of daily operational work, Rothwell (2010b) encourages 
incorporating succession into the daily activities of every leader.  He also recommends 
increasing the awareness of succession and development throughout the organization 
and that the use of an effective succession plan can link the top-down strategic 
objectives with the bottom-up talent progression that already exists. 
Forward thinking organizations expect leaders at all levels to plan for their own 
exit strategy in an effort to minimize gaps, maintain unit performance and meet 
organizational goals.  In fact, Groves (2007) and others suggest that in order to ensure 
that succession planning and leader development is a top priority for all leaders, 
succession planning responsibilities should be integral to all leadership performance 
123 
 
expectations and incorporated into their appraisal measurements.  This investment should 
focus on all key leadership positions within the organization and not just those of upper 
administration.  A bottom-up approach encourages all leaders of an organization to 
evaluate their strategic leadership positions and any high potential employees who might 
be looking to grow within the organization.  It also encourages internal reflection on a 
leader’s own professional path and progress made towards individual career growth 
potential.  Pragmatic leaders understand that their current positions are not permanent and 
they recognize that long-term organizational success depends on their successor’s 
accomplishments as much as their own. 
Hospital boards and incumbent CEOs should also be held accountable to and 
encourage active involvement in the entire succession and development process.  For 
prudent CEOs, succession is just one more process that needs to be organized and 
structured so that it is well managed.  As stated earlier, management of the succession 
process is often a reflection of the overall management of the organization.  Surveys 
indicate that only 27 percent of hospital CEOs said that they had identified at least one 
individual to succeed them (Garman & Tyler, 2007), up slightly from 21 percent in 2004 
(Garman & Tyler, 2004).  However, still problematic for most hospital CEOs 
considering this figure is nearly 60 percent in other businesses (Weil, 2006). 
The incumbent CEO must start investing heavily in succession planning early on 
in their tenure with some sources indicating this should begin after their very first year 
with the organization (Bower, 2007b).  To ensure strategic mission and vision needs of 
the organization are met, the current CEO must be heavily involved in succession 
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planning and leadership development program processes from initiation to ongoing 
evaluation.  The incumbent CEO must ensure that he or she has the leadership team in 
place to successfully implement the desired organizational strategy.  An adept and poised 
CEO embraces succession planning as a means to promote connectedness, strength and 
stability for the long-term.  He or she sets the tone and readies the cultural environment 
for positive succession within an organization. 
Executive support is vital in the development of future talent and healthcare 
executives must understand the importance of an active and operational succession plan 
that persistently grooms future leaders.  A strong and visible CEO, committed to the 
succession planning process will demonstrate for employees its essential nature and 
significance to future organizational health.  Without this personal involvement and 
significant time investment by the CEO to know the status of his or her own leadership 
pipeline, organizational succession processes will continue to under deliver. 
Although critical to the ongoing success of most organizations, finding and 
retaining future leaders is futile if their ongoing development is overlooked, resulting in a 
lack of sufficient preparation for new job functions.  Groves (2006) found that two thirds 
of hospital CEOs anticipates a significant shortage of individuals prepared to assume 
executive leadership positions in healthcare.  Some propose that this can and should be 
remedied by developing existing talent from within the organization (Bower, 2007b; 
Collins & Collins, 2007; Wilson, 2005).  According to them, capturing internal capital 
and creating a comprehensive set of assessment and development practices will provide 
inner strength and allow hospitals to become more strategic in executive recruitment and 
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succession.  However, Larcker and Miles (2010) cite statistics from their survey of CEOs 
indicating that almost 40 percent of respondents admitted that they had no viable internal 
candidates.  More than half of these same CEOs cited a dearth of leadership growth and 
development resources that potentially drive future executives away from healthcare. 
Several other sources in the literature also reveal education and training for on-
boarding new healthcare executives lacking in many institutions (Larcker & Miles, 2010; 
Garman & Tyler, 2007).  This lack of talent management by healthcare organizations 
could explain why outsiders were chosen six to one in the sampled hospitals of this 
study. Practical, cost-effective methods to bridge this knowledge gap in healthcare 
institutions are needed to further support the competitive advantages achieved through 
succinct executive succession.  Results from this study highlight the need for thoughtful, 
strategic executive succession to successfully navigate any disruptive effects and to 
emerge more prosperous with sustainable positive outcomes over the long term. 
Individual Leadership Impact 
The healthcare industry is constantly changing and the need for stable executive 
leadership is paramount.  Increased utilization, inadequate reimbursement, and 
constrained capacity have placed U.S. hospitals in a very fragile state (American 
Hospital Association, 2005b).  As demand for value-based purchasing increases, so does 
the interest in the relationship between hospital performance and leadership.  Creating 
value by enhancing the effectiveness of healthcare delivery systems and developing the 
human potential necessary for its future should be of great significance to health 
researchers, care providers and policy makers. 
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Strong executive healthcare leadership is not only imperative because of the need 
for cost effective, quality care that provides consumers value, but also because of the 
scope and intricacy of today’s healthcare organizations.  Healthcare in our nation 
provides great promise, but without strong leadership at the highest executive level, 
current industry pressures can jeopardize that promise (American Hospital Association, 
2005b).  Previous succession research has revealed disconnects between perceived 
capabilities of internal candidates and benchmarks to measure them against the external 
marketplace.  In order to develop a diverse group of leadership candidates for comparison 
within healthcare, scholars must come to a consensus on measures of their aptitude and 
their ability to impact outcomes.  The methods and techniques used in this study should 
advance that endeavor and better guide performance measurement after executive 
leadership change. 
Uncertainty surrounding the skills and abilities of future healthcare leaders also 
contributes to concerns that individuals with the proper balance of talent and passion to 
tackle these roles are in limited supply.  Larcker and Miles (2010) found that only half 
of their study sample of CEOs had written criteria for the required skills of their 
successor and question the discernment and appreciation of the necessary skills if not 
written and not communicated to all internal and external stake holders.  Their research 
indicates that it is challenging for most organizations to accurately identify these 
necessary skills for successful executive leadership. 
The belief of many executives that the skills necessary to become an effective 
leader are not teachable also hinders much of the leadership development efforts at the 
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executive level according to Collins and Collins (2007).  They suggest that the 
identification of these skills is extremely important prior to implementing any leadership 
succession or development planning.  The lack of research in the area of healthcare 
executive leadership succession influence makes future transition a particularly 
concerning issue for the industry.  Techniques from this research used to assess and 
benchmark executive influence on performance may support healthcare organizations in 
the direct measurement of individuals being considered to lead.  Failure to resolve 
disparities between leadership expectations and candidate abilities can significantly 
disturb the most well planned leadership transition and cause even the most well 
qualified candidate to stumble. 
Significant debate still exists in the literature as to the impact that individual 
executive leaders have on organizational performance.  Leading scholars still pose the 
question: “Do leaders matter?” and argue both perspectives, for and against (Augier & 
Teece, 2009; Boyne et al., 2011a; Rowe et al., 2005).  The extent of a leader’s 
organizational influence on healthcare providers and quality care provision has 
conventionally been linked to his or her style of leadership (Boga & Ensari, 2009). 
Findings from the literature review for this project present several examples in the current 
literature indicating that executive leadership succession can significantly impact 
organizational performance and that inappropriate leadership succession can lead to less 
than optimal outcomes (Carriere et al., 2009; Collins & Collins, 2007; Giambatista et al., 
2005; Zhang & Rajagopalan, 2010b). 
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As early as 1960, Grusky’s common sense perspective suggested that top leaders 
do impact organizational performance but a lack of definitive, empirical evidence to 
substantiate this view has not been available for some time.  This study adds empirical 
evidence in support of an individual leader’s impact, both positively and negatively, on 
organizational performance.  Overall in this sample of U.S. hospitals, change in 
executive leadership did lead to an improvement in baseline organizational performance.  
As discussed in the previous chapter, a five-year panel analysis provided evidence that 
leadership selection does matter and the executive leaders chosen from outside the 
organization were able to close the performance gap faster than insiders. 
Transformational leadership was successfully used in the study to conceptually 
demonstrate the impact executive leaders can have on healthcare organizations.  
Elements of transformational leadership aid in the comprehension of the mutual strategic 
goals that must be met to expand services, improve quality and recruit or retain the best 
care providers in healthcare.  Succession processes guided by transformational leadership 
appeal to the values and needs of both the organization and potential leaders and 
followers.  Within transformational leadership succession, a relationship is formed where 
the needs and aims of both the organization and individual become unified towards a 
collective purpose.  According to Baker (1992), this collective purpose is a crucial 
concept of transformational leadership and one of its strategic benefits. 
Senior leadership succession continues to generate remarkable interest from 
individuals both inside and outside healthcare organizations.  Even employees without 
leadership aspirations need to understand how organizational leaders are selected and 
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how the succession process is handled.  A transparent process can encourage employee 
engagement and should be viewed positively.  Understanding how leaders are chosen 
may frame how individuals think about the organizations they aspire to be or are 
presently employed with. 
Employees at all levels of an organization should recognize that leadership 
matters and the selection of future leaders is important to enduring success.  They 
should also know that traditional ways of promoting leaders has not always been the 
right answer.  Choosing leaders like interchangeable machine parts only to be discarded 
if short-term targets such as quarterly returns or profit margins are not met, sends the 
wrong message organizationally.  Similarly, those successful at the operational level 
with short-term deliverables may not be suitable for championing long-term successes 
and profitability.  According to Bower (2007a), competition for the highest office within 
most organizations remains extremely political, in spite of colossal risks at stake.  He 
insists that a great deal of succession talk occurs under a cloak of secrecy, behind locked 
doors and in whispered tones.  True transformational leadership and thoughtful 
succession does not invite or encourage politics or surreptitious behavior. 
Exploration of the effect executive leadership change has on organizational 
performance in U.S. hospitals as in this research, better informs future succession 
efforts. Given the importance of CEO transition on organizational performance 
identified in this project and the lack of succession planning in healthcare compared to 
other industries (Weil, 2006), competitive advantage related to executive leadership 
succession in healthcare should be given a renewed focus.  Recommendations for future 
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research are described in detail below as opportunities to replicate this study in a variety 
of settings abound. 
Future Research 
This current study acknowledges several limitations that may provide some 
interesting future research avenues.  Similar to previous executive succession research, 
this study relies on existing data providing quantitative outcomes.  CEO behaviors are 
not directly observed, studied or quantified.  These limitations interfered with the ability 
to study underlying or preexisting factors of the successor or organization which might 
have contributed to the succession origin chosen.  Research into different strategic 
priorities and change implementations of insiders versus outsiders would make for 
interesting future research.  More qualitative analysis through the use of interview or 
survey data would have allowed for further insight into what successors actually do 
when initiating change.  Qualitative analysis of primary data in conjunction with real-
time, direct observations of executives’ behaviors might provide further insight into the 
dynamics of executive decision making and organizational outcomes.  Analysis of 
primary survey and interview data combined with currently available quantitative works 
contributes to a more holistic view of the insider versus outsider succession origin 
phenomena. 
This study measured organizational inefficiency as a deviation from a cost 
efficiency, best-practice frontier by which all organizations in the sample were 
measured. While this is an improvement over other methods which utilize an index of 
performance in the form of stock prices or revenues, it still limits our ability to 
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understand specific organizational or individual differences that may have existed during 
the time period studied.  The frontier also represents a pattern of efficient allocation and 
resource utilization in key competitive dimensions across this sample of U.S. hospitals 
and in this case, the impacts as a result of executive leadership change but it does not 
capture other strategic nuances that may exist.  Further study using this dataset in 
conjunction with SFE while isolating other strategic initiatives in healthcare may 
provide greater discernment of their organizational performance impacts as well. 
This study utilized a large sample of public, acute care healthcare organizations 
and this study contributes specifically to this population.  This sample does not capture 
the research phenomena in industries other than healthcare or organizations providing 
more specialized services than acute, inpatient hospital care.  Future research studying the 
executive succession – organizational performance relationship in other industries or 
organizations may provide new knowledge not discovered here.  Replicating and 
extending this study’s methodology into other contexts including smaller, specialty, or 
government owned facilities may address the paucity of research in these areas. 
According to the literature, executive succession is most likely to occur in 
poorly performing organizations.  Although selection bias based on prior performance 
is controlled for using PSM in this study, prior organizational performance is not an 
active, independent variable of study.  Boyne et al. (2011a) suggests that executive 
successions can have positive or negative effects on an organization but this is 
dependent on the organization’s prior performance leading up to the succession event.  
They hypothesize that when prior organizational performance is low, succession will 
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have a more positive effect and conversely when prior performance is high, executive 
succession is more disruptive.  This panel data could be utilized in future research to 
analyze organizational performance prior to the succession event and further test this 
hypothesis.  The application of SFE and PSM techniques and the use of this large, 
longitudinal sample may affirm or refute the findings of Boyne et al. (2011a) as they 
relate to U.S. hospitals, thus furthering knowledge on the subject. 
Additional study is needed in regards to SFE and quality outcomes in this 
population.  Although hospitals may be performing very close to the cost efficiency 
frontier, there is limited information in this study about quality outcomes achieved at the 
frontier.  In other words, is less truly more and is low cost healthcare sustainable while at 
the same time maximizing quality or is quality being sacrificed for the sake of 
efficiency? It is not clear from the current literature whether efficient use of capital and 
labor alone have a direct impact on outcomes or quality in healthcare. 
It is acknowledged that the quality indicators used in this study as covariates to 
compare like organizations were not the strongest available and they were in no way 
intended to be the sole, definitive measure of quality in the sampled hospitals.  Other 
indicators of quality outcomes in healthcare such as hospital accreditation status and risk 
adjusted mortality rates could potentially be used in the future, in addition to cost, as 
outcomes of healthcare production.  However, there are no clear, evidence-based quality 
outcome variables identifiable in a large hospital dataset such as the one used here which 
would have provided a true quantitative measure of care quality being delivered along 
the frontier.  Teaching status was chosen in this study as a measure of quality because of 
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its prevalence in the existing dataset and the structural advantages for hospitals it 
commonly represents (Rosko & Mutter, 2008). 
Although SFE represents a more global measure of competitive advantage and 
accounts for random factors that affect performance not addressed with previous 
methods, future healthcare research could benefit from improvements upon this 
methodology by adding definitive representations of care quality outcomes along with 
cost efficiency.  Maximizing the two represents the principles of creating consumer value 
and of value based purchasing as indicated in previous chapters.  Establishing direct 
measures of value in healthcare and combining these with SFE techniques used here to 
create a value frontier may provide for a better analysis of outcomes-based efficiency. 
Both executive change and succession origin in this study were measured as 
dichotomous variables.  CEO succession origin was a dichotomous variable used to 
represent unobservable characteristics of human capital at the executive level and to 
measure the effects of CEO origin on organizational performance and competitive 
advantage.  Artificially dichotomizing such a complex, multidimensional construct might 
not provide the best description of the phenomenon occurring.  Karaevili (2007) suggests 
measuring insiderness or outsiderness as a continuum rather than a dichotomous variable 
and that, combined with the methods of this current study may provide new insight to the 
phenomenon occurring. 
Approaching continuous variables and combining them with SFE techniques may 
provide new findings not gleaned from this study.  The panel data and techniques from 
this study could be used to address the performance implications of a succession origin 
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continuum.  Expanding upon this study’s findings, future research should assess if 
varying degrees of executive background and experience from outside an organization 
are associated with changes in the competitive performance gap found here.  In other 
words, does Karaevli’s (2007) outsiderness continuum hypothesis hold true with this 
panel data and do executives with longer tenure outside an organization or industry close 
the performance gap even faster than those with less outside experience.  This 
longitudinal panel analysis is a good beginning to succession – performance research but 
further discernment around this continuum is needed over the long-term. 
Executive change in this study was also measured dichotomously as a 
representation of organizational change at the CEO level.  This measurement only 
denoted the presence or absence of CEO succession and no other magnitude of change 
was represented such as succession of other executive team positions occurring in 
conjunction with the CEO, length of vacancy of the position in question prior to filling, 
or previous CEO tenure in the position being succeeded.  Measuring other dimensions 
of executive change occurring within the panel data to supplement the executive change 
measured here might prove valuable in future research. 
According to Barron, Chulkov, and Waddell (2011), other senior leadership 
successions, not only that of the CEO, affect team composition and team dynamics 
which has great potential to influence strategic decision making and organization 
performance. Replicating this study with the demographics of the entire senior executive 
team may provide new insight into the succession–performance relationship not revealed 
here. Team dynamics before and after a CEO change may further impact organizational 
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performance results beyond that of the CEO succession alone.  For example, an outsider 
CEO with a predominantly insider senior leadership team and vice versa might result in 
alternative performance results. 
In addition, CEO succession events in conjunction with the departures of other 
executive team members shortly thereafter and the origins of their replacements chosen 
could expand on the knowledge gained in this research.  SFE and panel data that 
evaluates the entire executive team rather than just the CEO may provide clarity in the 
literature related to the influence of executive team dynamics and their effects on 
organizational performance.  Future research using similar data and methodology could 
investigate how changes in executive team dynamics affect strategic decision making and 
organization performance.  Focusing on CEO succession alone without considering other 
executive team changes may not precisely depict the executive succession–organizational 
performance relationship in its entirety. 
Factors inherent in the organization and those that compose the surrounding 
external environment may have the potential to significantly influence executive 
leadership transition and may be related to post-succession organizational performance. 
Previous research has suggested that many factors alone can influence organizational 
performance (Shen & Cannella, 2002) including:  location, size, ownership and 
governance structure, primary service delivery and many other external market factors. 
What is not known is if an association exists between organizational or environmental 
characteristics and the perceived need for executive leadership change in healthcare. Also 
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 unclear from previous research, is if these same characteristics influence the decision to 
select an outsider over an insider to succeed as CEO. 
Organization size has been specifically related to the likelihood of having 
succession planning practices in place and translated into the need for outside succession 
but further empirical analysis is needed.  Hospitals larger than 130 beds are most likely to 
have succession planning programs in place while those with 60 beds or less are likely to 
go without (Garman & Tyler, 2007; Giambatista et al., 2005).  Because the disruptive 
effects of succession are likely more pronounced in smaller organizations where 
leadership development resources tend to be scarcest, an increased focus on small to 
mid-sized organizations is pressing.  Research into whether lack of human capital in 
smaller organizations leads to increased succession from the outside would be beneficial 
in this population.  If so, ensuring that the same performance benefits realized here with 
this broad sample population are also seen in outside executive successions of smaller 
organizations would be essential. 
Reconciling inconsistent findings on the influence of internal and external 
factors associated with executive leadership succession may provide additional 
understanding of their post-succession influence towards improved performance in U.S. 
hospitals.  Although controlled for in this current study using PSM techniques to 
simulate random selection, organizational and environmental factors of U.S. hospitals 
could have very specific influence on the need for executive change, the origin of the 
successor chosen, and subsequently the post-succession organizational performance.  
Organizational and environmental factors may be particularly significant in the CEO 
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succession – organizational performance context and their level of influence would be 
very suitable for further study. 
Often scholars have theorized that inside successions signal intent to maintain a 
particular strategic course or direction and outside succession is indicative of needed 
change.  However, these suggested effects lack empirical evidence to take them beyond 
hypothetical concepts and further study of these effects which accompany inside versus 
outside succession is necessary.  These suggested effects are not well understood and 
may have a more pronounced effect on organizational performance than characteristics of 
the individual successor.  Panel data and methodologies such as those used in this study 
may help differentiate true succession effects rather than the suggested effects of inside 
versus outside succession. 
The findings of this study confirm that executive succession can take a year or 
more to affect strategic change and organizational performance.  These findings are 
consistent with previous literature stressing the importance of new CEOs, especially 
outsiders, learning the organizational culture and gaining the social or political capital 
necessary to promote change (Karaevli, 2007).  The longitudinal dataset in this study only 
allowed for panel analysis of the performance change occurring in the two years 
following a succession event.  A longer, more robust longitudinal dataset might provide a 
more complete analysis of the succession impact occurring later in executive tenure. 
Additionally, more extensive longitudinal research would unveil whether or not the 
performance improvements and increased gains with outsiders are maintained after he or 
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 she is succeeded or if they matriculate back to or further below the baseline of the 
original succession event. 
The methodology advances which are integral to this study could be applied in 
many other realms.  Gaps in the literature related to the executive succession–
organizational performance phenomenon in other sectors remain and would be improved 
upon with future analysis.  Expanding this study to other settings and industries would 
expand upon the generalizability of the methods and techniques used as well as the 
succession – performance results uncovered.  Also of interest would be to use this panel 
data to study things beyond the control of the CEO such as simultaneous changes to 
organizational structures, strategies or processes which might make performance 
enhancements difficult or impossible in the short-term.  This might include changes to an 
organization’s mission or service offerings, changes to the organizational board or 
governance structures or significant workforce reductions prior to CEO arrival.  Changes 
such as these may impact any CEO’s ability to improve organizational performance and 
should be further evaluated over a longer time frame. 
Replacing insider versus outsider executive succession in this current study with 
alternative independent variables and then controlling for succession origin may provide 
an entirely different main effect also worthy of analysis.  Other characteristics of CEOs 
such as age, educational background, gender and tenure as an executive may be of 
interest and may similarly supplement the knowledge gained here with regards to 
succession origin.  Voluntary versus involuntary turnover is another component that 
could provide useful information with regards to the executive succession–organizational 
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performance relationship.  This could be a worthwhile variable of measurement that 
provides further dimensionality on the topic.  Khaliq et al. (2006) found that CEO tenure 
is relatively the same for hospital CEOs regardless of whether they separate from their 
position voluntarily or involuntarily.  Further research into organizational performance 
consequences of voluntary versus involuntary executive separations and CEO tenure are 
warranted.  The short life cycle of hospital CEOs is of significant interest to healthcare 
research and whether the effect on performance in healthcare is greater than in other 
sectors would be very impactful.  Research in this area might identify characteristics 
specific to healthcare organizations dissuading our leaders from serving over the long 
term. 
Summary 
The need for further research into the executive succession–organizational 
performance phenomena and succession planning for healthcare executives is more 
important than ever to minimize the potential negative impacts of transition at the highest 
levels of our organizations.  Prior to this research, there was very limited empirical 
evidence available in the healthcare literature related to the influence executive 
succession has on performance in U.S. hospitals.  There was also limited knowledge as to 
whether inside or outside candidates to succeed the CEO performed better in these 
organizations.  Continued failure of researchers to address the lack of empirical evidence 
and to improve research designs and analytic inferences related to this phenomenon has 
been problematic.  This study overcame several empirical knowledge gaps in the  
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healthcare literature related to the influence CEO succession and CEO origin have on 
performance outcomes of healthcare organizations. 
This study adds to the works of Karaevli (2007; 2011) and others by seeking to 
understand the unique associations of the executive succession–organizational 
performance relationship in the context of U.S. hospitals.  Threats to determining a 
causal relationship between executive succession and organizational performance were 
presented in the review of literature.  An improved sampling design and analytic strategy 
that addresses these threats was employed with a sampling of U.S. hospitals to 
successfully analyze this phenomenon.  The methodologies of using PSM to identify a 
sample that approximates an RCT study design and the use of SFE to estimate 
organizations’ competitive positions relative to one another is ground-breaking for the 
healthcare literature and a noteworthy addition to current science in itself. 
Measurement of the insider-outsider succession’s impact on competitive 
advantage has thus far been scientifically inconclusive across multiple disciplines.  The 
preceding chapters have described an improved sampling design and analytic strategy for 
exploring the executive succession – organizational performance relationship.  This 
improved research study design was employed to conduct a quasi-experimental panel 
study of insider versus outsider executive successions and their impact on organizations’ 
competitive performances relative to organizations with no leadership change, furthering 
current empirical evidence on the subject. 
PSM was successfully employed, as described in the previous chapters, to 
identify an experimental control group and simulate a random sampling.  This study 
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confirms that PSM can be used in future studies to assist researchers in simulating 
random assignment of pre-intervention characteristics occurring in the past.  SFE was 
used to directly measure organizational performance and inefficiency relative to the 
marketplace and the resulting frontier provided new insights into how the executive 
succession–organizational performance relationship specifically impacts U.S. hospitals 
over time. The general trend in U.S. hospitals is that efficiency is improving and overall 
healthcare organizations are pushing the frontier of market performance.  Evidence from 
this study further substantiates that frontier estimation techniques can be a powerful 
direct measurement tool for relative inefficiency in U.S. hospitals. 
This study provided an empirical examination of CEO selection, specifically the 
dichotomy of CEO succession origin, and its implications for organizational performance.  
The pre- and post-succession measurement using a panel design was a significant 
strength of this study and in general, leadership change led to increased competitive 
capabilities where outsiders were able to close the competitive gap faster than insiders.  
Strong empirical evidence from this study provides support for the cause and effect 
associations of executive impact on organizational performance.  The evidence here is 
significant in support of the notion that leaders do matter and they do have an impact on 
organizational performance over the long-term. 
This research answers the call of Carriere et al. (2009) and furthers the 
establishment of a best-practice framework for succession planning and organizational 
performance in healthcare.  The consistency and transparency provided through 
transformational succession planning promotes optimum organizational efficiency, 
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improved leader and follower satisfaction and in turn, better patient care.  This research 
also emphasizes the need for a renewed focus on the essential nature of leadership 
succession planning in healthcare.  As indicated previously, the results from this 
longitudinal sample of U.S. hospitals reveals that outside successors are able to close the 
succession performance gap at a statistically significant rate that is faster than that of 
insiders.  These findings indicate that the internal leadership development efforts and 
investments made in healthcare thus far may not be providing the returns desired.  These 
leadership development failures internally may provide some explanation as to why the 
use of replacement planning rather than thoughtful, strategic succession planning has 
become the status quo in healthcare. 
Best practice organizations understand that strategic development of next 
generation leaders is now a fundamental part of daily operations rather than something 
only high-performing organizations invest time and effort undertaking.  Organizations at 
this level understand that great leadership is crucial to achieve sustained performance 
and that leadership development and succession planning processes are essential, core 
business initiatives crucial to outperforming their competition.  When organizations and 
their leaders begin to act nonchalant about their talent management processes and duties, 
their capacity to improve performance begins to spiral downward. 
Increasingly, healthcare professionals are being asked to do more with less and to 
improve performance in order to achieve organizational goals.  Diminishing healthcare 
resources in our country coupled with increased utilization results in a limited capacity to 
provide care where most needed.  As discussed in the introductory chapter, efficiency 
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and productivity in a healthcare organization often drive many performance optimization 
and quality of care initiatives.  In light of these trends and the gathering concern over the 
future of healthcare leadership, this study sought to examine how highly successful 
hospitals and healthcare systems might address these issues through a better 
understanding of the executive succession–organizational performance relationship. 
Greater effectiveness and efficiency through better utilization and management of 
available resources should be the utmost goal of any health system.  However, as stated 
earlier, this should not be at the expense of care quality or patient outcomes.  In studies 
they cited, Huerta et al. (2011) found that historical reforms geared towards improvement 
in healthcare efficiency and quality have centered around payment system reform rather 
than the strategic effectiveness of care delivery processes.  Executive leadership in 
healthcare organizations is a crucial link to the provision of many health system services 
targeted at quality patient outcomes and efficient service delivery.  After all, maintaining 
health system performance and the strategic planning for such is the true competitive 
advantage when it comes to an organization’s ability to provide needed services. 
Preserving the balance between efficiency and quality, strategy and vision in 
healthcare can be a big job.  The CEO post is critically important to healthcare 
organizations however, many people fail to measure up to this responsibility.  The 
complex and highly political environments that make up healthcare organizations can be 
difficult for new leaders to navigate and may necessitate a considerable transition period 
for both those inside and outside the organization.  These continually changing 
environments also make it critically important to continuously assess executives’ abilities 
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to meet the organizational needs post-succession.  Today’s healthcare organizations 
necessitate competent executive leadership to meet daily operational challenges and to 
maintain strategic focus. 
With executive leadership turnover steady at a relatively high rate, the healthcare 
industry must begin to investigate what inherent characteristics are dissuading leaders 
from entering and remaining in these positions.  Given current talent misalignments, the 
way we go about executive succession may be misguided.  The importance of the 
succession process is often overlooked or not well planned during executive transition. 
Healthcare organizations are particularly vulnerable as they tend not to place adequate 
emphasis on leadership succession and the cultivation of future leaders needed to sustain 
organizational performance advantage and lasting stability. 
Succession planning is more important now, than ever in the history of 
healthcare. With fewer than 20 percent having an active executive succession plan, most 
hospitals and health systems have settled in to a reactionary, do nothing approach.  
Failed preparation can be costly for organizations both in the short- and long-terms as 
vacancies can happen without warning and at the most inopportune time.  Replacement 
planning for healthcare leaders is not working.  Strategic and thoughtful succession 
planning from the bottom–up is urgently needed in the healthcare industry in this 
country.  Reinvigoration of succession essentials that focus on people, their talents and 
the development of both is vital to the continuation of performance improvements 
achieved within the industry and to reduce the immediate post-succession disruption. 
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This research fills several knowledge gaps and should serve to inform other 
disciplines about the predictability of the succession–performance relationship based on 
pre-succession factors, specifically the CEO origin dichotomy of insider versus outsider. 
Further exploration of the significance of this impact will improve predictions of the 
organizational efficiency and productivity gained or lost as a result.  We may also better 
control or manipulate this impact through improved succession plans and processes.  A 
better understanding of these concepts in healthcare will assist in making appropriate 
leadership decisions that maximize access to already scarce healthcare resources.  By 
improving our understanding of executive leadership succession in U.S. hospitals and 
the organizational performance impacts of it, this study has contributed significantly to 
the existing knowledge on the topic. 
The concept of transformational leadership was successfully used as a framework 
to guide this study and to emphasize the influence healthcare leaders have on 
organizational performance.  The CEO’s influence on overall organizational change and 
his or her ability to be truly transformational should be emphasized.  The CEO’s 
transformational role in leading quality improvement and positive patient outcomes 
should be recognized and supported across all disciplines.  Leadership skills and abilities 
of the CEO are significant to the smooth operation of healthcare organizations. 
Healthcare CEOs positively influence the work environment and foster staffs’ 
commitment to stimulate greater achievement and enhance the organization’s competitive 
advantage.  Transformational CEOs who provide meaning, safety and growth for 
followers in the workplace will be able to promote innovation, change and creativity 
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throughout the organization.  These contributions typically translate into quality patient 
care, excellent customer service, and superior patient outcomes that continue to move 
healthcare in our country forward. 
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APPENDIX A 
 
THEORIES AND CONSTRUCTS IN THE SUCCESSION-PERFORMANCE LITERATURE 
 
 
Theory / 
Construct 
 Article Use Findings Future Implications 
Agency Theory Combs, J. G., Ketchen, D. J., 
Perryman, A. A., and Donahue, 
M. S. (2007). The moderating 
effect of CEO power on the 
board composition–firm 
performance relationship. 
Journal of Management 
Studies, 44 (8), 301-323. DOI: 
10.1111/j.1467-
6486.2007.00708.x. 
Agency theory considers 
relationships where 
responsibility is delegated 
from principals to agents. 
Agents are assumed to be self-
interested and to possess goals 
that diverge from those of 
principals. 
According to agency theory, 
CEOs are self-interested, risk 
averse, and possess goals that 
diverge from those of 
shareholders. Thus, CEOs will 
engage in self-serving actions at 
shareholders’ expense when given 
an opportunity.  The position of 
CEO confers considerable power 
over a firm’s resources because 
shareholders are widely dispersed 
and no one shareholder can exert 
direct control. 
 
Application of these ideas to 
the executive suite suggests 
that, without adequate 
incentives and monitoring, 
CEO-agents will emphasize 
their personal wealth and job 
security at shareholder-
principals’ expense.  Thus, 
principals must align agent 
interests with their own 
through some combination of 
incentives that tie agent 
rewards to principals’ 
outcomes and direct 
monitoring of agent behavior. 
Shen, W. and Cho, T. S. (2005). 
Exploring involuntary 
executive turnover through a 
managerial discretion 
framework. Academy of 
Management Review, 30 (4), 
843–854. 
Agency theory is used to 
develop a theoretical 
framework of involuntary 
executive turnover through the 
environmental and 
organizational contexts 
executives face. Framework 
posits that objectives and 
actions interact to affect the 
causes and performance 
consequences of involuntary 
executive turnover, as well as 
which executives will be 
forced to depart. 
Organizational governance of 
organizations (e.g., ownership 
structure, board composition, and 
investor activism) can have an 
important effect on the occurrence 
of involuntary executive turnover 
during periods of poor 
performance. Executives do not 
necessarily align themselves with 
these control mechanisms. 
Executives are responsible for 
organizational performance 
and should be dismissed when 
performance becomes poor.  
Executive dismissals under 
poor performance will increase 
shareholder wealth. 
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 Article Use Findings Future Implications 
Agency Theory 
(continued) 
Zajac, E. J.  (1990). CEO 
selection, succession, 
compensation and firm 
performance:  A theoretical 
integration and empirical 
analysis.  Strategic 
Management Journal, 2, 217-
230. 
The agency approach popular 
in assessing CEO 
compensation has not yet been 
used to address CEO 
selection/succession issues 
that have been studied 
extensively in the 
organizational literature, e.g. 
the choice of an insider versus 
outsider CEO. 
The study offers a more complete 
conceptual model of the 
relationship between CEO-related 
issues and firm performance, 
based on a combined agency and 
organizational perspective on 
CEO selection, succession, 
compensation, and firm 
performance. 
 
 Zhang, Y. (2005). A selection 
that cannot stand the test:  
Succession contexts and new 
CEO dismissal. Academy of 
Management Best Conference 
Paper 2005. Academy of 
Management. 
This study used agency theory 
to examine new CEO 
dismissal (i.e. within three 
years after succession) and the 
potential for inappropriate 
selections and any preceding 
succession contexts that may 
have been related to 
inappropriate choice. 
With a sample of 204 CEO 
successions in the time period of 
1993-1998, the authors found that 
the origin of the new CEO and the 
characteristics of the board of 
directors at the succession time 
have significant impact on the 
likelihood of new CEO dismissal. 
Based upon agency theory and 
human capital theory, the 
author argued that new CEO 
dismissal may represent a 
correction to an inappropriate 
CEO selection and 
accordingly, succession 
contexts that tend to lead to an 
inappropriate CEO selection 
will increase the likelihood of 
new CEO dismissal. 
Common- Sense Multiple works use the 
construct conceptually in the 
succession-performance 
literature. 
See literature review for 
definition and usage of this 
construct. 
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Complementarity 
Theory 
 Choi, B., Poon, S. K., & Davis, J. 
G. (2008). Effects of knowledge 
management strategy on 
organizational performance: A 
complementarity theory-based 
approach. Omega - The 
International Journal of 
Management Science, 36, 235–
251. 
The authors present a 
framework of 
complementarity analysis 
as the theoretical basis for 
analyzing the impact of 
knowledge management 
(KM) strategies on 
organizational performance. 
By drawing on the 
complementarity theory from 
the economics literature the 
authors seek to determine which 
knowledge management 
strategies work well together 
and what the performance 
implications to the organization 
are. 
 
Contingency 
Theory 
Boyne, G. A., James, O., John, P., 
& Petrovsky, N. (2011a). 
Leadership succession and 
organizational success: When do 
new chief executives make a 
difference? Public Money and 
Management, 31(5), 339-346. 
DOI: 
10.1080/09540962.2011.598345. 
The authors use 
contingency theory to test 
whether management 
matters and if leadership 
succession impact is 
contingent on prior 
performance. 
Changes in the top management 
team lead to improvements 
when initial performance is bad, 
but result in deterioration when 
initial performance is good. 
The results support the view 
that high-performing 
organizations should attempt 
to retain members of their 
senior management team, 
whereas low performers 
should seek to replace them. 
 Guthrie, J. P., & Datta, D. K. 
(1997). Contextual influences on 
CEO selection: Firm 
characteristics and CEO 
experience. Journal of 
Management Studies, 34(4), 537–
560. DOI: 10.1111/1467-
6486.00062. 
Based on the strategic 
choice (Child, 1972) and 
upper echelons (Hambrick 
and Mason, 1984) 
perspectives, this work 
examined the linkages 
between executive 
characteristics and the 
formulation and 
implementation of strategy. 
The type of manager required 
for effective organizational 
performance is contingent upon 
a firm's critical functions, 
including those of the 
environmental context. 
Although cognitive styles or 
personality constructs may be 
more important determinants 
of a person's suitability for an  
organization, it is clear that 
the observable attributes of 
firm tenure, chronological 
age and functional 
background serve as salient, 
differentiating candidate 
characteristics. 
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Article Use Findings Future Implications 
Contingency 
Theory 
(continued) 
Boyne, G. A., James, O., John, 
P., & Petrovsky, N. (2011b, July 
| August). Top management 
turnover and organizational 
performance: A test of a 
contingency model. Public 
Administration Review, pp. 572-
581. 
The authors use contingency 
theory concepts to construct 
an executive succession 
model applicable to CEOs. 
Executive change is most 
significant when the new 
executive has different motives 
and cognitive schema then the 
predecessor, but performance 
implications are moderated by 
internal and external variables 
and constraints. 
Contingency theory presently 
provides a major framework 
for organizational design. 
There are, however, several 
major challenges to it. The 
contingency theory of 
organizational structure is 
said to be obsolete because of 
new organizational forms, but 
this lacks credibility. 
 Katou, A. A. (2008). Measuring 
the impact of HRM on 
organizational performance. 
Journal of Industrial 
Engineering and Management, 
1(2), 119-142. DOI: 
10.3926/jiem.2008.v1n2.p119-
142. 
The authors hypothesize that 
according to the resource- 
based view (RBV); human 
resource management 
(HRM) policies do influence 
employee outcomes and 
subsequently improved 
organizational performance. 
The purpose of this research 
was to analyze this impact in 
the context of any external 
contingencies. 
Data were collected from 178 
organizations and demonstrated 
that HRM polices did have a 
direct impact on organizational 
performance however, strategic 
vision and business systems 
partially mediated improved 
organizational performance 
associated with HRM policies. 
The influence an event may 
have on organizational 
performance is contingent on 
factors external to that event 
and should be considered as 
potential mediators. 
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Human Capital 
Theory 
Landeta, J., Barrutia, J. 
and Hoyos, J. (2009). 
Management turnover 
expectations: A variable 
to explain company 
readiness to engage in 
continuous management 
training. The 
International Journal of 
Human Resource 
Management, 20 (1), 
164–185. DOI: 
10.1080/095851908025
28557. 
The authors analyze the 
behavior of companies 
against human capital 
theory and their 
expectations of the 
benefits of continuous 
management training. 
These benefits, in turn are 
assessed with regard to 
the firms’ expectations 
that their managers will 
leave without having the 
chance to recover the 
outlay invested. 
The empirical study carried out by 
the authors with over 300 Spanish 
companies revealed that company 
projections for voluntary turnover 
of management employees are 
positively connected with earlier 
experiences of turnover, with 
markets prone to change, and with 
business risk. Negative 
associations were found with 
developed social management 
networks, satisfied managers and 
their degree of company 
specificity. No significant 
relationship was observed 
between expected turnover and 
the intensity of training. 
The risk of not recovering the 
investment in training due to 
management turnover is more 
complex than strictly economic. 
According to the authors, human 
capital theory is the best-known 
theoretical contribution in the field of 
training.  Human capital theory 
presents training as an investment 
made with the expectation of 
recovering it later in the form of 
greater income and higher 
productivity. It also explains the 
investment that companies make in 
management training resources and 
their cautious behavior when they are 
not sure they will be able to recuperate 
the investment. 
 Bailey, E. E. and Helfat 
C. E. (2003). External 
management 
succession, human 
capital, and firm 
performance: An 
integrative analysis. 
Managerial and 
Decision Economics, 
24, 347-369. DOI: 
10.1002/mde.l 119. 
The authors draw on 
human capital theory from 
economics, and analyze 
top management as a 
critical resource that may 
create positive value for 
the firm. Economic 
analysis of human capital 
is used to analyze whether 
differences between 
external successors and 
the transferability of their 
human capital affects firm 
performance. 
By comparing external successors 
that have within-industry and 
related-industry skills, the authors 
found that successors with less 
transferable skills have greater 
variance of firm performance. 
This analysis provides an example of 
the benefits of integrating economic 
concepts with empirical research in 
the traditional strategic management 
literature and economic analysis of 
human capital as it affects firm 
performance. 
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Human Capital 
Theory 
(continued) 
Zhang, Y. (2005). A selection 
that cannot stand the test: 
Succession contexts and new 
CEO dismissal. Academy of 
Management Conference 
Paper 2005. Academy of 
Management. 
See agency theory above.   
Knowledge Transfer 
Theory 
Grossman, W. (2007). Intra-
industry executive 
succession, competitive 
dynamics and firm 
performance: Through the 
knowledge transfer lens. 
Journal of Managerial Issues, 
19, 340-361. 
The author cites limited emphasis 
on the possible effect of changes to 
the executive ranks of a firm on 
knowledge flows, rivalry, and 
competitive strategy. The author 
suggests that more research should 
be directed to understanding 
personnel flows between 
organizations and how related 
knowledge transfer not only enables 
firms to adopt innovation, but also 
to differentiate and distinguish itself 
from rivals. 
The author recommends that 
firms avoid viewing new 
executives as a commodity 
that carries highly 
specialized, technically 
relevant knowledge. The 
commoditization of human 
resources in this way may be 
a self-defeating tactic if it 
leads to the homogenization 
of a firm's core product or 
services. In other words, the 
complexity of resources and 
interpersonal relations must 
be considered. 
In order to absorb new 
knowledge, innovate, and 
secure a competitive 
advantage through intra-
industry succession, 
organizations must consider 
the attributes of the new 
executive, and effectively 
manage the way they are 
integrated into the 
organization. 
 Organizational 
Adaptation Theory 
Shen, W., & Cho, T. S. 
(2005). Exploring involuntary 
executive turnover through a 
managerial discretion 
framework. Academy of 
Management Review, 30(4), 
843–854. 
Organizational adaption theory is 
used to conceptualize involuntary 
executive turnover as a mechanism 
through which organizational 
governance purposely replaces 
individual executives to better align 
with the changing environmental 
demands. 
Following this perspective, 
the authors found that poor 
performance and 
environmental shifts are 
important indicators of the 
need for change in an 
organization’s top 
management group. 
Managerial discretion 
framework predicts an 
improvement in 
organizational performance 
following involuntary 
executive turnover. 
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Organizational 
Learning Theory 
Soebbing, B. P., & Washington, 
M. (2011). Leadership 
succession and organizational 
performance: Football coaches 
and organizational issues. 
Journal of Sport Management, 
25, 550-561.  
The authors attempted to 
integrate organizational learning 
into the three common constructs 
of leadership succession, 
common sense, vicious cycle 
and ritual scapegoating. 
Incorporating organizational 
theories with leadership 
succession constructs provide 
a greater context to with 
which to explain the 
selections made by 
organizations in the 
succession process. 
 
Zhang, Y., & Rajagopalan, N. 
(2004). When the known devil is 
better than an unknown God: An 
empirical study of the 
antecedents and consequences of 
relay CEO successions. Academy 
of Management Journal, 47, 483-
500. 
Organizational learning theory is 
used to hypothesize that relay 
CEO succession has a positive 
effect on post- succession 
performance because relay 
successors are able to start their 
learning process prior to taking 
office. Few empirical studies 
have used organizational 
learning theory in the context of 
CEO succession research and 
mainly focused on the timing of 
the learning process during a 
succession event. 
Theory assumes that the 
departure of an incumbent 
CEO always leaves a gap that 
the new CEO cannot instantly 
fill. Rather, a learning process 
on the side of the new CEO 
as well as on the side of the 
organization is initiated that 
requires some time and at first 
leads to a decline in firm 
performance – an effect that 
is later reversed as the 
learning process proceeds. 
This initial learning phase of 
a newly appointed CEO lasts 
for about two and a half 
years before learning 
becomes more incremental. 
An initial performance 
decline after a CEO 
succession event may be 
reversed over this period of 
time. Organizational 
learning offers an 
explanation for this initial 
performance decline and its 
reversal during the early 
tenure of a new CEO. 
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Power Circulation 
Theory 
Combs, J. G., Ketchen, D. J., 
Perryman, A. A., & Donahue, 
M. S. (2007). The moderating 
effect of CEO power on the 
board composition–firm 
performance relationship. 
Journal of Management 
Studies, 44, 301-323. DOI: 
10.1111/j.1467-
6486.2007.00708. 
The authors suggest power 
constantly circulates rather than 
just during times of organizational 
decline. Unlike agency theory 
which primarily focuses on self- 
serving behaviors by the CEO, the 
authors suggest power circulation 
theory centers on the latent and 
overt jockeying for position among 
rival executives. 
The authors found an 
interaction between CEO 
power and power of others, 
specifically those who sit on 
the board. This interaction 
has ramifications for board 
structure and how the 
circulation of power varies 
across an organization. 
The authors add to the work 
of Shen and Cannella (2002) 
by offering a contribution to 
power circulation theory that 
focuses on the consequences 
of contestation of power to 
investors rather than that of 
the incumbent. 
Shen, W., & Cannella, A. A. 
(2002). Revisiting the 
performance consequences of 
CEO succession: The impacts 
of successor type, post-
succession senior executive 
turnover, and departing CEO 
tenure. Academy of 
Management Journal, 45(4), 
717-733. 
Highlighting the importance of 
succession context, this study 
follows a power circulation theory 
of control and the authors 
suggested three types of CEO 
successors: followers, contenders, 
and outsiders. The power 
circulation theory of control 
suggests that incumbent CEOs face 
a risk of power contests initiated 
by other senior executives as well 
as by outsider directors. CEOs are 
surrounded by senior executives 
who are typically ambitious 
individuals with strong needs for 
power and control. The power of a 
CEO is thus, from time to time, is 
subject to challenge and 
contestation from these senior 
executives. 
From their sample of 228 
CEO successions, the authors 
discovered that successor type 
interacts with post-succession 
senior executive turnover to 
influence organizational 
performance and that there is 
a difference in the strategic 
mandates and ability of 
incumbent CEOs to initiate 
strategic change. The authors 
were able to distinguished 
two types of insider 
successors, contenders and 
followers, on the basis of how 
their predecessors left the 
positions to which they 
succeeded. 
Outside successors may have 
the mandate to change the 
direction of the firm, but the 
lack of firm-specific 
knowledge and the 
resistance of the remaining 
management team members 
put outsiders at a 
disadvantage. The authors 
found a strong negative 
impact of outsider 
succession on post-
succession operational 
performance. So-called 
contenders performed better 
in this study. 
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Theory / Construct 
 
Article Use Findings Future Implications 
Resource-Based View 
(RBV) 
Katou, A. A. (2008). Measuring the 
impact of HRM on organizational 
performance. Journal of Industrial 
Engineering and Management, 
1(2), 119-142. DOI: 
10.3926/jiem.2008.v1n2.p119-142. 
See contingency theory 
above. 
  
 Landeta, J., Barrutia, J., & Hoyos, 
J. (2009). Management turnover 
expectations: A variable to explain 
company readiness to engage in 
continuous management training. 
The International Journal of 
Human Resource Management, 
20(1), 164–185. DOI: 
10.1080/09585190802528557. 
The Resource-Based View 
(RBV) assumes that each 
company accumulates 
resources and capabilities 
differentiating it from others 
to attain a competitive 
advantage. The authors set 
out to determine what 
influenced decisions for 
organizations to invest in or 
discontinue Continuous 
Management Training 
(CMT). Specifically, they 
wanted to determine if an 
organization’s projections of 
managerial turnover had a 
significant influence on this 
decision. 
The authors analyzed 
organizational behaviors of 
over 300 Spanish 
organizations and found that 
projections for voluntary 
turnover of managers are 
associated positively with 
past turnover experiences, 
with business markets prone 
to change, and with increased 
business risk. They found 
these projections to be 
negatively associated with 
existing social management 
systems, manager satisfaction 
and their level of 
specialization within the 
company.  No relationship 
was found between projected 
management turnover and the 
amount or intensity of 
training conducted. 
RBV has been successfully 
used in empirical studies as a 
conceptual framework to 
guide business decisions in 
the interest of improving an 
organization’s competitive 
advantage. 
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Ritual Scapegoating Multiple works use the construct 
conceptually in the succession-
performance literature. 
See literature review for 
definition and usage of this 
construct. 
  
Social Network 
Perspective 
Cao, Q., Maruping, L. M., & 
Takeuchi, R. (2006). Disentangling 
the effects of CEO turnover and 
succession. Organization Science, 
17, 563–576. DOI: 
10.1287/orsc.1060.0201. 
With the theoretical lens of 
social network perspective as 
a guide, the authors develop 
a framework to examine the 
impact of CEO turnover and 
succession on organizational 
capabilities. 
With this conceptual 
framework, the authors are 
able to identify conditions in 
which CEO turnover is 
expected to influence 
organizational discovery and 
future performance 
capacities. 
The developed framework 
may provide a tool to future 
researchers to understand 
contingencies by which CEO 
succession might moderate 
the performance impacts to 
organizations related to CEO 
turnover. 
Socialization Theory Fondas, N., & Wiersema, M. 
(1997). Changing of the guard: The 
influence of CEO socialization on 
strategic change. Journal of 
Management Studies, 34(4), 561-
584. 
The authors hypothesize that 
consideration of prior work 
experience and background 
of new CEOs allows for 
greater understanding of 
strategic change and 
competitive advantage. 
Findings indicate that a more 
critical view of desired 
industry and career 
experience, education and 
personal strengths of new 
CEOs can provide greater 
perspective of needed 
organizational change. This, 
along with awareness of 
situational demands and the 
make-up of top management 
teams can springboard new 
executives to successfully 
launch change initiatives. 
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Transformational 
Leadership 
Colbert, A. E., Kristof-
Brown, A. L., Bradley, 
B. H., & Barrick, M. R. 
(2008). CEO 
transformational 
leadership: The role of 
goal importance 
congruence in top 
management teams. 
Academy of 
Management Journal, 
51(1), 81–96. 
The authors aimed to better understand 
the relationship between 
transformational leadership and 
organizational goals and their 
associations with critical outcomes. 
Although research has begun to 
examine a transformational 
leadership–organizational performance 
link, little is known about the 
mechanisms that explain this 
relationship. The authors propose that 
CEO transformational leadership is 
associated with higher levels of goal 
congruence. Several characteristic of 
transformational leaders support this 
association. 
Using data from 94 top 
management teams (TMTs), the 
authors found that goal 
congruence between CEOs and 
vice presidents partially mediated 
the relationship of CEO leadership 
and individual attitudes. Their 
analyses suggested that at the 
organizational level, CEO 
transformational leadership was 
positively related to within-team 
goal congruence, which in turn 
was positively related to 
organizational performance. 
The authors aimed to extend 
previous research on 
transformational leadership 
to the organizational level of 
analysis. To fill this gap, they 
suggest that research must 
move beyond the leader-
follower relationship to 
examine how 
transformational CEOs relate 
to the top management teams 
and how that translates to 
improved performance. By 
focusing on transformational 
leadership within TMTs, the 
authors were able to examine 
CEO leadership and the 
associated organizational 
performance impact. 
Upper Echelons 
Theory 
Barron, J. M., Chulkov, 
D. V., & Waddell, G. R. 
(2011). Top 
management team 
turnover, CEO 
succession type, and 
strategic change. 
Journal of Business 
Research, 64(8), 904-
910. DOI: 
10.1016/j.jbusres.2010.
09.004. 
Upper echelons and power circulation 
theories are used to challenge prior 
research of executive turnover and 
organizational performance which 
typically focus solely on CEO 
turnover rather than that of top 
management teams (TMTs). The 
authors predict a failure to distinguish 
outsider succession which occurs 
concurrently with TMT turnover from 
that which does not, may explain the 
conflicting results discovered by 
Karaevli (2007). 
The authors found that 
discontinued operations associated 
with CEO departure occurred 
more frequently when other 
members of the TMT also left the 
organization. This finding is 
significant considering their 
assertion that previous empirical 
studies commonly limited analysis 
to only cases of CEO turnover 
especially in the finance and 
economics literatures. 
This research supports upper 
echelons theory and 
questions previous research 
and theory that fail to 
account for the significant 
organizational impact of 
other TMT turnover that may 
also be associated with CEO 
turnover. 
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Article Use Findings Future Implications 
Upper Echelons 
Theory 
(continued) 
Karaevli, A. (2007). Performance 
consequences of new CEO 
‘outsiderness': Moderating effects of 
pre- and post-succession contexts. 
Strategic Management Journal, 28, 
681–706. DOI: 10.1002/smj.589. 
The author attempts to 
reconcile inconsistent 
findings of the associations 
between CEO succession 
origin and organizational 
performance using upper 
echelon theory as a 
conceptual guide. 
A longitudinal study of 30 
years of data from three 
different industries in the 
U.S. revealed a strong 
association of executive 
tenure within an industry and 
performance during times of 
uncertainty supporting the 
upper echelon theory in this 
type of research. 
Findings supported a strong, 
experienced senior executive 
team particularly when CEO 
organization or industry 
tenure was limited. The 
author suggests future 
research on the influence of 
the executive team and 
particular dynamics that may 
affect organizational 
performance during 
succession events. 
Shen, W., & Cannella, A. A. (2002). 
Revisiting the performance 
consequences of CEO succession: 
The impacts of successor type, post-
succession senior executive 
turnover, and departing CEO tenure. 
Academy of Management Journal, 
45(4), 717-733. 
The authors use upper 
echelons theory to 
conceptualize that CEO 
turnover influences top 
management team and 
hypothesize that this turnover 
has significant impact on 
strategic decision making and 
organizational performance. 
The findings indicate that 
focusing on the CEO alone 
does not fully capture the 
performance consequences of 
CEO transition and an 
expanded focus on the top 
management team level and 
post-succession executive 
turnover is necessary. 
According to upper echelons 
theory and this author’s 
work, a firm's CEO alone is 
not responsible for shaping 
strategic decisions but in fact 
it is dependent on the entire 
management team. 
Waldman, D. A., Ramirez, G. C., 
House, R. J., & Puranam, P. (2001). 
Does leadership matter? CEO 
leadership attributes and. Academy 
of Management Journal, 44(1), 
134-143. 
The authors attempt to 
extend upper echelons 
theory beyond individual 
qualities and on to 
encompass such personal as 
charismatic leadership. 
The authors found a 
connection between top 
managers and firm 
outcomes dependent on the 
managers' charismatic 
leadership, under conditions 
of perceived uncertainty. 
Upper echelons theory 
suggests that specific 
characteristics and the 
leadership of top managers 
do indeed make a difference 
in strategy formulation and 
organizational performance. 
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Upper Echelons 
Theory 
(continued) 
Zhang, Y., & Rajagopalan, N. 
(2010b). Once an outsider, always 
an outsider? CEO origin, strategic 
change, and firm performance. 
Strategic Management Journal, 
31(3), 334-346. 
The authors examine 
relationships between the 
strategic change and 
resource allocation in firms 
led by inside and outside 
CEOs. 
Based on longitudinal data 
of 193 CEO transitions, the 
authors found a positive 
effect on firm performance 
when the level of strategic 
change was low and a 
negative effect on firm 
performance when the level 
of strategic change was 
high. They found that these 
effects were more 
pronounced for outside 
CEOs than for inside CEOs. 
The upper echelons 
perspective suggests that the 
difference between outside 
and inside CEOs in the 
relationship between the 
level of strategic change and 
firm performance exists. The 
authors found evidence that 
outsider succession has a 
complex non-linear 
relationship with firm 
performance and is heavily 
dependent on CEO tenure. 
Vicious- Circle Multiple works use the construct 
conceptually in the succession- 
performance literature. 
See literature review for 
definition and usage of this 
construct. 
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APPENDIX B 
 
PROPENSITY SCORE MATCHING ALGORITHM 
 
 
The propensity score is the probability of participating in an intervention based 
on observed, pre-treatment characteristics.  This score summarizes multiple pre-treatment 
characteristics in a single figure using a standard probability model.  PSM uses this 
propensity score to determine group membership (e.g., treatment and control) and to 
control for selection bias by matching scores of those who were exposed to the 
intervention to those who were not.  Therefore, the pre-treatment characteristics used 
must not be affected by the intervention.  Large sample sizes help to balance the groups 
when matching based on propensity scores is used. 
Matching and propensity score methods are often used in observational studies 
(i.e., ‘natural experiments’) to create control groups for the estimation of binary 
treatment effects (Dehejia & Wahba, 2002).  The main assumption is that selection on 
observable characteristics reduces conditions that interfere with the measurement of the 
treatment and allow for inferences about the causal effect of said treatment.  This scoring 
helps to reduce the dimensionality of covariates that may impact the treatment effect 
(Dehejia & Wahba, 2002).  A limitation of this method is that it relies heavily on a robust 
sample from which to find matching comparison subjects for every treatment subject to 
avoid those that go unmatched.  There are, at a minimum, four decisions to make in 
specifying a PSM algorithm. 
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 The first decision is whether or not to include an outcome of interest as part of the 
model.  Including an outcome covariate puts the PSM into its most commonly used form 
where the average treatment effect on the treated (ATT) is the basis for calculating 
propensities.  The expected value of ATT is defined as the difference between expected 
outcome values with and without treatment for those who actually participated in 
treatment.  There are numerous probability models that can be used to calculate the firms’ 
propensities (for example, Heckman (1979) logit, probit, and Bayesian approaches).  The 
logit model is well documented in the statistics literature and is amongst the simplest to 
use per Formula Two: 
 
(2) 
 
Pr(T1 = 1|X1) =                               
 
where Ti is the treatment status (i.e., CEO succession events versus no leadership change) 
and h(Xi) is the linear terms of the covariates on which potential matches are identified. 
The second decision is whether or not to allow control group subjects to be 
matched with multiple treatment group subjects (i.e., ‘with replacement’).  Matching 
with replacement minimizes the distance between matched treatment and control group 
subjects and has been shown to perform better than other alternatives (Dehejia & Wahba, 
2002).  Each treatment subject is matched to the closest control subject regardless is it 
has been previously matched.  Using this specification is beneficial in terms of bias 
reduction, but may lead to smaller than desired control group sizes.  In order to overcome 
  1 + eλh ( X i ) 
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this limitation, the third decision to make is whether or not to match multiple control 
subjects to treatment subjects (see 3-to-1 matching above).  By using multiple control 
group observations per subject, the precision of subsequent estimates is increased, but at 
the expense of introducing more bias.  The bias issue is tested in the aforementioned 
balancing hypothesis in the Methods Section. 
The last issue is the method of selecting comparison subjects.  The most common 
method in the literature is the nearest-neighbor approach, which matches the control 
subject to a treatment subject with the closest propensity score.  To perform nearest- 
neighbor matching, subjects in both the control and treatment groups are randomly 
ordered and then matched to subjects with the closest propensity score in the opposite 
group.  According to Dehejia and Wahba (2002), nearest-neighbor performed equally to 
other methods of selection. 
STATA was used for all the PSM functions.  The 11.2 version of the STATA 
software does not have a default command available for propensity score matching. 
Becker and Ichino (2002) have created the user-written routine pscore2 that implements 
the propensity score matching algorithm.  Users can install the pscore2 routine by typing 
findit pscore2 into the command window.  Download links for STATA automatically 
installing the routine are provided.  Documentation for this routine can be accessed by 
typing ‘help pscore2’. 
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APPENDIX C 
 
TECHNICAL DESCRIPTION OF THE SFE MODEL 
 
 
The original stochastic frontier production model developed by Aigner, Lovell, 
and Schmidt (1977) and Meeusen and van den Broeck (1977) was specified for cross- 
sectional data and involved a production function with a two component error term. 
These two components from the original model are regression residuals and account for 
inefficiency and other random error effects of a production function.  Using this model, 
inefficiency is delineated from random statistical regression error and a non-negative 
value (0-1) representing the ratio of actual to potential production remains.  This ratio 
quantifies inefficiency of an individual unit and is visually represented by their distance 
from a best practice frontier.  Formula Three represents an expression of this original 
model: 
 
(3) Yi = f(xiβ) + (Vi - Ui) i=1, ..., N 
 
 
where Yi is the production output that is a function of a vector of inputs (xi) and a vector 
of unknown coefficients to be estimated (β) plus Vi representing random regression 
effects and Ui representing the non-negative, production inefficiency term. 
SFE assumes that each organization potentially produces less than it might due to 
a degree of inefficiency.  Units with a value of one are considered completely efficient 
and have obtained the maximum feasible output.  Therefore, these units reside on the 
frontier of maximum efficiency.  Values less than one indicate a shortfall in efficiency 
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and a gap between the unit and the maximum feasible output. 
This inefficiency term is the focus of this, and other inefficiency studies in that 
researchers can manipulate or control for a variety of covariates and assess for their 
impact on efficiency.  For the past two decades, the original specification model has been 
used in a wide variety of empirical research applications.  During this time, the 
methodology has been extended to include cost production and other functional models 
and has been altered for use with longitudinal data and time-varying efficiencies as is the 
case with this study.  The trans-log extension of the Cobb-Douglas cost production 
function is used to create a cost efficiency frontier of hospitals as follows: 
 
(4) Yi = f(Ki, Li, β) + (Vi - Ui) i=1, ..., N 
 
 
where the vector of inputs (xi) is replaced with capital (Ki) and labor (Li). 
 
STATA was used for all the SFE functions and the 11.2 version of the software 
has specific features to estimate either technical or cost inefficiency effects.  These 
stochastic frontier estimators can be used with either cross-sectional or panel data and 
both the time-invariant and time-varying decay models. 
APPENDIX D 
 
TABLES 
 
 
Table 1. 
 
Descriptive Statistics of AHA Estimation Procedure Variables used for PSMa 
 
 
Variables 
Population 
Meana 
Population 
s.d. 
Sample 
Meanb 
Sample 
s.d 1 2 3 4 5 6 7 
Total facility 
admissions 7,718 9,154 7,454 8,564 1.00 
      Adjusted admissions 12,589 13,259 12,239 12,479 0.98 1.00 
     Total births 
(excluding fetal 
death) 836 1,291 833 1,307 0.83 0.83 1.00 
    
Total facility 
inpatient days 46,092 55,805 43,506 48,955 0.89 0.85 0.70 1.00 
   Full time 
equivalents 806 1,102 748 941 0.90 0.88 0.70 0.89 1.00 
  
Total surgical 
operations 5,953 7,630 5,858 7,180 0.87 0.88 0.69 0.76 0.81 1.00 
 Total outpatient 
visits 121,900 145,453 120,337 144,347 0.69 0.73 0.56 0.65 0.75 0.66 1.00 
Adjusted patient 
days 73,956 78,746 70,839 71,125 0.88 0.88 0.71 0.97 0.88 0.78 0.69 
aN = 3,941 
bn = 1,640 
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Table 2. 
 
 
Definitions and Descriptive Statistics for Hospital Cost Function Variables 
 
 
Name Variable Description n Meana Std. Dev. 
ADJADM Adjusted admissions 6349 10,087 12,696 
COTH Member of Council of Teaching Hospitals (binary) 6349 0.06 0.23 
DEPEXP Depreciation and interest expense 4767 836 1,291 
HITECH6 Hospitals that have at least 6 of 8 high-technology services (binary) 6349 0.52 0.50 
MNTEACH Not COTH but one or > full-time equivalent medical resident (binary) 6349 0.44 0.50 
OPDSURG Ratio of outpatient surgeries to total outpatient visits x 100 5912 4.48% 8.98 
PAYTOT Sum of employee benefits and other payroll expenses 6349 $38.3m $62.8m 
PK Price of capital 4766 $22,610 31,657 
PL Price of Labor 6345 $44,697 15,805 
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Table 3. 
 
 
Correlates of Efficiency Variables 
 
Name Variable Description 1. 2. 3. 4. 5. 6. 7. 8. 
LNNTC ln (normalized total cost) 1.00        
LNNPK ln (normalized price of capital) 0.36 1.00       
LNADJADM ln (adjusted admissions) 0.90 0.36 1.00      
LNVTOT ln (total outpatient visits) 0.79 0.34 0.82 1.00     
LNADJPD ln (adjusted patient days) 0.86 0.12 0.79 0.70 1.00    
OPDSURG  -0.03 0.12 -0.03 -0.21 -0.15 1.00   
HITECH6  0.45 0.28 0.51 0.45 0.34 0.02 1.00  
COTH  0.44 0.10 0.33 0.35 0.36 -0.04 0.13 1.00 
MNTEACH  0.02 0.00 0.01 -0.01 0.01 0.02 -0.18 -0.18 
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Table 4. 
 
Propensity Score Matching Results 
 
 
Variables Coefficient Std. Err. z P > |z| 
Intercept -2.542485 0.598045 -4.250000 0.000000 
Total facility admissions 0.000026 0.000020 1.300000 0.194000 
Total births (excluding fetal deaths) -0.000055 0.000067 -0.830000 0.408000 
Total facility inpatient days 0.000001 0.000002 0.720000 0.472000 
Full time total personnel 0.000000 0.000000 -0.300000 0.768000 
Total surgical operations -0.000102 0.000184 -0.550000 0.581000 
Total outpatient visits -0.000001 0.000015 -0.060000 0.956000 
Adjusted patient days 0.000000 0.000000 -0.700000 0.486000 
  Efficiency measure  0.508285  0.473742  1.070000  0.283000   
Number of observations 
Log-likelihood 
Prob. > chi-squared 
3,941 
-1,437.16 
0.637300 
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Table 5. 
 
 
Means, Standard Deviations and Correlations Used in SFE Model (Appendix C) 
 
 
 
Variables 
Sample 
Mean 
Sample 
s.d. 
 
9. 
 
10. 
 
11. 
 
12. 
 
13. 
 
14. 
Total facility expenses 
(excluding bad debt)(million $) 
 
119.00 
 
173.00 
 
1.00 
     
Depreciation expense (million $) 5.32 9.64 0.81 1.00     
Payroll expense (million $) 49.30 72.20 0.99 0.81 1.00    
Price of capital 26,208.10 34,332.13 0.23 0.44 0.21 1.00   
Price of labor 45,811.28 14,486.14 0.37 0.27 0.39 0.21 1.00  
Log of normalized total expenses 7.09 1.22 0.75 0.62 0.73 0.24 0.33 1.00 
Log of normalized price of capital -0.89 0.97 0.20 0.37 0.18 0.60 -0.01 0.32 
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Table 6. 
 
 
Longitudinal Stochastic Frontier Estimation Results 
 
# Variables Coefficient Std. Err. P > z 
 Intercept 2.6941 0.1901 0.0000 
 Natural log of normalized price of capital    
1. (LNNPK) 0.2108 0.0233 0.0000 
 Natural log of adjusted admissions    
2. (LNCMAJADM) -0.6988 0.0463 0.0000 
 Natural log of total outpatient visits    
3. (LNVTOT) 0.1026 0.0280 0.0000 
 Natural log of adjusted patient days    
4. (LNADJPD) 0.3916 0.0438 0.0000 
 
5. 
Ratio of outpatient surgeries to total 
outpatient visits (OPDSURG) 
 
0.7501 
 
0.0374 
 
0.0000 
6. HITECH6 indicator 0.0250 0.0066 0.0000 
7. Council of Teaching Hospitals (COTH) 0.3585 0.0117 0.0000 
8. Teaching hospital other than COTH 0.0860 0.0057 0.0000 
Squares     
2 and 2 LNCMAJADM * LNCMAJADM 0.1093 0.0038 0.0000 
3 and 3 LNVTOT * LNVTOT 0.0497 0.0012 0.0000 
4 and 4 LNADJPD * LNADJPD 0.0150 0.0037 0.0000 
Cross-products 
2 and 1 LNCMAJADM * LNNPK 0.0014 0.0039 0.6950 
3 and 1 LNVTOT * LNNPK -0.0038 0.0027 0.1520 
4 and 1 LNADJPD * LNNPK -0.0065 0.0035 0.0610 
2 and 3 LNCMAJADM * LNVTOT -0.0719 0.0044 0.0000 
2 and 4 LNCMAJADM * LNADJPD 0.0038 0.0061 0.5230 
  3 and 4  LNVTOT * LNADJPD  -0.0373  0.0036 
 0.0000   
γ 0.7259 0.0103 
Log-likelihood -7390.414 0.0000 
Wald chi-squared 20,783.40  
Number of observations 1,640  
Number of iterations 8  
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Table 7. 
 
 
Null Hypotheses Testing for Diagnostics of Appropriate Analytical Modeling 
 
Null 
Hypothesis Test Statistic p-value Decision Implication 
H0: В = 0 В = 7075.942 >0.000 Reject 
Use trans-log model 
rather than Cobb-Douglas 
H0: γ = 0 γ = 2400 >0.000 Reject 
Use SFE rather than 
OLS 
H0: µ = 0 ** ** Reject 
Use half-normal 
distribution rather than 
turncated half-normal 
**The truncated model fails to converge 
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Table 8. 
 
Longitudinal Regression Results 
 
  
Fixed effects regression Random effects regression 
Coefficient Std. Err. P > t Coefficient Std. Err. P > z 
Intercept 4.8364 0.0004 0.0000 4.8464 0.0367 0.0000 
Outsider's 
Intercept 
0.1394 0.0018 0.0000 0.0122 0.0018 0.0000 
Insider's 
Intercept 
0.0638 0.0041 0.0020 0.0127 0.0041 0.0020 
Time 0.1183 0.0003 0.0000 -0.0024 0.0008 0.0280 
Outsider's 
slope 
-0.3688 0.1500 0.0090 -0.0024 0.0008 0.0280 
Insider's 
slope 
-0.1606 0.3476 0.1520 -0.0014 0.0018 0.5910 
sigma_u 1.4867 
 
  1.4845 
  sigma_e 0.0217 
 
  0.0217 
  Rho 0.9998     0.9998     
Number of 
groups 1,640 
 
  1,640 
  F 3905.3 
 
  
   Wald 
chi2(5) 
  
  19514.22 
  Prob > F 0.0000     0.0000     
Use the Fixed Effects Model (Hausman test fails to reject the null at p= 0.0834) 
 
Table 9. 
 
Frontier Estimation Results in Hospitals Experiencing Leadership Change 
 
 
Variables Coefficient Std. Err. z P > |z| 95% Conf. Interval 
 
Base line poor performance a -0.361 0.153 -2.36 0.018 -0.661 -0.061 
Negative jolt after change b -0.352 0.180 -1.96 0.051 -0.705 0.000 
 
 
 
 
 
 
 
n = 734 
a FY2003 
b FY 2005 
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Year Meana s.d. Meana s.d. 
2003 0.212 0.085 0.819 0.060 
2004 0.058 0.014 0.945 0.013 
2005b 0.127cd 0.030 0.884cd 0.025 
2006 0.184cd 0.059 0.840cd 0.044 
2007 0.055d 0.008 0.947d 0.008 
 
Table 10. 
 
Descriptive Statistics of Efficiency Frontier Estimates 
In 
Hospitals Experiencing Leadership Changea 
 
Inefficiency 
(Non-random error) 
 
Efficiency 
 
 
 
 
 
 
 
 
 
 
a   n = 734 
b   year of change 
c   more inefficient / less efficient than previous 
year 
d   improved over baseline 
Table 11. 
 
Longitudinal Panel Analysis Results (FY2003-FY2007) 
 
 
Variables Coefficient Std. Err. z P > |z| 95% Conf. Interval 
 
General trend in efficiency of sample; 
Gap to the frontier is closing a 
 
-0.180 
 
0.078 
 
-2.33 
 
0.020 
 
-0.332 
 
-0.028 
CEO change intervention moved       
away from the frontier b 0.044 0.018 2.36 0.018 0.007 0.080 
 
 
 
 
 
 
 
a N = 1,640 
b n = 734 
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